molecule_chembl_id,target_chembl_id,target_pref_name,assay_description,smiles,readout,standard_value,standard_units,pActivity
CHEMBL81485,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity for human cloned Alpha-2A adrenergic receptor,CNCC1CC2c3ccccc3Cc3ccccc3N2O1,IC50,436.52,nM,6.35999585346894
CHEMBL83658,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity for human cloned Alpha-2A adrenergic receptor,CN(C)CC1CC2c3ccccc3Cc3ccccc3N2O1,IC50,371.54,nM,6.429994423238211
CHEMBL6437,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity for human cloned Alpha-2A adrenergic receptor,CN1CCN2c3ccccc3Cc3ccccc3C2C1,IC50,20.89,nM,7.680061560019691
CHEMBL83658,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity against Alpha-2A adrenergic receptor,CN(C)CC1CC2c3ccccc3Cc3ccccc3N2O1,IC50,371.54,nM,6.429994423238211
CHEMBL315772,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity against Alpha-2A adrenergic receptor,CN(C)CC1CC2c3ccccc3Cc3ccc(Cl)cc3N2O1,IC50,478.63,nM,6.32000008377078
CHEMBL133455,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibitory concentration required against Alpha-2A adrenergic receptor using [3H]clonidine radioligand,C[C@H](N)Cc1c[nH]c2ccc3c(c12)CCCO3,IC50,19000.0,nM,4.721246399047171
CHEMBL138809,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of idazoxane binding to noradrenaline alpha-2 receptor,COC1OC2(CCN(Cc3ccccc3)CC2)c2ccccc21,IC50,6200.0,nM,5.207608310501746
CHEMBL138458,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of idazoxane binding to noradrenaline alpha-2 receptor,COC1Cc2ccccc2C2(CCN(CCCc3ccccc3)CC2)O1,IC50,3100.0,nM,5.508638306165727
CHEMBL141209,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of idazoxane binding to noradrenaline alpha-2 receptor,COC1Cc2ccccc2C2(CCN(Cc3ccccc3)CC2)O1,IC50,3000.0,nM,5.522878745280337
CHEMBL162436,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.,O=c1c(CCN2CCc3oc4ccccc4c3C2)c(Cc2ccccc2)nc2ccccn12,IC50,2.188,nM,8.659952682338607
CHEMBL164612,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.,Cc1nc2ccccn2c(=O)c1CCN1CCc2oc3c(Cl)cccc3c2C1,IC50,0.8913,nM,9.049976093476673
CHEMBL162490,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.,COc1cccn2c(=O)c(CCN3CCc4oc5ccccc5c4C3)c(C)nc12,IC50,0.2951,nM,9.53003079050004
CHEMBL351483,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.,Cc1nc2ccc(Cl)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1,IC50,0.2138,nM,9.669992299127241
CHEMBL165677,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.,Cc1nc2ccccn2c(=O)c1CCN1CCc2oc3ccc(Cl)cc3c2C1,IC50,3.89,nM,8.410050398674292
CHEMBL165350,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.,Cc1nc2ccc(Br)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1,IC50,0.3548,nM,9.45001638884031
CHEMBL165796,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.,Cc1ccn2c(=O)c(CCN3CCc4oc5ccccc5c4C3)c(C)nc2c1,IC50,0.4467,nM,9.349984047528162
CHEMBL162058,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.,COc1cc2nc(C)c(CCN3CCc4oc5ccccc5c4C3)c(=O)n2cc1OC,IC50,3.548,nM,8.45001638884031
CHEMBL162501,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.,Cc1nc2ccccn2c(=O)c1CCN1CCc2oc3ccccc3c2C1,IC50,0.5495,nM,9.260032303240491
CHEMBL165776,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.,Cc1nc2ccccn2c(=O)c1CCCN1CCc2oc3ccccc3c2C1,IC50,10.23,nM,7.99012436628784
CHEMBL162826,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.,Cc1nc2c(O)cccn2c(=O)c1CCN1CCc2oc3ccccc3c2C1,IC50,0.6918,nM,9.160019442321657
CHEMBL10316,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.,c1ccc2c(c1)OCC(C1=NCCN1)O2,IC50,8.318,nM,8.079981083971084
CHEMBL163247,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.,Cc1nc2c(Cl)cc(Cl)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1,IC50,0.5888,nM,9.230032198670557
CHEMBL162232,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.,Cc1cc(C)n2c(=O)c(CCN3CCc4oc5ccccc5c4C3)c(C)nc2c1,IC50,0.3388,nM,9.47005659834133
CHEMBL351200,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.,Cc1nc2c(C)cccn2c(=O)c1CCN1CCc2oc3ccccc3c2C1,IC50,0.6026,nM,9.219970872662662
CHEMBL162147,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.,Cc1nc2c(Cl)cc(C(F)(F)F)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1,IC50,1.175,nM,8.929962133392245
CHEMBL162682,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.,Cc1nc2ccc(I)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1,IC50,0.2399,nM,9.61996975203217
CHEMBL165181,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.,Cc1nc2ccccn2c(=O)c1CCN1CCc2sc3ccccc3c2C1,IC50,1.738,nM,8.759950227887352
CHEMBL654,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.,CN1CCN2c3ncccc3Cc3ccccc3C2C1,IC50,85.11,nM,7.070019409484486
CHEMBL162370,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.,Cc1ccc2nc(C)c(CCN3CCc4oc5ccccc5c4C3)c(=O)n2c1,IC50,0.3467,nM,9.460046158343603
CHEMBL163190,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.,Cc1nc2cccc(C)n2c(=O)c1CCN1CCc2oc3ccccc3c2C1,IC50,0.2884,nM,9.540004743952608
CHEMBL84931,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity for human cloned Alpha-2A adrenergic receptor,CN(C)CC1CC2c3ccccc3Cc3ccc(F)cc3N2O1,IC50,501.19,nM,6.299997602857746
CHEMBL315772,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity for human cloned Alpha-2A adrenergic receptor,CN(C)CC1CC2c3ccccc3Cc3ccc(Cl)cc3N2O1,IC50,478.63,nM,6.32000008377078
CHEMBL83658,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity for human cloned Alpha-2A adrenergic receptor,CN(C)CC1CC2c3ccccc3Cc3ccccc3N2O1,IC50,371.54,nM,6.429994423238211
CHEMBL346389,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of [3H]- MK-912 binding against human recombinant Alpha-2A adrenergic receptor,O=C1COc2cc(CN3CCN(c4ccc(Cl)cc4)CC3)ccc2N1,IC50,1100.0,nM,5.958607314841775
CHEMBL180003,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells,CN(C)c1nc(N[C@H]2CC[C@@H](NS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12,IC50,57.0,nM,7.2441251443275085
CHEMBL360081,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells,COc1cc(OC)cc(C(=O)N[C@H]2CC[C@@H](Nc3nc(N(C)C)c4ccccc4n3)CC2)c1,IC50,71.0,nM,7.1487416512809245
CHEMBL181184,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells,CN(C)c1nc(NC2CCC(NC(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12,IC50,390.0,nM,6.4089353929735005
CHEMBL359510,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells,CN(C)c1nc(N[C@H]2CC[C@@H](NC(=O)c3cccc(Br)c3)CC2)nc2ccccc12,IC50,63.0,nM,7.200659450546418
CHEMBL367355,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells,CN(C)c1nc(NCC2CCC(CNC(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12,IC50,9.9,nM,8.00436480540245
CHEMBL360117,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells,CN(C)c1nc(NCC2CCC(CNCc3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12,IC50,31.0,nM,7.508638306165727
CHEMBL178084,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells,CN(C)c1nc(NC2CCC(NCc3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12,IC50,170.0,nM,6.769551078621726
CHEMBL180962,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells,Cc1cccc(C(=O)N[C@H]2CC[C@@H](Nc3nc(N(C)C)c4ccccc4n3)CC2)c1,IC50,110.0,nM,6.958607314841775
CHEMBL181632,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells,CN(C)c1nc(N[C@H]2CC[C@@H](NC(=O)c3cccc(C(F)(F)F)c3)CC2)nc2ccccc12,IC50,60.0,nM,7.221848749616356
CHEMBL182235,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells,CN(Cc1ccc(Br)cc1OC(F)(F)F)CC1CCC(CNc2nc(N(C)C)c3ccccc3n2)CC1,IC50,44.0,nM,7.356547323513812
CHEMBL360876,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells,CN(C)c1nc(NC2CCN(Cc3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12,IC50,520.0,nM,6.2839966563652006
CHEMBL362193,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells,CN(C)c1nc(N[C@H]2CC[C@@H](NC(=O)c3cccc(F)c3)CC2)nc2ccccc12,IC50,130.0,nM,6.886056647693163
CHEMBL181099,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells,CN(C)c1nc(N[C@H]2CC[C@@H](NC(=O)c3cccc(C#N)c3)CC2)nc2ccccc12,IC50,150.0,nM,6.823908740944319
CHEMBL181393,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells,CN(C)c1nc(NC2CCC(CNC(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12,IC50,570.0,nM,6.2441251443275085
CHEMBL537846,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells,CN(C)c1nc(NC[C@H]2CC[C@H](CNS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12.Cl,IC50,7.7,nM,8.113509274827518
CHEMBL181466,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells,CN(C)c1nc(NC2CCC(CNCc3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12,IC50,360.0,nM,6.443697499232712
CHEMBL181217,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells,CN(C)c1nc(N[C@H]2CC[C@@H](CNS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12,IC50,130.0,nM,6.886056647693163
CHEMBL361442,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells,CN(C)c1nc(N[C@H]2CC[C@@H](NC(=O)c3ccc(F)cc3)CC2)nc2ccccc12,IC50,150.0,nM,6.823908740944319
CHEMBL179878,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells,CN(C)c1nc(N[C@H]2CC[C@@H](NC(=O)c3cccc(Cl)c3)CC2)nc2ccccc12,IC50,76.0,nM,7.119186407719209
CHEMBL181383,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells,CN(C)c1nc(N[C@H]2CC[C@@H](NC(=O)c3cccc([N+](=O)[O-])c3)CC2)nc2ccccc12,IC50,97.0,nM,7.013228265733755
CHEMBL360671,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells,CN(C)c1nc(NC2CCN(S(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12,IC50,170.0,nM,6.769551078621726
CHEMBL182150,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells,CN(C)c1nc(N[C@H]2CC[C@@H](NC(=O)c3ccc(F)c(F)c3)CC2)nc2ccccc12,IC50,260.0,nM,6.585026652029182
CHEMBL362400,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells,CN(C)c1nc(N[C@H]2CC[C@@H](NC(=O)c3ccc(Cl)c(Cl)c3)CC2)nc2ccccc12,IC50,47.0,nM,7.327902142064282
CHEMBL360159,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells,CN(C)c1nc(N[C@H]2CC[C@@H](NC(=O)c3ccc(F)c(F)c3F)CC2)nc2ccccc12,IC50,200.0,nM,6.698970004336019
CHEMBL181727,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells,CN(C)c1nc(NCC2CCC(CN(C)S(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12,IC50,34.0,nM,7.468521082957745
CHEMBL193438,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912,CN(C)c1nc(NCC2CCC(CNS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12,IC50,7.7,nM,8.113509274827518
CHEMBL17645,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912,Nc1nc(NC[C@H]2CC[C@H](CNS(=O)(=O)c3cccc4ccccc34)CC2)nc2ccccc12,IC50,97.0,nM,7.013228265733755
CHEMBL192266,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912,Nc1nc(NCC2CCC(CNS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12,IC50,100.0,nM,7.0
CHEMBL425012,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912,O=S(=O)(NCC1CCC(CNc2ncc3ccccc3n2)CC1)c1ccc(Br)cc1OC(F)(F)F,IC50,140.0,nM,6.853871964321762
CHEMBL195123,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912,CN(C)c1nc(NCC2CCC(CNS(C)(=O)=O)CC2)nc2ccccc12,IC50,86.0,nM,7.0655015487564325
CHEMBL193666,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912,CCCCS(=O)(=O)NCC1CCC(CNc2nc(N(C)C)c3ccccc3n2)CC1,IC50,58.0,nM,7.236572006437063
CHEMBL193970,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912,CN(C)c1nc(NCC2CCC(NS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12,IC50,21.0,nM,7.6777807052660805
CHEMBL194602,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912,CN(C)c1nc(NC2CCC(CNS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12,IC50,110.0,nM,6.958607314841775
CHEMBL193771,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912,CN(C)c1nc(NC2CCC(NS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12,IC50,47.0,nM,7.327902142064282
CHEMBL195810,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912,O=S(=O)(NCC1CCC(Nc2ncc3ccccc3n2)CC1)c1ccc(Br)cc1OC(F)(F)F,IC50,130.0,nM,6.886056647693163
CHEMBL195346,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912,O=S(=O)(NC1CCC(Nc2ncc3ccccc3n2)CC1)c1ccc(Br)cc1OC(F)(F)F,IC50,57.0,nM,7.2441251443275085
CHEMBL194173,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912,CN(C)c1nc(NCC2CCN(S(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12,IC50,5.6,nM,8.2518119729938
CHEMBL360671,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912,CN(C)c1nc(NC2CCN(S(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12,IC50,170.0,nM,6.769551078621726
CHEMBL493091,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]MK912 from human cloned adrenergic alpha-2a receptor,CN(C)CCCOc1ccc(CCNC(=O)c2cc(Br)c[nH]2)cc1Br,IC50,185.0,nM,6.732828271596986
CHEMBL461571,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of radioligand from adrenergic alpha2A receptor,Cc1c(C(=O)c2ccc(Cl)cc2)c2ccc(OC(F)(F)F)cc2n1Cc1cccc(O[C@H](C)C(=O)O)c1,IC50,1650.0,nM,5.782516055786093
CHEMBL257991,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of adrenergic alpha2A receptor,O=C(Nc1ccccc1-c1cn2c(CN3CCNCC3)csc2n1)c1cnc2ccccc2n1,IC50,2830.0,nM,5.548213564475709
CHEMBL470432,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 form human recombinant alpha2A adrenergic receptor,CCCN1CCC(COc2nc3scc(C)c3n3cccc23)CC1,IC50,891.25,nM,6.050000457140078
CHEMBL475969,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of human adrenergic alpha2A receptor,CC1=C(CCN(C)C)c2cc(S(=O)(=O)Nc3cccc4ccccc34)ccc2C1,IC50,1097.0,nM,5.959793372425288
CHEMBL477650,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of human adrenergic alpha2A receptor,CC1=C(CCN(C)C)c2cc(NS(=O)(=O)c3csc4ccccc34)ccc2C1,IC50,700.0,nM,6.154901959985743
CHEMBL584606,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]MK9112 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cells after 60 mins,C=Cc1c(C)nn(CCCN2CCN(c3ccc(C)cc3)CC2)c(=O)c1N,IC50,320.0,nM,6.494850021680094
CHEMBL537669,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]MK9112 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cells after 60 mins,COC(=O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O.Cl,IC50,3.67,nM,8.435333935747911
CHEMBL584554,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of adrenergic alpha2A receptor,CCN(CC)C(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C(=O)Nc2ccccc2)C1,IC50,1930.0,nM,5.714442690992226
CHEMBL182150,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]MK-912 from human adrenergic alpha2A receptor,CN(C)c1nc(N[C@H]2CC[C@@H](NC(=O)c3ccc(F)c(F)c3)CC2)nc2ccccc12,IC50,104.0,nM,6.982966660701219
CHEMBL567791,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]MK-912 from human adrenergic alpha2A receptor,Cc1cc(N(C)C)nc(N[C@H]2CC[C@@H](NC(=O)c3ccc(Cl)cc3)CC2)n1,IC50,730.0,nM,6.136677139879544
CHEMBL568400,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]MK-912 from human adrenergic alpha2A receptor,Cc1cc(N(C)C)nc(N[C@H]2CC[C@@H](NC(=O)c3ccc(Cl)c(Cl)c3)CC2)n1,IC50,130.0,nM,6.886056647693163
CHEMBL583014,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]MK-912 from human adrenergic alpha2A receptor,Cc1cc(N(C)C)nc(N[C@H]2CC[C@@H](NC(=O)c3cc(C(F)(F)F)cc(C(F)(F)F)c3)CC2)n1,IC50,200.0,nM,6.698970004336019
CHEMBL567993,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]MK-912 from human adrenergic alpha2A receptor,Cc1cccc(C(=O)N[C@H]2CC[C@@H](Nc3ncc(C)c(N(C)C)n3)CC2)c1,IC50,580.0,nM,6.236572006437063
CHEMBL578170,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]MK-912 from human adrenergic alpha2A receptor,Cc1ccc(C(=O)N[C@H]2CC[C@@H](Nc3ncc(C)c(N(C)C)n3)CC2)cc1,IC50,1770.0,nM,5.752026733638193
CHEMBL565551,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]MK-912 from human adrenergic alpha2A receptor,Cc1cnc(N[C@H]2CC[C@@H](NC(=O)c3ccc(F)cc3)CC2)nc1N(C)C,IC50,470.0,nM,6.327902142064282
CHEMBL577912,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]MK-912 from human adrenergic alpha2A receptor,Cc1cnc(N[C@H]2CC[C@@H](NC(=O)c3ccc(Cl)cc3)CC2)nc1N(C)C,IC50,1590.0,nM,5.798602875679549
CHEMBL577904,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]MK-912 from human adrenergic alpha2A receptor,Cc1cnc(N[C@H]2CC[C@@H](CNC(=O)c3ccc(F)c(F)c3)CC2)nc1N(C)C,IC50,210.0,nM,6.6777807052660805
CHEMBL566075,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]MK-912 from human adrenergic alpha2A receptor,Cc1cnc(N[C@H]2CC[C@@H](CNC(=O)c3cc(C(F)(F)F)cc(C(F)(F)F)c3)CC2)nc1N(C)C,IC50,310.0,nM,6.508638306165727
CHEMBL605938,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of human alpha-2a adrenergic receptor,O=S(=O)(Nc1ccc2c(c1)C(C1CCNC1)=CC2)c1c(Cl)nc2sccn12,IC50,891.0,nM,6.050122295963125
CHEMBL593889,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of human alpha-2a adrenergic receptor,CC1=C(C2CCCN(C)C2)c2cc(NS(=O)(=O)c3c(Cl)nc4sccn34)ccc2C1,IC50,1213.0,nM,5.916139199133427
CHEMBL1083787,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity to adrenergic alpha2A receptor,O=C(NCCCCN1CCCCC1)Nc1ccc(-c2ccc(F)cc2)nc1,IC50,35000.0,nM,4.455931955649724
CHEMBL221753,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1.[Cl-],IC50,3102.0,nM,5.508358206522414
CHEMBL493,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12,IC50,15.0,nM,7.823908740944319
CHEMBL990,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CN(Cc1ccc(C(C)(C)C)cc1)Cc1cccc2ccccc12,IC50,3644.3,nM,5.438385878959815
CHEMBL508112,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),c1ccc2sc(SSc3nc4ccccc4s3)nc2c1,IC50,899.0,nM,6.046240308266771
CHEMBL290106,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),Oc1c(Cl)cc(Cl)cc1Sc1cc(Cl)cc(Cl)c1O,IC50,3824.0,nM,5.417482116395938
CHEMBL1201203,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CN1[C@@H]2CC[C@H]1C[C@@H](OC(c1ccccc1)c1ccccc1)C2,IC50,544.0,nM,6.26440110030182
CHEMBL296419,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1,IC50,4846.0,nM,5.314616590198513
CHEMBL844,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),Brc1c(NC2=NCCN2)ccc2nccnc12,IC50,298.0,nM,6.525783735923745
CHEMBL1113,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2,IC50,1314.0,nM,5.8814046347762385
CHEMBL1381098,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),S=C=Nc1cccc2ccccc12,IC50,6272.0,nM,5.202593950323617
CHEMBL153062,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CCCCCCCCCc1ccc(O)cc1,IC50,6780.0,nM,5.168770306132936
CHEMBL195437,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CCCCCCCCc1ccc(O)cc1,IC50,14288.0,nM,4.845028558455529
CHEMBL633,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1,IC50,312.0,nM,6.505845405981557
CHEMBL1403281,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12,IC50,7.946,nM,8.099851439280656
CHEMBL1365675,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),Cc1ccc(/N=C/N(C)/C=N/c2ccc(C)cc2C)c(C)c1,IC50,926.9,nM,6.032967117841298
CHEMBL629,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CN(C)CCC=C1c2ccccc2CCc2ccccc21,IC50,351.0,nM,6.454692883534176
CHEMBL311469,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CC(=O)Nc1ccc2c(c1)Cc1ccccc1-2,IC50,21061.0,nM,4.676521011869841
CHEMBL1491,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl,IC50,602.0,nM,6.220403508742176
CHEMBL1289,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),Clc1cc(Cl)c(OCC#CI)cc1Cl,IC50,1222.0,nM,5.912928794093465
CHEMBL305660,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1,IC50,831.6,nM,6.080085519340568
CHEMBL64894,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1.[Cl-],IC50,536.0,nM,6.270835210307229
CHEMBL808,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1,IC50,4325.0,nM,5.3640138881991675
CHEMBL679,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CNC[C@H](O)c1ccc(O)c(O)c1,IC50,737.0,nM,6.132532512140949
CHEMBL420,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),N=C(N)N/N=C/c1c(Cl)cccc1Cl,IC50,41.0,nM,7.3872161432802645
CHEMBL496,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),Oc1c(Cl)cc(Cl)c(Cl)c1Cc1c(O)c(Cl)cc(Cl)c1Cl,IC50,5496.5,nM,5.259913767694496
CHEMBL50588,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21,IC50,38.0,nM,7.42021640338319
CHEMBL862,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),N=C(N)NC(=O)Cc1c(Cl)cccc1Cl,IC50,134.0,nM,6.872895201635192
CHEMBL1385840,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12,IC50,6.296,nM,8.200935280648991
CHEMBL30008,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),Fc1ccc(C(c2ccc(F)cc2)N2CCN(C/C=C/c3ccccc3)CC2)cc1,IC50,581.0,nM,6.235823867609669
CHEMBL119443,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),C[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1,IC50,1680.0,nM,5.774690718274137
CHEMBL726,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,IC50,215.0,nM,6.667561540084394
CHEMBL442,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)C[C@H]21,IC50,2.123,nM,8.673050005834002
CHEMBL1108,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1,IC50,2965.0,nM,5.527975302299719
CHEMBL54,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,IC50,4973.0,nM,5.303381540767775
CHEMBL134,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),Clc1cccc(Cl)c1NC1=NCCN1,IC50,280.0,nM,6.552841968657781
CHEMBL7002,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CC1(COc2ccc(CC3SC(=O)NC3=O)cc2)CCCCC1,IC50,16551.0,nM,4.781175761322598
CHEMBL1729,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CCCOc2ccc(F)cc2)CC1OC,IC50,1777.0,nM,5.750312572194698
CHEMBL1628227,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CN(C)CCC=C1c2ccccc2COc2ccccc21,IC50,1335.0,nM,5.874518734299405
CHEMBL648,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CN1CCN(C(c2ccccc2)c2ccccc2)CC1,IC50,1551.0,nM,5.809388202186395
CHEMBL1255837,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O.CS(=O)(=O)O,IC50,1.993,nM,8.700492701299513
CHEMBL1732,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21,IC50,1.032,nM,8.986320302708808
CHEMBL964,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CCN(CC)C(=S)SSC(=S)N(CC)CC,IC50,4904.0,nM,5.309449538489641
CHEMBL104,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1,IC50,11886.0,nM,4.9249642740778095
CHEMBL411,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1,IC50,14127.0,nM,4.849950054837615
CHEMBL954,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CCN(CC)CCOc1ccc(/C(=C(/Cl)c2ccccc2)c2ccccc2)cc1,IC50,936.0,nM,6.028724151261895
CHEMBL42,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,IC50,90.0,nM,7.045757490560675
CHEMBL1200406,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CN(C)CCOC(c1ccccc1)c1ccccc1.Cn1c(=O)c2[nH]c(Cl)nc2n(C)c1=O,IC50,4313.0,nM,5.365220541854049
CHEMBL71,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21,IC50,352.0,nM,6.453457336521868
CHEMBL43064,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),C(=C/c1ccccc1)\CN1CCN(C(c2ccccc2)c2ccccc2)CC1,IC50,444.0,nM,6.35261702988538
CHEMBL219916,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),O=c1[nH]c2ccccc2n1CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1,IC50,2740.0,nM,5.562249437179612
CHEMBL415,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21,IC50,1414.0,nM,5.84955059053912
CHEMBL516,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CN1CCC(=C2c3ccccc3C=Cc3ccccc32)CC1,IC50,283.0,nM,6.548213564475709
CHEMBL1479,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C,IC50,18328.0,nM,4.736884923818659
CHEMBL1201353,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CN(C)CC[C@@H](c1ccc(Cl)cc1)c1ccccn1,IC50,20333.0,nM,4.691798539348924
CHEMBL723,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12,IC50,106.0,nM,6.97469413473523
CHEMBL334255,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CCCCCCCCCCCCCCCC[n+]1ccccc1.[Br-],IC50,242.0,nM,6.616184634019569
CHEMBL1626,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1,IC50,183.0,nM,6.73754891026957
CHEMBL762,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1,IC50,23.0,nM,7.638272163982407
CHEMBL55,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,IC50,1375.0,nM,5.861697301833718
CHEMBL564,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CN(C)CCCN1c2ccccc2Sc2ccccc21,IC50,337.0,nM,6.4723700991286615
CHEMBL643,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CC(CN1c2ccccc2Sc2ccccc21)N(C)C,IC50,681.0,nM,6.166852888087215
CHEMBL531,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CCCN1C[C@H](CSC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21,IC50,264.0,nM,6.578396073130168
CHEMBL2,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC,IC50,2638.0,nM,5.5787252087896535
CHEMBL511,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),COc1ccc(CN(CCN(C)C)c2ccccn2)cc1,IC50,2976.0,nM,5.526367073126159
CHEMBL715,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1,IC50,541.0,nM,6.266802734893431
CHEMBL597,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),Cc1ccc(N(CC2=NCCN2)c2cccc(O)c2)cc1,IC50,6.0,nM,8.221848749616356
CHEMBL1909072,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),NC(=O)C1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,IC50,66.0,nM,7.180456064458131
CHEMBL1262,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1,IC50,4082.7,nM,5.3890525312039435
CHEMBL445,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CNCCC=C1c2ccccc2CCc2ccccc21,IC50,732.0,nM,6.135488918941608
CHEMBL716,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1,IC50,2491.4,nM,5.603556539887572
CHEMBL728,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,IC50,169.0,nM,6.772113295386326
CHEMBL7568,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12,IC50,2280.0,nM,5.642065152999546
CHEMBL900,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),Cc1ccccc1C(OCCN(C)C)c1ccccc1,IC50,2156.0,nM,5.666351243485298
CHEMBL21731,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CNCCCC12CCC(c3ccccc31)c1ccccc12,IC50,1824.0,nM,5.738975166007602
CHEMBL86,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC,IC50,2721.0,nM,5.565271458220242
CHEMBL6437,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CN1CCN2c3ccccc3Cc3ccccc3C2C1,IC50,43.0,nM,7.366531544420413
CHEMBL91,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1,IC50,3966.0,nM,5.401647290130716
CHEMBL1200633,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2.CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(CC[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@]54O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O,IC50,5839.8,nM,5.233602026240979
CHEMBL1221512,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CC[C@H](C)[C@@H](CO[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCS(C)(=O)=O)C(=O)OC(C)C)NC[C@@H](N)CS,IC50,432.0,nM,6.364516253185088
CHEMBL19215,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CN1C[C@H](CNC(=O)OCc2ccccc2)C[C@@H]2c3cccc4c3c(cn4C)C[C@H]21,IC50,58.0,nM,7.236572006437063
CHEMBL157138,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CCN(CC)C(=O)N[C@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1,IC50,0.31,nM,9.508638306165727
CHEMBL787,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)O)CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1,IC50,3919.0,nM,5.406824736521898
CHEMBL1909065,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CO[C@@H]1[C@@H](OC)[C@H](C)[C@@](O)(CC(=O)O)O[C@H]1[C@H](C)[C@H]1O[C@@]2(CC[C@@](C)([C@H]3CC[C@@](C)([C@@H]4O[C@@H]([C@H]5O[C@](C)(O)[C@H](C)C[C@@H]5C)C[C@@H]4O[C@@H]4C[C@H](OC)[C@@H](OC)[C@H](C)O4)O3)O2)C[C@H](O)[C@H]1C,IC50,180.0,nM,6.7447274948966935
CHEMBL1411979,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CN(C)CCN(Cc1cccs1)c1ccccn1,IC50,1165.0,nM,5.933674074637962
CHEMBL60889,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CCOc1cc(N)c(Cl)cc1C(=O)NCC1CN(Cc2ccc(F)cc2)CCO1,IC50,3679.4,nM,5.434222995982492
CHEMBL1201356,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1,IC50,1590.0,nM,5.798602875679549
CHEMBL157101,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,IC50,19783.0,nM,4.703707849005139
CHEMBL395110,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1,IC50,1456.0,nM,5.836838625022981
CHEMBL1670,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),Clc1ccc(C(c2ccccc2Cl)C(Cl)Cl)cc1,IC50,7347.0,nM,5.133889960155623
CHEMBL1065,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4c3c(cn4C)C[C@H]2N(C)C1,IC50,1631.0,nM,5.787546038959724
CHEMBL534,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CN1CCC(=C2c3ccccc3CC(=O)c3sccc32)CC1,IC50,2187.0,nM,5.660151216962364
CHEMBL119385,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl,IC50,34167.0,nM,4.466393152329222
CHEMBL621,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12,IC50,909.0,nM,6.041436116778033
CHEMBL6966,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC,IC50,579.0,nM,6.237321436272564
CHEMBL15245,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),COC(=O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O,IC50,6.151,nM,8.211054272976252
CHEMBL611,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC,IC50,13832.0,nM,4.8591150197341335
CHEMBL479,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2,IC50,133.0,nM,6.876148359032914
CHEMBL972,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),C#CCN(C)[C@H](C)Cc1ccccc1,IC50,1798.0,nM,5.74521031260279
CHEMBL1221,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),Clc1ccc(CSC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1,IC50,4043.0,nM,5.393296258666325
CHEMBL83,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CC/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,IC50,1935.0,nM,5.71331903064507
CHEMBL84158,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CCN(CC)CCNC(=O)c1cc(S(C)(=O)=O)ccc1OC,IC50,2078.0,nM,5.6823544567788415
CHEMBL822,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CN(C/C=C/C#CC(C)(C)C)Cc1cccc2ccccc12,IC50,5702.9,nM,5.2439042436751
CHEMBL85,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2,IC50,9.674,nM,8.014393916947563
CHEMBL12948,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CC1CCC(NC(=O)N(CCCl)N=O)CC1,IC50,4809.0,nM,5.317945222926193
CHEMBL809,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21,IC50,288.8,nM,6.5394028111023985
CHEMBL404849,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CCCCCCCCNC(C)C(O)c1ccc(SC(C)C)cc1,IC50,2023.2,nM,5.693961183663651
CHEMBL833,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),Clc1ccccc1CN1CCc2sccc2C1,IC50,382.0,nM,6.417936637088291
CHEMBL1306,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,IC50,983.0,nM,6.007446482167865
CHEMBL26,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC,IC50,2019.0,nM,5.694863681056361
CHEMBL81,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2cc(O)ccc12,IC50,1664.0,nM,5.778846678045294
CHEMBL2203713,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of alpha2A adrenergic receptor,N=C(Nc1ccc2c(c1)CCN2C1CCNCC1)c1cccs1,IC50,24000.0,nM,4.619788758288394
CHEMBL513389,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity to human adrenergic alpha2 receptor by radioligand displacement assay,Cc1ccc(OCC(O)C(C)NC(C)C)c2c1CCC2,IC50,0.5,nM,9.301029995663981
CHEMBL15245,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]MK912 from human recombinant alpha2A adrenergic receptor expressed in Sf9 cells after 60 mins,COC(=O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O,IC50,8.4,nM,8.075720713938118
CHEMBL3403995,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of alpha-adrenoceptor 2A (unknown origin),COCCCOc1cc(C(=O)N(C[C@@H]2CNC[C@H]2OC(=O)NCc2ccccc2)C(C)C)ccc1OC,IC50,1000.0,nM,6.0
CHEMBL4061793,CHEMBL1867,Alpha-2a adrenergic receptor,Antagonist activity at alpha2A-adrenergic receptor (unknown origin),O=S(=O)(Nc1nccs1)c1cc(Cl)c(NCC23CCCN2CCC3)cc1F,IC50,8000.0,nM,5.096910013008056
CHEMBL3091687,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of adrenergic alpha2A receptor (unknown origin),NCCCCN(C[C@H]1Cc2ccccc2CN1)[C@H]1CCCc2cccnc21,IC50,3700.0,nM,5.431798275933005
CHEMBL4174290,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of adrenergic alpha2A receptor (unknown origin),c1ccc2c(c1)CN[C@@H](CN(CC[C@H]1CCCNC1)[C@H]1CCCc3cccnc31)C2,IC50,5900.0,nM,5.229147988357855
CHEMBL1800685,CHEMBL1867,Alpha-2a adrenergic receptor,Adrenergic alpha2A Eurofins-Panlabs radioligand binding assay,O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1,IC50,4070.0,nM,5.39040559077478
CHEMBL3091687,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of alpha 2A adrenergic receptor (unknown origin),NCCCCN(C[C@H]1Cc2ccccc2CN1)[C@H]1CCCc2cccnc21,IC50,3700.0,nM,5.431798275933005
CHEMBL5070958,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of alpha 2A adrenergic receptor (unknown origin),NCCCCN(C[C@H]1Cc2ncccc2CN1)[C@H]1CCCc2cccnc21,IC50,11000.0,nM,4.958607314841775
CHEMBL5076569,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of alpha 2A adrenergic receptor (unknown origin),NCCCCN(C[C@H]1Cc2cccnc2CN1)[C@H]1CCCc2cccnc21,IC50,1300.0,nM,5.886056647693163
CHEMBL5093818,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of alpha 2A adrenergic receptor (unknown origin),CN(CCCCN(C[C@H]1Cc2ncccc2CN1)[C@H]1CCCc2cccnc21)C1CCC(F)(F)CC1,IC50,810.0,nM,6.0915149811213505
CHEMBL5077132,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of alpha 2A adrenergic receptor (unknown origin),CN(CCCCN(C[C@H]1Cc2ncccc2CN1)[C@H]1CCCc2cccnc21)C1CCOCC1,IC50,28000.0,nM,4.552841968657781
CHEMBL5083458,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of alpha 2A adrenergic receptor (unknown origin),c1cnc2c(c1)CN[C@@H](CN(CCCCNC1COC1)[C@H]1CCCc3cccnc31)C2,IC50,24000.0,nM,4.619788758288394
CHEMBL5082142,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of alpha 2A adrenergic receptor (unknown origin),c1cnc2c(c1)CN[C@@H](CN(CCCCN1CCOCC1)[C@H]1CCCc3cccnc31)C2,IC50,620.0,nM,6.207608310501746
CHEMBL5398630,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]-rauwolscine from human recombinant adrenergic alpha-2A receptor expressed in CHO-K1 cells incubated for 60 mins by spectrophotometric analysis,O=C(O)/C=C/C(=O)O.[2H]C([2H])(Cc1c[nH]c2ccccc12)N(C)C,IC50,3030.0,nM,5.518557371497695
CHEMBL3183055,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]-rauwolscine from human recombinant adrenergic alpha-2A receptor expressed in CHO-K1 cells incubated for 60 mins by spectrophotometric analysis,CN(C)CCc1c[nH]c2ccccc12.O=C(O)/C=C/C(=O)O,IC50,2220.0,nM,5.653647025549361
CHEMBL836,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligand,CCOc1ccccc1OCCN[C@H](C)Cc1ccc(OC)c(S(N)(=O)=O)c1,KI,13.4,nM,7.872895201635192
CHEMBL134,CHEMBL1867,Alpha-2a adrenergic receptor,Compound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cells,Clc1cccc(Cl)c1NC1=NCCN1,KI,3.8,nM,8.42021640338319
CHEMBL298936,CHEMBL1867,Alpha-2a adrenergic receptor,Compound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cells,Cc1c(NC2=NCCN2)ccc2c1NCCO2,KI,1.2,nM,8.920818753952375
CHEMBL49137,CHEMBL1867,Alpha-2a adrenergic receptor,Compound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cells,Cc1c(NC2=NCCN2)ccc2nccnc12,KI,2.0,nM,8.698970004336019
CHEMBL49284,CHEMBL1867,Alpha-2a adrenergic receptor,Compound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cells,Cc1c(NC2=NCCN2)ccc2c1NCCN2,KI,9.6,nM,8.017728766960431
CHEMBL40650,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligand,COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccnc54)c3=O)C[C@@H]21,KI,94.9,nM,7.022733787572707
CHEMBL611,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligand,COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC,KI,1500.0,nM,5.823908740944319
CHEMBL647,CHEMBL1867,Alpha-2a adrenergic receptor,Compound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cells,Nc1cc(Cl)c(N=C2NCCN2)c(Cl)c1,KI,2.9,nM,8.537602002101044
CHEMBL92221,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity towards Alpha-2 adrenergic receptor,Cc1c(NC2=NCCN2)cccc1-c1ccccc1,KI,19.0,nM,7.721246399047171
CHEMBL27251,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity towards Alpha-2 adrenergic receptor,CN1CCc2ccc3c4c2[C@H]1Cc1cccc(c1-4)[C@@H]3N,KI,92.8,nM,7.032452023781138
CHEMBL30739,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity towards Alpha-2A adrenergic receptor,Cc1sc(C)c2c1CCCC2c1c[nH]cn1,KI,68.0,nM,7.167491087293763
CHEMBL30534,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity towards Alpha-2A adrenergic receptor,c1cc(-c2c[nH]cn2)c2ccsc2c1,KI,277.0,nM,6.557520230935552
CHEMBL30955,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity towards Alpha-2A adrenergic receptor,C1=C(c2c[nH]cn2)c2sccc2CC1,KI,224.0,nM,6.649751981665837
CHEMBL286246,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity towards Alpha-2A adrenergic receptor,C1=C(c2c[nH]cn2)c2ccsc2CC1,KI,254.0,nM,6.5951662833800615
CHEMBL134,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity towards Alpha-2A adrenergic receptor,Clc1cccc(Cl)c1NC1=NCCN1,KI,853.0,nM,6.069050968832477
CHEMBL284795,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity towards Alpha-2A adrenergic receptor,Cc1sc(C)c2c1CCC=C2c1c[nH]cn1,KI,25.0,nM,7.6020599913279625
CHEMBL284213,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity towards Alpha-2A adrenergic receptor,c1nc(C2CCCc3sccc32)c[nH]1,KI,27.0,nM,7.568636235841012
CHEMBL407509,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cell,C1=NCC(CC2=Cc3ccccc3CC2)N1,KI,100.0,nM,7.0
CHEMBL353972,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cell,CCC1(c2c[nH]cn2)Cc2ccccc2C1,KI,3.162,nM,8.500038134403809
CHEMBL167644,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cell,C1=NCC(Cc2cc3ccccc3o2)N1,KI,19.95,nM,7.700057099977233
CHEMBL168168,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cell,Clc1cccc2ccc(CC3CN=CN3)cc12,KI,25.12,nM,7.599980364934842
CHEMBL354611,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cell,C1=NC[C@@H](C2C[C@@]23CCc2ccccc2C3)N1,KI,3.162,nM,8.500038134403809
CHEMBL353843,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cell,C1=NCC(CC2Cc3ccccc3C2)N1,KI,3.981,nM,8.400007822415901
CHEMBL41,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cell,CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1,KI,6.31,nM,8.199970640755865
CHEMBL165529,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cell,C1=NC[C@]2(CC[C@@H]3Cc4ccccc4C[C@H]3C2)N1,KI,1.259,nM,8.899974269892137
CHEMBL353139,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cell,Fc1cccc2c1C=C(CC1CN=CN1)CC2,KI,39.81,nM,7.400007822415902
CHEMBL262777,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cell,CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O,KI,50.12,nM,7.299988937677888
CHEMBL353200,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cell,Clc1cccc2c1C=C(CC1CN=CN1)CC2,KI,31.62,nM,7.50003813440381
CHEMBL436234,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cell,Fc1ccc2c(c1)C=C(CC1CN=CN1)CC2,KI,158.49,nM,6.799998134593398
CHEMBL353212,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cell,C1=NC[C@H](C[C@]23CCc4ccccc4C2C3)N1,KI,63.1,nM,7.199970640755866
CHEMBL555190,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand,Cl.Cl.O=C(NCCCCCNC(=O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O,KI,1.73,nM,8.761953896871205
CHEMBL268758,CHEMBL1867,Alpha-2a adrenergic receptor,Ancillary Binding affinity towards cloned human Alpha-2A adrenergic receptor,COc1ccccc1N1CCN(CCn2c(=O)[nH]c3scc(-c4ccccc4)c3c2=O)CC1,KI,77.8,nM,7.109020403010311
CHEMBL551711,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand,Cl.Cl.O=C(NCCCCCCCCCCCCNC(=O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O,KI,1.18,nM,8.928117992693874
CHEMBL538808,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand,Cl.Cl.O=C(NCCCCCCCCNC(=O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O,KI,0.76,nM,9.119186407719209
CHEMBL540594,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand,Cl.Cl.O=C(NCCCNC(=O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O,KI,52.0,nM,7.2839966563652006
CHEMBL539824,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand,Cl.Cl.O=C(NCCCCNC(=O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O,KI,15.3,nM,7.815308569182401
CHEMBL554019,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand,Cl.Cl.O=C(NCCCCCCCCCCNC(=O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O,KI,0.39,nM,9.4089353929735
CHEMBL539606,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand,Cl.Cl.O=C(NCCCCCCCCCNC(=O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O,KI,1.25,nM,8.903089986991944
CHEMBL542520,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand,Cl.Cl.O=C(NCCNC(=O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O,KI,26.4,nM,7.578396073130169
CHEMBL543232,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand,Cl.Cl.O=C(NCCCCCCCNC(=O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O,KI,0.87,nM,9.060480747381382
CHEMBL13856,CHEMBL1867,Alpha-2a adrenergic receptor,Ancillary Binding affinity towards cloned human Alpha-2A adrenergic receptor,COc1ccccc1N1CCN(CCn2c(=O)[nH]c3scc(-c4cccc(C)c4)c3c2=O)CC1,KI,82.5,nM,7.0835460514500745
CHEMBL15245,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand,COC(=O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O,KI,0.42,nM,9.3767507096021
CHEMBL542527,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand,Cl.Cl.O=C(NCCCCCCNC(=O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O,KI,1.35,nM,8.869666231504993
CHEMBL707,CHEMBL1867,Alpha-2a adrenergic receptor,"Binding affinity against Alpha-2A adrenergic receptor, from human clones.",COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC,KI,729.0,nM,6.137272471682025
CHEMBL315392,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor,CC1=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)N(C)C)=C(C)N1,KI,954.99,nM,6.020001176026261
CHEMBL88448,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor,CO/C(O)=C1\C(C)=NC(C)=C(C(=O)N(C)CCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1,KI,676.08,nM,6.17000191130262
CHEMBL279516,CHEMBL1867,Alpha-2a adrenergic receptor,The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.,O=C(NC1CCN(CCc2c[nH]c3ccccc23)CC1)c1ccccc1,KI,2240.0,nM,5.649751981665837
CHEMBL314960,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor,CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(Cl)cc1,KI,2137.96,nM,5.670000424450807
CHEMBL327931,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor,CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)CC2)C1c1ccc(Cl)c([N+](=O)[O-])c1,KI,109.65,nM,6.959991363986458
CHEMBL315538,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor,CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(OC)cc1,KI,2187.76,nM,5.660000322371772
CHEMBL91956,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor,CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1,KI,446.68,nM,6.350003492533959
CHEMBL313160,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor,CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])c(OC)c1,KI,630.96,nM,6.199998172182031
CHEMBL420060,CHEMBL1867,Alpha-2a adrenergic receptor,The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.,COc1ccccc1N1CCN(CCCNc2c(C)c(=O)n(C)c(=O)n2C)CC1,KI,612.0,nM,6.213248577854438
CHEMBL89243,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor,CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(C#N)cc1,KI,758.58,nM,6.119998611678231
CHEMBL92322,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor,CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2ccccc2c1,KI,1584.89,nM,5.800000874803203
CHEMBL5483012,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor,COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1.Cl,KI,1202.26,nM,5.920001601921648
CHEMBL327775,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor,CC1=C(C#N)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1,KI,630.96,nM,6.199998172182031
CHEMBL88628,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor,CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2c(c1)OCO2,KI,2089.3,nM,5.679999195735272
CHEMBL25554,CHEMBL1867,Alpha-2a adrenergic receptor,"Binding affinity against Alpha-2A adrenergic receptor, from human clones.",COc1cccc(OC)c1OCCNCC1COc2ccccc2O1,KI,3.5,nM,8.455931955649724
CHEMBL597,CHEMBL1867,Alpha-2a adrenergic receptor,The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.,Cc1ccc(N(CC2=NCCN2)c2cccc(O)c2)cc1,KI,2.6,nM,8.585026652029182
CHEMBL313251,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor,CC1=C(C(=O)O)C(c2ccc3c(c2)OCO3)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1,KI,1174.9,nM,5.929999096197655
CHEMBL114166,CHEMBL1867,Alpha-2a adrenergic receptor,"Binding affinity against Alpha-2A adrenergic receptor, from human clones.",CC(C)=CCOc1ccc(Cl)c2c1CCN(C)CC2,KI,114.0,nM,6.943095148663527
CHEMBL611,CHEMBL1867,Alpha-2a adrenergic receptor,"Binding affinity against Alpha-2A adrenergic receptor, from human clones.",COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC,KI,3702.0,nM,5.431563585583115
CHEMBL327712,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor,CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(Cl)c(Cl)c1,KI,912.01,nM,6.040000399696793
CHEMBL91415,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor,CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2c(c1)OCO2,KI,1122.02,nM,5.949999401714239
CHEMBL2,CHEMBL1867,Alpha-2a adrenergic receptor,"Binding affinity against Alpha-2A adrenergic receptor, from human clones.",COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC,KI,2133.0,nM,5.671009144550571
CHEMBL91022,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor,CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1,KI,275.42,nM,6.560004526046192
CHEMBL284103,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor,CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1,KI,398.11,nM,6.399996913372259
CHEMBL313953,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor,CC(C)C1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C(C)C)N1,KI,676.08,nM,6.17000191130262
CHEMBL88388,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor,CC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2c(c1)OCO2,KI,954.99,nM,6.020001176026261
CHEMBL279436,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor,CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1,KI,151.36,nM,6.819988880942283
CHEMBL315914,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor,CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(C)cc1,KI,1288.25,nM,5.889999848866887
CHEMBL611,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor,COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC,KI,549.54,nM,6.260000690598032
CHEMBL312871,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor,CC1=C(C(N)=O)C(c2ccc3c(c2)OCO3)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1,KI,501.19,nM,6.299997602857746
CHEMBL279436,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor,CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1,KI,302.0,nM,6.51999305704285
CHEMBL69733,CHEMBL1867,Alpha-2a adrenergic receptor,Compound was evaluated for binding affinity against Alpha-2A adrenergic receptor using radioligand binding assay,COc1ccc(CCCN2CCC(CCC(=O)c3cc(Cl)c(N)c4c3OCCO4)CC2)cc1OC,KI,100.0,nM,7.0
CHEMBL91550,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor,CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(CC)N1,KI,354.81,nM,6.450004148469349
CHEMBL279436,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor,CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1,KI,371.54,nM,6.429994423238211
CHEMBL89685,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor,CC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1,KI,602.56,nM,6.219999701663429
CHEMBL284470,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor,CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1,KI,645.65,nM,6.190002844637807
CHEMBL1076,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay,COc1ccc(OC)c(C(O)CN)c1,KI,1445.44,nM,5.839999931118699
CHEMBL111496,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay,CCS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1,KI,131.83,nM,6.879985747921933
CHEMBL109848,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay,CC(=O)Nc1cccc2c1CCCC2c1c[nH]cn1,KI,549.54,nM,6.260000690598032
CHEMBL61006,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay,CC(N)C(O)c1ccccc1,KI,275.42,nM,6.560004526046192
CHEMBL323402,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay,Nc1cccc2c1CCCC2c1c[nH]cn1,KI,72.44,nM,7.140021558357979
CHEMBL111554,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay,CS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1,KI,104.71,nM,6.980011840408714
CHEMBL109783,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay,CS(=O)(=O)Nc1c(O)ccc2c1CCCC2C1=NCCN1,KI,33.11,nM,7.4800408192479315
CHEMBL111771,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay,CCS(=O)(=O)Nc1cccc2c1CCC2c1c[nH]cn1,KI,97.72,nM,7.010016541698601
CHEMBL326702,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay,CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1,KI,169.82,nM,6.770011163455189
CHEMBL317912,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay,Oc1cccc2c1CCCC2c1c[nH]cn1,KI,8.71,nM,8.059981844992336
CHEMBL327116,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay,CCS(=O)(=O)Nc1ccc2c(c1)C(c1c[nH]cn1)CCC2,KI,22.91,nM,7.6399749108106025
CHEMBL108804,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay,CS(=O)(=O)Nc1c(O)ccc2c1CCCC2c1c[nH]cn1,KI,44.67,nM,7.349984047528162
CHEMBL110751,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay,O=C(Nc1cccc2c1CCCC2c1c[nH]cn1)C(F)(F)F,KI,309.03,nM,6.509999358109048
CHEMBL111463,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay,CN(c1cccc2c1CCCC2c1c[nH]cn1)S(C)(=O)=O,KI,85.11,nM,7.070019409484486
CHEMBL321644,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay,O=S(=O)(CC(F)(F)F)Nc1cccc2c1CCCC2c1c[nH]cn1,KI,954.99,nM,6.020001176026261
CHEMBL294649,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity against Alpha-2A adrenergic receptor,Cn1cc(C(=O)C(=O)N[C@H]2CN3CCC2CC3)c2ccccc21,KI,7943.28,nM,5.100000128334196
CHEMBL25467,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor,C=Cc1sc2ccc(Cl)c3c2c1CN(C)CC3,KI,24.0,nM,7.619788758288394
CHEMBL123448,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor,CCc1sc2ccc(Cl)c3c2c1CN(C)CC3,KI,31.0,nM,7.508638306165727
CHEMBL298612,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity against Alpha-2A adrenergic receptor,Cn1cc(C(=O)C(=O)N[C@@H]2CN3CCC2CC3)c2ccccc21,KI,31622.78,nM,4.499999953328896
CHEMBL279436,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor,CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1,KI,148.0,nM,6.8297382846050425
CHEMBL5483012,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor,COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1.Cl,KI,3300.0,nM,5.481486060122112
CHEMBL114166,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor,CC(C)=CCOc1ccc(Cl)c2c1CCN(C)CC2,KI,114.0,nM,6.943095148663527
CHEMBL3392246,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor,COC(=O)C1=C(C)NC(C)=C(C(=O)OCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1,KI,1023.0,nM,5.99012436628784
CHEMBL405355,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor,COC(=O)C1=C(C)NC(C)=C(C(=O)OCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)[C@H]1c1cccc([N+](=O)[O-])c1,KI,645.0,nM,6.1904402853647325
CHEMBL15245,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor,COC(=O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O,KI,7.5,nM,8.1249387366083
CHEMBL122404,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor,COC(=O)C1=CO[C@@H](C)[C@@H]2CN3CCc4c([nH]c5ccccc45)[C@H]3C[C@H]12,KI,106.0,nM,6.97469413473523
CHEMBL3392247,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor,COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1cccc([N+](=O)[O-])c1,KI,1550.0,nM,5.809668301829708
CHEMBL284103,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor,CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1,KI,398.0,nM,6.400116927926312
CHEMBL123138,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor,CN1CCc2c(Cl)ccc3oc(Br)c(c23)C1,KI,54.0,nM,7.267606240177031
CHEMBL10347,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor,COC(=O)[C@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@H]2CC[C@@H]1O,KI,4.6,nM,8.337242168318426
CHEMBL123349,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor,CN1CCc2cccc(Cl)c2CC1,KI,9.4,nM,8.0268721464003
CHEMBL31410,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor,COC(=O)[C@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O,KI,1218.0,nM,5.914352711703144
CHEMBL71479,CHEMBL1867,Alpha-2a adrenergic receptor,Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells,Cc1ccc(S(C)(=O)=O)c(NCC2=NCCN2)c1,KI,3890.45,nM,5.410000161858408
CHEMBL70740,CHEMBL1867,Alpha-2a adrenergic receptor,Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells,O=S1(=O)CCCc2cccc(NCC3=NCCN3)c21,KI,794.33,nM,6.0999990348465305
CHEMBL74114,CHEMBL1867,Alpha-2a adrenergic receptor,Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells,CS(=O)(=O)c1cccc(F)c1NCC1=NCCN1,KI,870.96,nM,6.060001790087838
CHEMBL544290,CHEMBL1867,Alpha-2a adrenergic receptor,Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells,CS(=O)(=O)c1ccccc1NCC1=NCCN1.Cl,KI,5623.41,nM,5.250000251143582
CHEMBL70692,CHEMBL1867,Alpha-2a adrenergic receptor,Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells,CSc1c(F)cccc1NCC1=NCCN1,KI,165.96,nM,6.779996573843064
CHEMBL540035,CHEMBL1867,Alpha-2a adrenergic receptor,Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells,CCSc1ccccc1NCC1=NCCN1.Cl,KI,81.28,nM,7.090016305060156
CHEMBL306792,CHEMBL1867,Alpha-2a adrenergic receptor,Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells,CSc1cc(F)ccc1NCC1=NCCN1,KI,58.88,nM,7.230032198670558
CHEMBL74467,CHEMBL1867,Alpha-2a adrenergic receptor,Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells,CS(=O)(=O)c1ccc(F)cc1NCC1=NCCN1,KI,4466.84,nM,5.349999603463148
CHEMBL70973,CHEMBL1867,Alpha-2a adrenergic receptor,Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells,CCS(=O)(=O)c1ccccc1NCC1=NCCN1,KI,1318.26,nM,5.879998925531604
CHEMBL553276,CHEMBL1867,Alpha-2a adrenergic receptor,Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells,CC(C)Sc1ccccc1NCC1=NCCN1.Cl,KI,81.28,nM,7.090016305060156
CHEMBL70691,CHEMBL1867,Alpha-2a adrenergic receptor,Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells,COc1ccc(SC)c(NCC2=NCCN2)c1,KI,218.78,nM,6.6599923820033275
CHEMBL70751,CHEMBL1867,Alpha-2a adrenergic receptor,Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells,CSc1ccc(Cl)cc1NCC1=NCCN1,KI,41.69,nM,7.3799681048737025
CHEMBL72724,CHEMBL1867,Alpha-2a adrenergic receptor,Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells,CSc1ccc(C(F)(F)F)cc1NCC1=NCCN1,KI,199.53,nM,6.699991797446187
CHEMBL71001,CHEMBL1867,Alpha-2a adrenergic receptor,Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells,COc1ccc(S(C)(=O)=O)c(NCC2=NCCN2)c1,KI,3630.78,nM,5.440000065513061
CHEMBL74071,CHEMBL1867,Alpha-2a adrenergic receptor,Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells,CC(C)S(=O)(=O)c1ccccc1NCC1=NCCN1,KI,2951.21,nM,5.529999886197674
CHEMBL70563,CHEMBL1867,Alpha-2a adrenergic receptor,Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells,CS(=O)(=O)c1cc(Cl)ccc1NCC1=NCCN1,KI,5011.87,nM,5.300000202445418
CHEMBL72441,CHEMBL1867,Alpha-2a adrenergic receptor,Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells,CSc1ccc(C)cc1NCC1=NCCN1,KI,63.1,nM,7.199970640755866
CHEMBL72768,CHEMBL1867,Alpha-2a adrenergic receptor,Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells,CSc1ccc(F)cc1NCC1=NCCN1,KI,18.2,nM,7.739928612014925
CHEMBL540542,CHEMBL1867,Alpha-2a adrenergic receptor,Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells,CSc1ccccc1NCC1=NCCN1.Cl,KI,47.86,nM,7.320027305722581
CHEMBL542402,CHEMBL1867,Alpha-2a adrenergic receptor,Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells,C[S+]([O-])c1ccccc1NCC1=NCCN1.Cl,KI,977.24,nM,6.009998764965339
CHEMBL762,CHEMBL1867,Alpha-2a adrenergic receptor,Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells,Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1,KI,16.22,nM,7.789949150124863
CHEMBL70326,CHEMBL1867,Alpha-2a adrenergic receptor,Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells,CS(=O)(=O)c1cc(F)ccc1NCC1=NCCN1,KI,398.11,nM,6.399996913372259
CHEMBL179334,CHEMBL1867,Alpha-2a adrenergic receptor,Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor,CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)[C@H]1c1ccc([N+](=O)[O-])cc1,KI,1300.0,nM,5.886056647693163
CHEMBL5483012,CHEMBL1867,Alpha-2a adrenergic receptor,Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor,COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1.Cl,KI,1100.0,nM,5.958607314841775
CHEMBL2051956,CHEMBL1867,Alpha-2a adrenergic receptor,Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor,COC(=O)C1=C(C)NC(C)=C(C(=O)OCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)[C@@H]1c1cccc([N+](=O)[O-])c1,KI,900.0,nM,6.045757490560675
CHEMBL611,CHEMBL1867,Alpha-2a adrenergic receptor,Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor,COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC,KI,550.0,nM,6.259637310505756
CHEMBL2,CHEMBL1867,Alpha-2a adrenergic receptor,Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor,COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC,KI,210.0,nM,6.6777807052660805
CHEMBL405355,CHEMBL1867,Alpha-2a adrenergic receptor,Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor,COC(=O)C1=C(C)NC(C)=C(C(=O)OCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)[C@H]1c1cccc([N+](=O)[O-])c1,KI,530.0,nM,6.275724130399211
CHEMBL290860,CHEMBL1867,Alpha-2a adrenergic receptor,Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor,CO/C(O)=C1\C(C)=NC(C)=C(C(=O)OCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1,KI,800.0,nM,6.096910013008056
CHEMBL5483012,CHEMBL1867,Alpha-2a adrenergic receptor,Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor,COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1.Cl,KI,1200.0,nM,5.920818753952375
CHEMBL328631,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity to the human alpha-2A adrenergic receptor,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccc(F)cc4F)CC3)[C@@H]1CO2,KI,9.3,nM,8.031517051446064
CHEMBL98889,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity to the human alpha-2A adrenergic receptor,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4cccnc4)CC3)[C@@H]1CO2,KI,22.0,nM,7.657577319177793
CHEMBL328114,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity to the human alpha-2A adrenergic receptor,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C/c4ccccc4)CC3)[C@@H]1CO2,KI,8.8,nM,8.05551732784983
CHEMBL95218,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity to the human alpha-2A adrenergic receptor,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C/c4cccc(F)c4)CC3)[C@@H]1CO2,KI,5.9,nM,8.229147988357855
CHEMBL419894,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity to the human alpha-2A adrenergic receptor,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C/c4ccc(F)cc4)CC3)[C@@H]1CO2,KI,9.0,nM,8.045757490560675
CHEMBL101411,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity to the human alpha-2A adrenergic receptor,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C/c4ccc(Cl)cc4)CC3)[C@@H]1CO2,KI,69.0,nM,7.161150909262744
CHEMBL101361,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity to the human alpha-2A adrenergic receptor,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccccc4OC)CC3)[C@@H]1CO2,KI,5.2,nM,8.2839966563652
CHEMBL419336,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity to the human alpha-2A adrenergic receptor,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4cccc(F)c4F)CC3)[C@@H]1CO2,KI,3.0,nM,8.522878745280337
CHEMBL99916,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity to the human alpha-2A adrenergic receptor,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccco4)CC3)[C@@H]1CO2,KI,1.7,nM,8.769551078621726
CHEMBL98646,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity to the human alpha-2A adrenergic receptor,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4cccs4)CC3)[C@@H]1CO2,KI,1.7,nM,8.769551078621726
CHEMBL101596,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity to the human alpha-2A adrenergic receptor,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccsc4)CC3)[C@@H]1CO2,KI,1.1,nM,8.958607314841775
CHEMBL328195,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity to the human alpha-2A adrenergic receptor,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccsc4)CC3)[C@@H]1CO2,KI,1.4,nM,8.853871964321762
CHEMBL319573,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity to the human alpha-2A adrenergic receptor,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C/c4ccccc4F)CC3)[C@@H]1CO2,KI,2.9,nM,8.537602002101044
CHEMBL319119,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity to the human alpha-2A adrenergic receptor,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4cc(F)ccc4F)CC3)[C@@H]1CO2,KI,0.3,nM,9.522878745280337
CHEMBL329065,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity to the human alpha-2A adrenergic receptor,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccc(O)cc4)CC3)[C@@H]1CO2,KI,1.9,nM,8.721246399047171
CHEMBL318235,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity to the human alpha-2A adrenergic receptor,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccc(F)cc4)CC3)[C@@H]1CO2,KI,3.4,nM,8.468521082957745
CHEMBL98541,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity to the human alpha-2A adrenergic receptor,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccc(F)cc4)CC3)[C@@H]1CO2,KI,2.9,nM,8.537602002101044
CHEMBL91157,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity to the human alpha-2A adrenergic receptor,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccccc4)CC3)[C@@H]1CO2,KI,0.8,nM,9.096910013008056
CHEMBL419316,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity to the human alpha-2A adrenergic receptor,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccccc4)CC3)[C@@H]1CO2,KI,0.3,nM,9.522878745280337
CHEMBL99868,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity to the human alpha-2A adrenergic receptor,COc1ccccc1/C=C(\C)CN1CCN(C[C@@H]2ON=C3c4cc(OC)c(OC)cc4OC[C@H]32)CC1,KI,1.0,nM,9.0
CHEMBL100879,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity to the human alpha-2A adrenergic receptor,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4cccs4)CC3)[C@@H]1CO2,KI,0.3,nM,9.522878745280337
CHEMBL263424,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity to the human alpha-2A adrenergic receptor,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4cccc(F)c4)CC3)[C@@H]1CO2,KI,1.1,nM,8.958607314841775
CHEMBL420830,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity to the human alpha-2A adrenergic receptor,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C\c4ccccc4)CC3)[C@@H]1CO2,KI,23.0,nM,7.638272163982407
CHEMBL319530,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity to the human alpha-2A adrenergic receptor,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccco4)CC3)[C@@H]1CO2,KI,0.5,nM,9.301029995663981
CHEMBL836,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity towards recombinant human alpha-2A adrenergic receptor was determined using [3H]MK-912 as radioligand,CCOc1ccccc1OCCN[C@H](C)Cc1ccc(OC)c(S(N)(=O)=O)c1,KI,63.0,nM,7.200659450546418
CHEMBL6310,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity towards alpha-2A-Adrenergic receptor,COc1ccc2c3c([nH]c2c1)CNCC3,KI,1370.0,nM,5.863279432843593
CHEMBL269538,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity towards alpha-2A-Adrenergic receptor,COc1ccc2c(c1)[nH]c1c(C)nccc12,KI,2540.0,nM,5.5951662833800615
CHEMBL19236,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity for human Alpha-2A adrenergic receptor,COc1nc(C)nc(Cl)c1NC1=NCCN1,KI,150.0,nM,6.823908740944319
CHEMBL1437,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity for human Alpha-2A adrenergic receptor,NC[C@H](O)c1ccc(O)c(O)c1,KI,66.0,nM,7.180456064458131
CHEMBL134,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity for human Alpha-2A adrenergic receptor,Clc1cccc(Cl)c1NC1=NCCN1,KI,3.8,nM,8.42021640338319
CHEMBL316495,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity against human Alpha-2a adrenergic receptor,CCCC1=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCC)=C(CC)N1,KI,955.0,nM,6.019996628416253
CHEMBL320736,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity against human Alpha-2a adrenergic receptor,CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCC(F)(F)F)N1,KI,2308.0,nM,5.636764195516307
CHEMBL133231,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligand,NC1=NC2(CCc3cccc(Cl)c3C2)CO1,KI,1.6,nM,8.795880017344075
CHEMBL95578,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity against human Alpha-2a adrenergic receptor,CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCCN)N1,KI,813.0,nM,6.089909454405932
CHEMBL336332,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligand,COc1cccc2c1CCC1(CN=CN1)C2,KI,12.0,nM,7.920818753952375
CHEMBL180561,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity against human Alpha-2a adrenergic receptor,CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1,KI,369.0,nM,6.432973633840939
CHEMBL131220,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligand,Fc1cccc2c1CC1(CC2)CN=CN1,KI,12.0,nM,7.920818753952375
CHEMBL338683,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligand,Clc1cc(Cl)c2c(c1)CC1(CC2)CN=CN1,KI,3.0,nM,8.522878745280337
CHEMBL98063,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity against human Alpha-2A adrenergic receptor,CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN=[N+]=[N-])N1,KI,468.0,nM,6.329754146925875
CHEMBL133579,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligand,COc1ccc2c(c1)CC1(CC2)CN=CN1,KI,51.0,nM,7.292429823902063
CHEMBL323579,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity against human Alpha-2a adrenergic receptor,CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN)N1,KI,403.0,nM,6.39469495385889
CHEMBL100045,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity against human Alpha-2a adrenergic receptor,CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COC)N1,KI,575.0,nM,6.2403321553103694
CHEMBL336970,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligand,COc1ccc2c(c1)CCC1(CN=CN1)C2,KI,87.0,nM,7.060480747381382
CHEMBL98471,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligand,Cc1ccc2c(c1)CC1(CC2)CN=CN1,KI,7.0,nM,8.154901959985743
CHEMBL130853,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligand,C1=NCC2(CCc3ccccc3C2)N1,KI,34.0,nM,7.468521082957745
CHEMBL99864,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity against human Alpha-2a adrenergic receptor,CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(CCCCOC)N1,KI,99.0,nM,7.00436480540245
CHEMBL131417,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligand,COc1cccc2c1CC1(CC2)CN=CN1,KI,51.0,nM,7.292429823902063
CHEMBL5483012,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity against human Alpha-2a adrenergic receptor,COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1.Cl,KI,2417.0,nM,5.61672334959235
CHEMBL95290,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity against human Alpha-2a adrenergic receptor,CCNC(=O)C1=C(CC)NC(COCCN)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1,KI,1698.0,nM,5.7700623140920655
CHEMBL101340,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligand,FC(F)(F)c1ccc(Cl)c(NC2=NCCN2)c1,KI,1560.0,nM,5.806875401645538
CHEMBL1788223,CHEMBL1867,Alpha-2a adrenergic receptor,Compound is evaluated for binding affinity towards Alpha-2A adrenergic receptor using [3H]prazosin,COc1ccccc1N1CCN(C[C@H]2CN=C3c4ccccc4N=C(SC)N32)CC1,KI,872.0,nM,6.059483515067432
CHEMBL1788222,CHEMBL1867,Alpha-2a adrenergic receptor,Compound is evaluated for binding affinity towards Alpha-2A adrenergic receptor using [3H]prazosin,COc1ccccc1N1CCN(C[C@H]2CN=C3c4ccccc4NC(=O)N32)CC1,KI,444.0,nM,6.35261702988538
CHEMBL302021,CHEMBL1867,Alpha-2a adrenergic receptor,Compound is evaluated for binding affinity towards Alpha-2A adrenergic receptor using [3H]prazosin,COc1ccccc1N1CCN(CC2CN3C(=O)Nc4ccccc4C3=N2)CC1,KI,547.0,nM,6.262012673666569
CHEMBL51433,CHEMBL1867,Alpha-2a adrenergic receptor,Compound is evaluated for binding affinity towards Alpha-2A adrenergic receptor using [3H]prazosin,COc1ccccc1N1CCN(CCn2c(=O)[nH]c3ccccc3c2=O)CC1,KI,1811.0,nM,5.742081549685942
CHEMBL2092927,CHEMBL1867,Alpha-2a adrenergic receptor,Compound is evaluated for binding affinity towards Alpha-2A adrenergic receptor using [3H]prazosin,COc1ccccc1N1CCN(C[C@@H]2CN=C3c4ccccc4N=C(SC)N32)CC1,KI,3000.0,nM,5.522878745280337
CHEMBL295186,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscine,c1ccc(C[C@H]2C3CCC(C3)[C@H]2NC2=NCCO2)cc1,KI,13.8,nM,7.860120913598763
CHEMBL50720,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscine,c1ccc(CCC[C@H]2CCCC[C@@H]2NC2=NCCO2)cc1,KI,15.14,nM,7.8198741248359465
CHEMBL47313,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscine,c1ccc(CC[C@H]2CCCC[C@@H]2NC2=NCCO2)cc1,KI,1.445,nM,8.840132152907433
CHEMBL297752,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscine,CCC[C@H]1CCCC[C@@H]1NC1=NCCO1,KI,2.951,nM,8.53003079050004
CHEMBL297228,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscine,c1ccc([C@H]2CCCC[C@@H]2NC2=NCCO2)cc1,KI,18.2,nM,7.739928612014925
CHEMBL50719,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscine,c1ccc(C[C@H]2CCCC[C@@H]2NC2=NCCO2)cc1,KI,20.89,nM,7.680061560019691
CHEMBL297827,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscine,C(=C/c1ccccc1)\C[C@H]1C2CCC(C2)[C@H]1NC1=NCCO1,KI,15.85,nM,7.79997073344623
CHEMBL48341,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscine,c1ccc(CCC[C@H]2C3CCC(C3)[C@H]2NC2=NCCO2)cc1,KI,30.9,nM,7.510041520575165
CHEMBL296660,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscine,CCC[C@H]1C2CCC(C2)[C@H]1NC1=NCCO1,KI,28.18,nM,7.550059011226662
CHEMBL93171,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine,COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C(C)=C/c4ccccc4)CC3)C1CO2,KI,0.8,nM,9.096910013008056
CHEMBL77913,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells,COc1ccc(Nc2ncc[nH]2)c(C)c1,KI,10.0,nM,8.0
CHEMBL90997,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine,Fc1ccc2c(c1)CC(CC1CN=CN1)C2,KI,5.9,nM,8.229147988357855
CHEMBL308863,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells,COc1ccc(Nc2ncc[nH]2)c(C)c1OC,KI,130.0,nM,6.886056647693163
CHEMBL422597,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine,COc1ccc2c(c1)C1=NOC(CN3CCN(C/C=C/c4ccccc4)CC3)C1CO2,KI,0.8,nM,9.096910013008056
CHEMBL91157,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccccc4)CC3)[C@@H]1CO2,KI,16.0,nM,7.795880017344075
CHEMBL419316,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccccc4)CC3)[C@@H]1CO2,KI,30.0,nM,7.522878745280337
CHEMBL94435,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine,COc1cc2c(cc1OC)C1=NOC(CN3CCN(Cc4cc5ccccc5s4)CC3)C1CO2,KI,98.0,nM,7.008773924307505
CHEMBL844,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells,Brc1c(NC2=NCCN2)ccc2nccnc12,KI,2.7,nM,8.568636235841012
CHEMBL432155,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells,Cc1c(Nc2ncc[nH]2)ccc2c1NCCO2,KI,6.0,nM,8.221848749616356
CHEMBL93801,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine,COc1cc2c(cc1OC)C1=NOC(CN3CCN(Cc4csc5ccccc45)CC3)C1CO2,KI,66.0,nM,7.180456064458131
CHEMBL91297,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine,COc1cc2c(cc1OC)C1=NOC(CN3CCN(Cc4cccc5ccccc45)CC3)C1CO2,KI,234.0,nM,6.630784142589857
CHEMBL75491,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells,Cc1c(Nc2ncc[nH]2)ccc2nccnc12,KI,31.0,nM,7.508638306165727
CHEMBL92860,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(Cc4ccc5ccccc5c4)CC3)[C@@H]1CO2,KI,93.0,nM,7.031517051446065
CHEMBL74544,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells,c1c[nH]c(Nc2ccc3[nH]cnc3c2)n1,KI,76.0,nM,7.119186407719209
CHEMBL75257,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells,COc1c(C(C)(C)C)cc(C)c(Nc2ncc[nH]2)c1C,KI,4.9,nM,8.309803919971486
CHEMBL328114,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C/c4ccccc4)CC3)[C@@H]1CO2,KI,2.6,nM,8.585026652029182
CHEMBL268258,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine,COc1cccc2c1CCC[C@H]2CN(C)CCc1ccc2ccoc2c1,KI,2.4,nM,8.619788758288394
CHEMBL420830,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C\c4ccccc4)CC3)[C@@H]1CO2,KI,23.0,nM,7.638272163982407
CHEMBL92496,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine,COc1cc2c(cc1OC)C1=NOC(CN3CCN(CCc4ccccc4)CC3)C1CO2,KI,234.0,nM,6.630784142589857
CHEMBL91157,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccccc4)CC3)[C@@H]1CO2,KI,0.3,nM,9.522878745280337
CHEMBL90966,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine,COc1cc2c(cc1OC)C1=NOC(CN3CCN(Cc4ccc5ncccc5c4)CC3)C1CO2,KI,117.0,nM,6.931814138253838
CHEMBL76457,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells,Brc1ccccc1Nc1ncc[nH]1,KI,210.0,nM,6.6777807052660805
CHEMBL1019,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells,Brc1c(Nc2ncc[nH]2)ccc2nccnc12,KI,510.0,nM,6.292429823902063
CHEMBL1022,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells,Clc1cccc(Cl)c1Nc1ncc[nH]1,KI,95.0,nM,7.022276394711152
CHEMBL308570,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells,Cc1c(Nc2ncc[nH]2)ccc2c1OCCO2,KI,1.7,nM,8.769551078621726
CHEMBL49137,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells,Cc1c(NC2=NCCN2)ccc2nccnc12,KI,2.0,nM,8.698970004336019
CHEMBL90419,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine,COc1cc2c(cc1OC)C1=NOC(CN3CCN(CCCc4ccccc4)CC3)C1CO2,KI,26.0,nM,7.585026652029182
CHEMBL90247,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine,COc1ccc2c(c1)OCC1C2=NOC1CN1CCN(C/C=C/c2ccccc2)CC1,KI,0.5,nM,9.301029995663981
CHEMBL328735,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine,COc1cc2c(cc1OC)C1=NOC(CN3CCN(CCC(=O)c4ccccc4)CC3)C1CO2,KI,12.0,nM,7.920818753952375
CHEMBL93489,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine,COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C=C/c4ccccc4)CC3)C1CO2,KI,8.8,nM,8.05551732784983
CHEMBL327875,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine,COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C=C(\C)c4ccccc4)CC3)C1CO2,KI,1.4,nM,8.853871964321762
CHEMBL328114,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C/c4ccccc4)CC3)[C@@H]1CO2,KI,25.0,nM,7.6020599913279625
CHEMBL90943,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine,C(=C/c1ccccc1)\CN1CCN(CC2ON=C3c4ccccc4OCC32)CC1,KI,0.9,nM,9.045757490560675
CHEMBL91824,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine,COc1cc2c(cc1OC)C1=NOC(CN3CCN(Cc4cnc5ccccc5c4)CC3)C1CO2,KI,34.0,nM,7.468521082957745
CHEMBL92860,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(Cc4ccc5ccccc5c4)CC3)[C@@H]1CO2,KI,1.3,nM,8.886056647693163
CHEMBL90843,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine,COc1cc2c(cc1OC)C1=NOC(CN3CCN(Cc4ccccc4)CC3)C1CO2,KI,186.0,nM,6.730487055782083
CHEMBL419316,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccccc4)CC3)[C@@H]1CO2,KI,0.3,nM,9.522878745280337
CHEMBL74449,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells,c1c[nH]c(Nc2ccc3nccnc3c2)n1,KI,3100.0,nM,5.508638306165727
CHEMBL94129,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine,COc1cc2c(cc1OC)C1=NOC(CN3CCN(Cc4ccc5ccccc5c4)CC3)C1CO2,KI,5.0,nM,8.301029995663981
CHEMBL328377,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine,COc1cc2c(cc1OC)C1=NOC(CN3CCN(CC4=Cc5ccccc5C4)CC3)C1CO2,KI,22.0,nM,7.657577319177793
CHEMBL78190,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells,COc1cc(C)c(Nc2ncc[nH]2)cc1C(C)(C)C,KI,39.0,nM,7.4089353929735005
CHEMBL147077,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity for recombinant human Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligand.,CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1,KI,760.0,nM,6.119186407719209
CHEMBL288772,CHEMBL1867,Alpha-2a adrenergic receptor,In vivo inhibitory effect against Alpha-2A adrenergic receptor,CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C,KI,4519.0,nM,5.344957658668799
CHEMBL42335,CHEMBL1867,Alpha-2a adrenergic receptor,In vivo inhibitory effect against Alpha-2A adrenergic receptor,CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1,KI,7852.0,nM,5.105019709072032
CHEMBL295395,CHEMBL1867,Alpha-2a adrenergic receptor,In vivo inhibitory effect against Alpha-2A adrenergic receptor,CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3F)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C,KI,3388.0,nM,5.470056598341331
CHEMBL291166,CHEMBL1867,Alpha-2a adrenergic receptor,In vivo inhibitory effect against Alpha-2A adrenergic receptor,CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C,KI,1862.0,nM,5.730020323354676
CHEMBL43491,CHEMBL1867,Alpha-2a adrenergic receptor,In vivo inhibitory effect against Alpha-2A adrenergic receptor,CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1,KI,1288.0,nM,5.890084136976206
CHEMBL43594,CHEMBL1867,Alpha-2a adrenergic receptor,In vivo inhibitory effect against Alpha-2A adrenergic receptor,CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C,KI,13646.0,nM,4.864994633056113
CHEMBL43860,CHEMBL1867,Alpha-2a adrenergic receptor,In vivo inhibitory effect against Alpha-2A adrenergic receptor,CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1,KI,229.0,nM,6.6401645176601125
CHEMBL295001,CHEMBL1867,Alpha-2a adrenergic receptor,In vivo inhibitory effect against Alpha-2A adrenergic receptor,CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3F)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1,KI,1972.0,nM,5.705093089394808
CHEMBL74283,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine,Brc1c(NC2=NCCN2)ccc2c1NCCN2,KI,6.457,nM,8.18996921359416
CHEMBL72995,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine,CC1CN=C(Nc2ccc3nccnc3c2Br)N1,KI,3801.89,nM,5.420000452721522
CHEMBL844,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine,Brc1c(NC2=NCCN2)ccc2nccnc12,KI,6.761,nM,8.169989064063882
CHEMBL72753,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine,Clc1c(NC2=NCCN2)ccc2nccnc12,KI,37.15,nM,7.430041181903406
CHEMBL49137,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine,Cc1c(NC2=NCCN2)ccc2nccnc12,KI,7.244,nM,8.14002155835798
CHEMBL74342,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine,Brc1c(NC2=N[C@@H]3CCCC[C@@H]3N2)ccc2nccnc12,KI,14791.08,nM,4.830000113973616
CHEMBL73164,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine,Brc1c(NC2=NCCO2)ccc2nccnc12,KI,26302.68,nM,4.579999998661813
CHEMBL49395,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine,c1cnc2cc(NC3=NCCN3)ccc2n1,KI,309.03,nM,6.509999358109048
CHEMBL70676,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine,Ic1c(NC2=NCCN2)ccc2nccnc12,KI,6.761,nM,8.169989064063882
CHEMBL73392,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine,Brc1c(NC2=NCCS2)ccc2nccnc12,KI,10232.93,nM,4.989999996723885
CHEMBL72147,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine,Cc1cnc2c(Br)c(NC3=NCCN3)ccc2n1,KI,74.13,nM,7.130005999878258
CHEMBL289480,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscine,C1COC(NC(C2CC2)C2CC2)=N1,KI,181.97,nM,6.740000204918113
CHEMBL15245,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of [3H]- MK-912 binding against human recombinant Alpha-2A adrenergic receptor,COC(=O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O,KI,3.1,nM,8.508638306165727
CHEMBL75201,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscine,C1COC(N2CCOCC2)=N1,KI,16595.87,nM,4.779999975777493
CHEMBL134,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscine,Clc1cccc(Cl)c1NC1=NCCN1,KI,7.943,nM,8.100015437450608
CHEMBL75030,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscine,c1ccc2c(c1)CCCC2NC1=NCCO1,KI,2.344,nM,8.630042392653946
CHEMBL310335,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscine,CCC[C@H]1CCCCC1NC1=NCCO1,KI,2.951,nM,8.53003079050004
CHEMBL305928,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscine,C1CCCC(NC2=NCCO2)CC1,KI,5.37,nM,8.270025714300445
CHEMBL306377,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscine,c1ccc2c(c1)CCCC2NC1=NCCCO1,KI,25.7,nM,7.590066876668706
CHEMBL346389,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of [3H]- MK-912 binding against human recombinant Alpha-2A adrenergic receptor,O=C1COc2cc(CN3CCN(c4ccc(Cl)cc4)CC3)ccc2N1,KI,411.0,nM,6.386158178123931
CHEMBL91157,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of [3H]- rauwolscine binding to human alpha-2A adrenergic receptor,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccccc4)CC3)[C@@H]1CO2,KI,0.3,nM,9.522878745280337
CHEMBL419316,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of [3H]- rauwolscine binding to human alpha-2A adrenergic receptor,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccccc4)CC3)[C@@H]1CO2,KI,0.3,nM,9.522878745280337
CHEMBL92860,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of [3H]- rauwolscine binding to human alpha-2A adrenergic receptor,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(Cc4ccc5ccccc5c4)CC3)[C@@H]1CO2,KI,1.3,nM,8.886056647693163
CHEMBL268258,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of [3H]- rauwolscine binding to human alpha-2A adrenergic receptor,COc1cccc2c1CCC[C@H]2CN(C)CCc1ccc2ccoc2c1,KI,2.5,nM,8.602059991327963
CHEMBL90997,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of [3H]- rauwolscine binding to human alpha-2A adrenergic receptor,Fc1ccc2c(c1)CC(CC1CN=CN1)C2,KI,5.9,nM,8.229147988357855
CHEMBL328114,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of [3H]- rauwolscine binding to human alpha-2A adrenergic receptor,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C/c4ccccc4)CC3)[C@@H]1CO2,KI,2.6,nM,8.585026652029182
CHEMBL2112978,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity for alpha-2A adrenergic receptor,C(=C/c1ccccc1)\CN1CCN(C[C@@H]2ON=C3c4ccccc4OC[C@H]32)CC1,KI,0.9,nM,9.045757490560675
CHEMBL2112981,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity for alpha-2A adrenergic receptor,C(=C/c1ccccc1)\CN1CCN(C[C@@H]2ON=C3c4ccccc4NC[C@H]32)CC1,KI,20.0,nM,7.698970004336019
CHEMBL2112984,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity for alpha-2A adrenergic receptor,c1ccc2c(c1)NC[C@@H]1C2=NO[C@H]1CN1CCN(Cc2ccc3ccccc3c2)CC1,KI,4.0,nM,8.397940008672037
CHEMBL2112970,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity for Alpha-2A adrenergic receptor,CN1C[C@@H]2C(=NO[C@H]2CN2CCN(C/C=C/c3ccccc3)CC2)c2ccccc21,KI,1.6,nM,8.795880017344075
CHEMBL2112973,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity for alpha-2A adrenergic receptor,CCNC(=O)N1C[C@@H]2C(=NO[C@H]2CN2CCN(C/C=C/c3ccccc3)CC2)c2ccccc21,KI,20.0,nM,7.698970004336019
CHEMBL2112975,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity for alpha-2A adrenergic receptor,CCOC(=O)N1C[C@@H]2C(=NO[C@H]2CN2CCN(C/C=C/c3ccccc3)CC2)c2ccccc21,KI,33.0,nM,7.481486060122112
CHEMBL426959,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity for alpha-2A adrenergic receptor,CC(=O)N1C[C@@H]2C(=NO[C@H]2CN2CCN(CCC/C=C/c3ccccc3)CC2)c2ccccc21,KI,47.0,nM,7.327902142064282
CHEMBL2112983,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity for alpha-2A adrenergic receptor,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C/c4ccccc4)CC3)[C@@H]1CN2,KI,7.9,nM,8.102372908709558
CHEMBL2112985,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity for alpha-2A adrenergic receptor,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccccc4)CC3)[C@@H]1CN2,KI,2.4,nM,8.619788758288394
CHEMBL2112971,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity for alpha-2A adrenergic receptor,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccccc4)CC3)[C@@H]1CN2,KI,6.5,nM,8.187086643357144
CHEMBL2112976,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity for alpha-2A adrenergic receptor,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(Cc4ccc5ccccc5c4)CC3)[C@@H]1CN2,KI,74.0,nM,7.130768280269024
CHEMBL2112969,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity for alpha-2A adrenergic receptor,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(CCOc4ccc(F)cc4)CC3)[C@@H]1CN2,KI,9.1,nM,8.040958607678906
CHEMBL2112977,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity for alpha-2A adrenergic receptor,COc1cc2c(cc1OC)N(C)C[C@@H]1C2=NO[C@H]1CN1CCN(CCC/C(C)=C/c2ccccc2)CC1,KI,11.0,nM,7.958607314841775
CHEMBL2112979,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity for alpha-2A adrenergic receptor,C1=C[C@@H]2C(=NO[C@H]2CN2CCN(C/C=C/c3ccccc3)CC2)c2ccccc21,KI,43.0,nM,7.366531544420413
CHEMBL2112982,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity for alpha-2A adrenergic receptor,COc1ccc2c(c1)C=C[C@@H]1C2=NO[C@H]1CN1CCN(C/C=C/c2ccccc2)CC1,KI,1.8,nM,8.744727494896694
CHEMBL2112972,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity for alpha-2A adrenergic receptor,COc1ccc2c(c1)C=C[C@@H]1C2=NO[C@H]1CN1CCN(Cc2ccc3ccccc3c2)CC1,KI,1.8,nM,8.744727494896694
CHEMBL176002,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity for alpha-2A adrenergic receptor,COc1ccc2c(c1)OC[C@@H]1C2=NO[C@H]1CN1CCN(C/C(C)=C/c2ccccc2)CC1,KI,0.5,nM,9.301029995663981
CHEMBL180470,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity for alpha-2A adrenergic receptor,C/C(=C\c1ccccc1)CN1CCN(C[C@@H]2ON=C3c4ccc(O)cc4OC[C@H]32)CC1,KI,0.2,nM,9.698970004336019
CHEMBL435352,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity for alpha-2A adrenergic receptor,COCCOc1ccc2c(c1)OC[C@@H]1C2=NO[C@H]1CN1CCN(C/C(C)=C/c2ccccc2)CC1,KI,0.1,nM,10.0
CHEMBL179237,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity for alpha-2A adrenergic receptor,CCOCCOCCOc1ccc2c(c1)OC[C@@H]1C2=NO[C@H]1CN1CCN(C/C(C)=C/c2ccccc2)CC1,KI,1.3,nM,8.886056647693163
CHEMBL369378,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity for alpha-2A adrenergic receptor,C/C(=C\c1ccccc1)CN1CCN(C[C@@H]2ON=C3c4ccc(OC5CCCC5)cc4OC[C@H]32)CC1,KI,1.3,nM,8.886056647693163
CHEMBL176261,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity for alpha-2A adrenergic receptor,C/C(=C\c1ccccc1)CN1CCN(C[C@@H]2ON=C3c4ccc(OCCN(C)C)cc4OC[C@H]32)CC1,KI,0.1,nM,10.0
CHEMBL176116,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity for alpha-2A adrenergic receptor,CC(=O)Oc1ccc2c(c1)OC[C@@H]1C2=NO[C@H]1CN1CCN(C/C(C)=C/c2ccccc2)CC1,KI,0.4,nM,9.397940008672037
CHEMBL175853,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity for alpha-2A adrenergic receptor,COCC(=O)Oc1ccc2c(c1)OC[C@@H]1C2=NO[C@H]1CN1CCN(C/C(C)=C/c2ccccc2)CC1,KI,0.7,nM,9.154901959985743
CHEMBL175911,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity for alpha-2A adrenergic receptor,C/C(=C\c1ccccc1)CN1CCN(C[C@@H]2ON=C3c4ccc(OC(=O)C5CC5)cc4OC[C@H]32)CC1,KI,0.9,nM,9.045757490560675
CHEMBL180322,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity for alpha-2A adrenergic receptor,C=CC(=O)Oc1ccc2c(c1)OC[C@@H]1C2=NO[C@H]1CN1CCN(C/C(C)=C/c2ccccc2)CC1,KI,0.9,nM,9.045757490560675
CHEMBL178588,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity for alpha-2A adrenergic receptor,C/C(=C\c1ccccc1)CN1CCN(C[C@@H]2ON=C3c4ccc(OC(=O)C(C)(C)C)cc4OC[C@H]32)CC1,KI,4.7,nM,8.327902142064282
CHEMBL425324,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity for alpha-2A adrenergic receptor,C/C(=C\c1ccccc1)CN1CCN(C[C@@H]2ON=C3c4ccc(OC(=O)c5ccncc5)cc4OC[C@H]32)CC1,KI,1.0,nM,9.0
CHEMBL287837,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligand,Clc1ccc2c(c1Cl)CNCC2,KI,6520.0,nM,5.185752404268079
CHEMBL26717,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligand,NS(=O)(=O)c1ccc2c(c1)CNCC2,KI,3400.0,nM,5.468521082957745
CHEMBL281289,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligand,O=[N+]([O-])c1ccc2c(c1)CNCC2,KI,3200.0,nM,5.494850021680094
CHEMBL59719,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligand,CC1Cc2ccc([N+](=O)[O-])cc2CN1,KI,4840.0,nM,5.315154638355588
CHEMBL59441,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligand,O=[N+]([O-])c1ccc2c(c1)CNC(CO)C2,KI,3900.0,nM,5.4089353929735005
CHEMBL97282,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligand,O=[N+]([O-])c1ccc2c(c1)CNC(CF)C2,KI,3200.0,nM,5.494850021680094
CHEMBL182376,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligand,O=[N+]([O-])c1ccc2c(c1)CNC(C(F)F)C2,KI,3600.0,nM,5.443697499232712
CHEMBL112351,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligand,O=[N+]([O-])c1ccc2c(c1)CNC(C(F)(F)F)C2,KI,3400.0,nM,5.468521082957745
CHEMBL112964,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligand,FC(F)(F)C1Cc2ccc(Br)cc2CN1,KI,4350.0,nM,5.361510743045363
CHEMBL366164,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor,CN(C)C[C@H]1C[C@@H]2c3ccccc3Sc3ccc(F)cc3[C@H]2O1,KI,156.0,nM,6.806875401645538
CHEMBL329566,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor,CN(C)C[C@H]1C[C@@H]2c3ccccc3Cc3ccccc3[C@H]2O1,KI,126.0,nM,6.899629454882437
CHEMBL42,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,KI,24.0,nM,7.619788758288394
CHEMBL715,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1,KI,192.0,nM,6.71669877129645
CHEMBL85,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2,KI,10.0,nM,8.0
CHEMBL654,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor,CN1CCN2c3ncccc3Cc3ccccc3C2C1,KI,20.0,nM,7.698970004336019
CHEMBL6437,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor,CN1CCN2c3ccccc3Cc3ccccc3C2C1,KI,4.8,nM,8.318758762624412
CHEMBL195706,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor,CN(C)C[C@@H]1CC2c3ccccc3Oc3ccc(F)cc3[C@H]2O1,KI,251.0,nM,6.600326278518962
CHEMBL194659,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor,CN(C)C[C@H]1CC2c3ccccc3Oc3ccc(F)cc3[C@H]2O1,KI,269.0,nM,6.570247719997592
CHEMBL364270,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor,CN(C)C[C@@H]1CC2c3ccccc3Oc3ccc(Cl)cc3[C@H]2O1,KI,302.0,nM,6.51999305704285
CHEMBL435301,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor,CN(C)C[C@H]1CC2c3ccccc3Oc3ccc(Cl)cc3[C@H]2O1,KI,10.0,nM,8.0
CHEMBL193435,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor,CN(C)C[C@H]1CC2c3ccccc3Oc3ccc(Br)cc3[C@H]2O1,KI,407.0,nM,6.39040559077478
CHEMBL363581,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor,CN(C)C[C@@H]1CC2c3ccccc3Sc3ccc(F)cc3[C@H]2O1,KI,72.0,nM,7.142667503568731
CHEMBL193639,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor,CN(C)C[C@H]1CC2c3ccccc3Sc3ccc(F)cc3[C@H]2O1,KI,66.0,nM,7.180456064458131
CHEMBL193639,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor,CN(C)C[C@H]1CC2c3ccccc3Sc3ccc(F)cc3[C@H]2O1,KI,79.0,nM,7.102372908709558
CHEMBL15245,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity towards alpha-2a adrenergic receptor,COC(=O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O,KI,1.4,nM,8.853871964321762
CHEMBL196451,CHEMBL1867,Alpha-2a adrenergic receptor,In vitro binding affinity towards alpha-2a adrenergic receptor,O=C(CCCNC(=O)[C@@H]1C2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O)OCc1ccccc1,KI,29.0,nM,7.537602002101044
CHEMBL597,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity towards human alpha-2A adrenergic receptor expressed in Chinese Hamster ovary (CHO) cells,Cc1ccc(N(CC2=NCCN2)c2cccc(O)c2)cc1,KI,55.9,nM,7.252588192113577
CHEMBL362954,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity towards human alpha-2A adrenergic receptor expressed in Chinese Hamster ovary (CHO) cells,COc1cccc(N(NC2=NCCN2)c2ccc(C)cc2)c1,KI,6.3,nM,8.200659450546418
CHEMBL194849,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity towards human alpha-2A adrenergic receptor expressed in Chinese Hamster ovary (CHO) cells,Cc1ccc(N(NC2=NCCN2)c2cccc(O)c2)cc1,KI,23.8,nM,7.623423042943488
CHEMBL370818,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity towards human alpha-2A adrenergic receptor expressed in Chinese Hamster ovary (CHO) cells,Cc1ccc(N(NC2=NCCO2)c2cccc(O)c2)cc1,KI,4.73,nM,8.32513885926219
CHEMBL199824,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity to adrenergic alpha-2A receptor,Cn1c(=O)cnn(CCCCN2CCN(c3cccc4ccc(O[11CH3])cc34)CC2)c1=O,KI,1012.0,nM,5.994819487496219
CHEMBL371300,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]clonidine from cloned human adrenergic alpha2A receptor expressed in Sf9 cells,C[C@H](N)Cn1ncc2ccc(O)cc21,KI,2270.0,nM,5.6439741428068775
CHEMBL426317,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity to alpha 2A adrenergic receptor by radioligand binding assay,COc1cccc(N2CCN(CCCCn3ncc(=O)n(C)c3=O)CC2)c1,KI,250.0,nM,6.6020599913279625
CHEMBL150161,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity to human cloned adrenergic alpha-2A receptor by radioligand binding assay,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)C1)c1ccc(F)cc1,KI,2239.0,nM,5.649945906420969
CHEMBL210578,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity to human cloned adrenergic alpha-2A receptor by radioligand binding assay,O=C(CCCN1C2CCC1CC(O)(c1ccc(Cl)cc1)C2)c1ccc(F)cc1,KI,2835.0,nM,5.547446936771075
CHEMBL150161,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity to human cloned adrenergic alpha-2A receptor by radioligand binding assay,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)C1)c1ccc(F)cc1,KI,5817.0,nM,5.235300936201632
CHEMBL212912,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity at adrenergic alpha2A receptor,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccccc3Cl)c3ccccc32)CC1,KI,455.0,nM,6.341988603342887
CHEMBL213834,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity at adrenergic alpha2A receptor,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3cccc4ccccc34)c3ccccc32)CC1,KI,882.0,nM,6.05453141486818
CHEMBL213424,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity at adrenergic alpha2A receptor,Cc1cccc(N)c1C(=O)NN1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21,KI,456.0,nM,6.341035157335565
CHEMBL213336,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity at adrenergic alpha2A receptor,Cc1cccc(C)c1C(=O)NN1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21,KI,791.0,nM,6.101823516502323
CHEMBL378669,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity at adrenergic alpha2A receptor,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3c(N)cccc3Cl)c3ccccc32)CC1,KI,327.0,nM,6.485452247339714
CHEMBL213492,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity at adrenergic alpha2A receptor,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3c(F)cccc3C(F)(F)F)c3ccccc32)CC1,KI,2000.0,nM,5.698970004336019
CHEMBL425069,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity at adrenergic alpha2A receptor,COc1cccc(OC)c1C(=O)NN1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21,KI,169.0,nM,6.772113295386326
CHEMBL106525,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,CN1CCN(c2ccc(Nc3c4ccccc4nc4ccccc34)cc2)CC1,KI,3200.0,nM,5.494850021680094
CHEMBL217366,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,CCN1CCN(c2ccc(Nc3c4ccccc4nc4ccccc34)cc2)CC1,KI,3600.0,nM,5.443697499232712
CHEMBL217768,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,CCc1c(C)nc2c(c1Nc1ccc(N3CCN(C)C(C)C3)cc1)CCCC2,KI,630.0,nM,6.200659450546418
CHEMBL217180,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,Cc1cncc(C)c1Nc1ccc(N2CCN(C)CC2)cc1,KI,3600.0,nM,5.443697499232712
CHEMBL216399,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,Cc1cc(Nc2ccc(N3CCN(C)CC3)cc2)c2ccccc2n1,KI,500.0,nM,6.301029995663981
CHEMBL384925,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,Cc1nc2ccccc2c(Nc2ccc(N3CCN(C)CC3)cc2)c1Cc1ccccc1,KI,580.0,nM,6.236572006437063
CHEMBL216290,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,Cc1nc2ccccc2c(Nc2ccc(N3CCN(C)CC3)cc2)c1-c1ccccc1,KI,1700.0,nM,5.769551078621726
CHEMBL425622,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,Cc1nc2ccccc2c(Nc2ccc(N3CCN(C)CC3)cc2)c1C(C)C,KI,1700.0,nM,5.769551078621726
CHEMBL425803,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,CCc1c(C)nc2ccccc2c1Nc1ccc(N2CCN(C)CC2)cc1,KI,1100.0,nM,5.958607314841775
CHEMBL267464,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,Cc1nc2ccccc2c(Nc2ccc(N3CCN(C)CC3)cc2)c1C,KI,2210.0,nM,5.655607726314889
CHEMBL217665,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,CN1CCN(c2ccc(Nc3ccnc4ccccc34)cc2)CC1,KI,720.0,nM,6.142667503568731
CHEMBL216727,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,Cc1nc2ccc(F)cc2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1C,KI,1230.0,nM,5.910094888560602
CHEMBL217568,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,Cc1nc2cccc(Cl)c2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1C,KI,775.0,nM,6.110698297493689
CHEMBL1689423,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,Cc1nc2cc(Cl)ccc2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1C,KI,1430.0,nM,5.844663962534938
CHEMBL384318,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,Cc1nc2c(C)ccc(C)c2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1C,KI,2300.0,nM,5.638272163982407
CHEMBL218730,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,Cc1cc(C)c2c(Nc3ccc(N4CCN(C)C(C)C4)cc3)c(C)c(C)nc2c1,KI,650.0,nM,6.187086643357144
CHEMBL217452,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,Cc1nc2cccc(C)c2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1C,KI,680.0,nM,6.167491087293763
CHEMBL217177,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,Cc1nc2c(C)cccc2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1C,KI,1900.0,nM,5.721246399047171
CHEMBL217278,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,Cc1ccc2c(Nc3ccc(N4CCN(C)[C@@H](C)C4)cc3)c(C)c(C)nc2c1,KI,1050.0,nM,5.978810700930062
CHEMBL383978,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,Cc1ccc2c(Nc3ccc(N4CCN(C)[C@H](C)C4)cc3)c(C)c(C)nc2c1,KI,910.0,nM,6.040958607678906
CHEMBL262901,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,Cc1ccc2c(Nc3ccc(N4CCN(C)C(C)C4)cc3)c(C)c(C)nc2c1,KI,840.0,nM,6.075720713938118
CHEMBL216674,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,Cc1ccc2c(Nc3ccc(N4CCN(C)[C@@H](C)C4)cc3)c(C)c(C)nc2c1C,KI,850.0,nM,6.070581074285707
CHEMBL217567,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,Cc1ccc2c(Nc3ccc(N4CCN(C)[C@H](C)C4)cc3)c(C)c(C)nc2c1C,KI,790.0,nM,6.102372908709558
CHEMBL217203,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,Cc1ccc2c(Nc3ccc(N4CCN(C)C(C)C4)cc3)c(C)c(C)nc2c1C,KI,1850.0,nM,5.732828271596986
CHEMBL217202,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,Cc1cnc2ccccc2c1Nc1ccc(N2CCN(C)C(C)C2)cc1,KI,1400.0,nM,5.853871964321762
CHEMBL218679,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,Cc1cnc2ccccc2c1Nc1ccc(N2CCN(C)C(C)(C)C2)cc1,KI,895.0,nM,6.048176964684088
CHEMBL425983,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,Cc1nc2ccccc2c(Nc2ccc(N3CCN4CCCCC4C3)cc2)c1C,KI,715.0,nM,6.145693958198919
CHEMBL218457,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,Cc1nc2ccccc2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1-c1ccccc1,KI,1400.0,nM,5.853871964321762
CHEMBL386169,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,CCc1c(C)nc2c(C)cccc2c1Nc1ccc(N2CCCN(C)CC2)cc1,KI,8000.0,nM,5.096910013008056
CHEMBL440594,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,Cc1nc2ccccc2c(Nc2ccc(NCCN3CCCC3)cc2)c1C,KI,1000.0,nM,6.0
CHEMBL216197,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,CCc1c(C)nc2c(C)cccc2c1Nc1ccc(NCCN(CC)CC)cc1,KI,900.0,nM,6.045757490560675
CHEMBL214661,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,C[C@@H]1CN(c2ccc(Nc3c(CO)cnc4ccc(F)cc34)cc2)CCN1C,KI,980.0,nM,6.008773924307505
CHEMBL424917,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,CN1CCN(c2ccc(Nc3c(CO)cnc4ccc(F)cc34)cc2)CC1(C)C,KI,1320.0,nM,5.8794260687941495
CHEMBL276417,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,CC1CN(c2ccc(Nc3c(CO)cnc4ccc(F)cc34)cc2)CCN1C,KI,1380.0,nM,5.860120913598763
CHEMBL216464,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,CN1CCN(c2ccc(Nc3c(CO)cnc4cc(Cl)ccc34)cc2)CC1(C)C,KI,960.0,nM,6.017728766960431
CHEMBL385722,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,C[C@@H]1CN(c2ccc(Nc3c(CO)cnc4ccccc34)cc2)CCN1,KI,9600.0,nM,5.017728766960431
CHEMBL217542,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,C[C@@H]1CN(c2ccc(Nc3c(CO)cnc4ccccc34)cc2)CCN1C,KI,2200.0,nM,5.657577319177793
CHEMBL268217,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,CN1CCN(c2ccc(Nc3c(CO)cnc4ccccc34)cc2)CC1(C)C,KI,1850.0,nM,5.732828271596986
CHEMBL217254,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,Cc1c(CO)nc2ccccc2c1Nc1ccc(N2CCN(C)[C@H](C)C2)cc1,KI,1870.0,nM,5.7281583934635005
CHEMBL217253,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,Cc1nc2ccccc2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1C(C)O,KI,3100.0,nM,5.508638306165727
CHEMBL218675,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,Cc1nc2ccccc2c(Nc2ccc(N3CCN(C)C(C)(C)C3)cc2)c1CO,KI,1170.0,nM,5.931814138253838
CHEMBL214996,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,Cc1nc2ccccc2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1CO,KI,3100.0,nM,5.508638306165727
CHEMBL217299,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity to human cloned adrenergic alpha 2A receptor,Oc1cc2c(cc1O)C1c3ccccc3CNC1CO2,KI,180.0,nM,6.7447274948966935
CHEMBL128168,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells,CC(Oc1ccccc1-c1ccccc1)C1=NCCN1,KI,47.86,nM,7.320027305722581
CHEMBL221989,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells,CC(Oc1ccccc1-c1ccccn1)C1=NCCN1,KI,1202.26,nM,5.920001601921648
CHEMBL222593,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells,CC(Oc1ccccc1-c1ccccc1)C1=NCCC1,KI,8128.31,nM,5.089999741487069
CHEMBL222591,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells,CC(Oc1ccccc1-c1ccccc1)C1=NCCO1,KI,8128.31,nM,5.089999741487069
CHEMBL1204386,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells,Cl.c1ccc(-c2ccccc2C2OC2C2=NCCN2)cc1,KI,1513.56,nM,5.820000358220838
CHEMBL222933,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells,c1ccc(-c2ccccc2C2OC2C2=NCCN2)cc1,KI,1230.27,nM,5.90999956608739
CHEMBL374954,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells,CC(Sc1ccccc1-c1ccccc1)C1=NCCN1,KI,338.84,nM,6.470005326930858
CHEMBL130884,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells,CC(Nc1ccccc1-c1ccccc1)C1=NCCN1,KI,91.2,nM,7.0400051616715835
CHEMBL223836,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells,CC(Oc1ccccc1-c1cccc(F)c1)C1=NCCN1,KI,14.79,nM,7.830031826003108
CHEMBL222371,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells,CC(Oc1ccccc1-c1cccc(N)c1)C1=NCCN1,KI,37.15,nM,7.430041181903406
CHEMBL221523,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells,CC(Oc1ccccc1-c1ccc([N+](=O)[O-])cc1)C1=NCCN1,KI,123.03,nM,6.909988975992853
CHEMBL222928,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells,CC(Oc1ccccc1-c1cccc([N+](=O)[O-])c1)C1=NCCN1,KI,60.26,nM,7.219970872662662
CHEMBL222138,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells,CC(Oc1ccccc1-c1ccccc1[N+](=O)[O-])C1=NCCN1,KI,173.78,nM,6.760000207113128
CHEMBL222798,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells,CC(Oc1ccccc1-c1ccc(O)cc1)C1=NCCN1,KI,33.88,nM,7.470056598341331
CHEMBL374584,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells,CC(Oc1ccccc1-c1cccc(O)c1)C1=NCCN1,KI,27.54,nM,7.560036064079095
CHEMBL373830,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells,CC(Oc1ccccc1-c1ccccc1O)C1=NCCN1,KI,309.03,nM,6.509999358109048
CHEMBL426900,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells,Cc1ccc(-c2ccccc2OC(C)C2=NCCN2)cc1,KI,41.69,nM,7.3799681048737025
CHEMBL222973,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells,Cc1cccc(-c2ccccc2OC(C)C2=NCCN2)c1,KI,51.29,nM,7.289967300934246
CHEMBL223830,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells,Cc1ccccc1-c1ccccc1OC(C)C1=NCCN1,KI,46.77,nM,7.330032630091496
CHEMBL385310,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells,CC(Oc1ccccc1-c1ccsc1)C1=NCCN1,KI,45.71,nM,7.339988778710669
CHEMBL223829,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells,CC(Oc1ccccc1-c1cccs1)C1=NCCN1,KI,16.98,nM,7.770062314092066
CHEMBL442045,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells,CC(Oc1ccccc1-c1ccncc1)C1=NCCN1,KI,281.84,nM,6.549997369826814
CHEMBL373535,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells,CC(Oc1ccccc1-c1cccnc1)C1=NCCN1,KI,138.04,nM,6.859995049380551
CHEMBL390718,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cells,COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C(C)=C/c4ccccc4)CC3)C1CN2,KI,2.4,nM,8.619788758288394
CHEMBL318235,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cells,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccc(F)cc4)CC3)[C@@H]1CO2,KI,28.0,nM,7.552841968657781
CHEMBL318235,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cells,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccc(F)cc4)CC3)[C@@H]1CO2,KI,3.1,nM,8.508638306165727
CHEMBL318235,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cells,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccc(F)cc4)CC3)[C@@H]1CO2,KI,3.4,nM,8.468521082957745
CHEMBL226636,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cells,COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C=C/c4ccc(F)cc4)CC3)C1CO2,KI,117.0,nM,6.931814138253838
CHEMBL226636,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cells,COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C=C/c4ccc(F)cc4)CC3)C1CO2,KI,54.0,nM,7.267606240177031
CHEMBL226636,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cells,COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C=C/c4ccc(F)cc4)CC3)C1CO2,KI,9.0,nM,8.045757490560675
CHEMBL390718,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cells,COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C(C)=C/c4ccccc4)CC3)C1CN2,KI,87.0,nM,7.060480747381382
CHEMBL390718,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cells,COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C(C)=C/c4ccccc4)CC3)C1CN2,KI,1.3,nM,8.886056647693163
CHEMBL128168,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cells,CC(Oc1ccccc1-c1ccccc1)C1=NCCN1,KI,47.86,nM,7.320027305722581
CHEMBL397753,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cells,C[C@H](Oc1ccccc1-c1cccc([N+](=O)[O-])c1)C1=NCCN1,KI,72.44,nM,7.140021558357979
CHEMBL242693,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cells,C[C@@H](Oc1ccccc1-c1cccc([N+](=O)[O-])c1)C1=NCCN1,KI,81.28,nM,7.090016305060156
CHEMBL222928,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cells,CC(Oc1ccccc1-c1cccc([N+](=O)[O-])c1)C1=NCCN1,KI,60.26,nM,7.219970872662662
CHEMBL223836,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cells,CC(Oc1ccccc1-c1cccc(F)c1)C1=NCCN1,KI,14.79,nM,7.830031826003108
CHEMBL374584,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cells,CC(Oc1ccccc1-c1cccc(O)c1)C1=NCCN1,KI,27.54,nM,7.560036064079095
CHEMBL373535,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cells,CC(Oc1ccccc1-c1cccnc1)C1=NCCN1,KI,138.04,nM,6.859995049380551
CHEMBL396013,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cells,C[C@H](Oc1ccccc1-c1ccccc1)C1=NCCN1,KI,91.2,nM,7.0400051616715835
CHEMBL242265,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cells,C[C@@H](Oc1ccccc1-c1ccccc1)C1=NCCN1,KI,186.21,nM,6.72999699989494
CHEMBL10316,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells,c1ccc2c(c1)OCC(C1=NCCN1)O2,KI,8.0,nM,8.096910013008056
CHEMBL247665,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells,COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(C(=O)N4CCC(N5CCCC5)CC4)cc13)CC2,KI,186.0,nM,6.730487055782083
CHEMBL394218,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells,COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(C(=O)NC4CN5CCC4CC5)cc13)CC2,KI,42.0,nM,7.376750709602099
CHEMBL247664,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells,COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(C(=O)NCC(C)(C)N)cc13)CC2,KI,141.0,nM,6.85078088734462
CHEMBL428407,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells,COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(C(=O)NCCN(C)C)cc13)CC2,KI,454.0,nM,6.342944147142896
CHEMBL392771,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells,COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4cccc(C(=O)NCCN(C)C)c4)cc13)CC2,KI,216.0,nM,6.665546248849069
CHEMBL246852,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells,COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccccc4C(F)(F)F)cc13)CC2,KI,304.0,nM,6.517126416391246
CHEMBL393597,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells,COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccccc4F)cc13)CC2,KI,857.0,nM,6.0670191780768015
CHEMBL246639,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells,COc1cccc(-c2cc3c(CN4CCc5cc(OC)c(OC)cc5C4)ccc(OC)c3o2)c1,KI,2552.0,nM,5.593119329950875
CHEMBL392992,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells,COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccccc4)cc13)CC2,KI,1742.0,nM,5.758951849328356
CHEMBL246229,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells,COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccccn4)cc13)CC2,KI,135.0,nM,6.8696662315049934
CHEMBL392991,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells,COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccco4)cc13)CC2,KI,204.0,nM,6.690369832574101
CHEMBL246228,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells,COc1cc2c(cc1OC)CN(Cc1cnc(N)n3nc(-c4ccco4)nc13)CC2,KI,400.0,nM,6.3979400086720375
CHEMBL537669,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells,COC(=O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O.Cl,KI,1.8,nM,8.744727494896694
CHEMBL191703,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]rauwolscine from human adrenergic alpha 2C10 receptor expressed in mouse LTK- cells,C[C@H]1[C@H]2CC[C@H]3[C@@H]4CC=C5C[C@@H](N(C)C)CC[C@]5(C)[C@H]4CC[C@]23CN1C,KI,660.69,nM,6.180002266489224
CHEMBL14638,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]rauwolscine from human adrenergic alpha 2C10 receptor expressed in mouse LTK- cells,O=C(c1ccc(OCCCc2c[nH]cn2)cc1)C1CC1,KI,42.66,nM,7.36997914888659
CHEMBL260374,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]rauwolscine from human adrenergic alpha 2C10 receptor expressed in mouse LTK- cells,S=C(NC1CCCCC1)N1CCC(c2cnc[nH]2)CC1,KI,125.89,nM,6.900008766455316
CHEMBL1627,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [125I]HEAT from adrenergic alpha2A receptor,CNC(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1,KI,1.0,nM,9.0
CHEMBL493091,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]MK912 from human cloned adrenergic alpha-2a receptor,CN(C)CCCOc1ccc(CCNC(=O)c2cc(Br)c[nH]2)cc1Br,KI,69.0,nM,7.161150909262744
CHEMBL494678,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity to adrenergic alpha2A receptor,CN1CCN(c2cc(-c3ccc(C#N)cc3)nc(N)n2)CC1,KI,74.0,nM,7.130768280269024
CHEMBL516088,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of human cloned alpha2A adrenergic receptor by competitive binding experiment,COc1c(OCCF)cccc1C(=O)C1CCN(CCc2ccc(F)cc2)CC1,KI,863.0,nM,6.06398920428479
CHEMBL597,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX781094 from alpha2 adrenergic receptor,Cc1ccc(N(CC2=NCCN2)c2cccc(O)c2)cc1,KI,1.7,nM,8.769551078621726
CHEMBL273485,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells,CC(Oc1ccccc1)C1=NCCN1,KI,26.92,nM,7.5699249444480605
CHEMBL492648,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells,COC1(C2=NCCN2)COc2cccc(-c3ccccc3)c2O1,KI,125.89,nM,6.900008766455316
CHEMBL492647,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells,COC1(C2=NCCN2)COc2c(cccc2-c2ccccc2)O1,KI,257.04,nM,6.589999287456538
CHEMBL522151,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells,c1ccc(-c2cccc3c2OC(C2=NCCN2)CO3)cc1,KI,239.88,nM,6.620005959834258
CHEMBL492445,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells,c1ccc(-c2ccc3c(c2)OC(C2=NCCN2)CO3)cc1,KI,398.11,nM,6.399996913372259
CHEMBL492444,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells,c1ccc(-c2ccc3c(c2)OCC(C2=NCCN2)O3)cc1,KI,281.84,nM,6.549997369826814
CHEMBL493272,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells,c1ccc(-c2cccc3c2OCC(C2=NCCN2)O3)cc1,KI,724.44,nM,6.139997578098902
CHEMBL523048,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells,c1ccc(-c2ccccc2OC(C2=NCCN2)c2ccccc2)cc1,KI,239.88,nM,6.620005959834258
CHEMBL451229,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells,CC(Oc1ccccc1C1CCCCC1)C1=NCCN1,KI,74.13,nM,7.130005999878258
CHEMBL495096,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells,CC(Oc1ccccc1C1CCCC1)C1=NCCN1,KI,50.12,nM,7.299988937677888
CHEMBL495095,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells,C=CCc1ccccc1OC(C)C1=NCCN1,KI,57.54,nM,7.2400301424456925
CHEMBL495097,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells,CC(Oc1ccccc1/C=N/OCc1ccccc1)C1=NCCN1,KI,213.8,nM,6.669992299127241
CHEMBL492639,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells,CCO/N=C/c1ccccc1OC(C)C1=NCCN1,KI,416.87,nM,6.379999357699932
CHEMBL442815,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells,CO/N=C/c1ccccc1OC(C)C1=NCCN1,KI,660.69,nM,6.180002266489224
CHEMBL493675,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells,CC(Oc1ccccc1/C=N/O)C1=NCCN1,KI,288.4,nM,6.540004743952609
CHEMBL128168,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells,CC(Oc1ccccc1-c1ccccc1)C1=NCCN1,KI,47.86,nM,7.320027305722581
CHEMBL10332,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells,COC1(C2=NCCN2)COc2ccccc2O1,KI,0.3631,nM,9.439973751087107
CHEMBL10316,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells,c1ccc2c(c1)OCC(C1=NCCN1)O2,KI,7.079,nM,8.15002808767115
CHEMBL494885,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells,c1ccc(OC(C2=NCCN2)c2ccccc2)cc1,KI,93.33,nM,7.029978734171634
CHEMBL518592,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay,COc1ccccc1N1CCN(CC2COc3ccccc3O2)CC1,KI,506.0,nM,6.2958494831602
CHEMBL477816,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay,O=C(NCCN1CCCN(CC2COc3ccccc3O2)CC1)c1cccnc1Oc1ccccc1,KI,220.0,nM,6.657577319177793
CHEMBL478026,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay,O=C(NCCN1CCN(CC2COc3ccccc3O2)CC1)c1cccnc1Oc1ccccc1,KI,27.0,nM,7.568636235841012
CHEMBL515331,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay,N#Cc1cccc(Oc2ncccc2C(=O)NCCN2CCCN(CC3COc4ccccc4O3)CC2)c1,KI,208.0,nM,6.681936665037238
CHEMBL477608,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay,CC(C)(C)Nc1ncccc1C(=O)NCCN1CCCN(CC2COc3ccccc3O2)CC1,KI,138.0,nM,6.860120913598763
CHEMBL514837,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay,CCCCOc1ncccc1C(=O)NCCN1CCCN(CC2COc3ccccc3O2)CC1,KI,81.0,nM,7.0915149811213505
CHEMBL476569,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay,CCCCOc1cccc(C(=O)NCCN2CCCN(CC3COc4ccccc4O3)CC2)n1,KI,118.0,nM,6.928117992693874
CHEMBL476774,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay,O=C(NCCN1CCCN(CC2COc3ccccc3O2)CC1)c1cccnc1,KI,443.0,nM,6.3535962737769305
CHEMBL491419,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay,c1ccc(Oc2ncccc2COCCN2CCCN(CC3COc4ccccc4O3)CC2)cc1,KI,66.1,nM,7.17979854051436
CHEMBL491420,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay,c1ccc(Oc2ncccc2-c2noc(CN3CCCN(CC4COc5ccccc5O4)CC3)n2)cc1,KI,44.8,nM,7.3487219860018556
CHEMBL179648,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay,c1ccc(CN2CCN(CC3CCc4ccccc4O3)CC2)cc1,KI,146.1,nM,6.835349784065704
CHEMBL524153,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay,O=C(NCCN1CCCN(C[C@H]2COc3ccccc3O2)CC1)c1cccnc1Oc1ccccc1,KI,94.4,nM,7.025028005701931
CHEMBL512062,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of adrenergic alpha2A receptor,c1ccc(-c2ccccc2[C@@H]2Cc3nccn3C2)cc1,KI,213.0,nM,6.671620396561263
CHEMBL448802,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of adrenergic alpha2A receptor,c1ccc([C@@H]2Cc3nccn3C2)c(-c2ncco2)c1,KI,805.0,nM,6.094204119632131
CHEMBL448147,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of adrenergic alpha2A receptor,c1ccc([C@H]2Cc3nccn3C2)c(-c2ncco2)c1,KI,1020.0,nM,5.991399828238082
CHEMBL468710,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of adrenergic alpha2A receptor,c1ccc([C@@H]2Cc3nccn3C2)c(-c2nccs2)c1,KI,1750.0,nM,5.756961951313706
CHEMBL468711,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of adrenergic alpha2A receptor,c1cncc(-c2ccccc2[C@@H]2Cc3nccn3C2)c1,KI,991.0,nM,6.003926345514724
CHEMBL512289,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of adrenergic alpha2A receptor,c1ccc([C@@H]2Cc3nccn3C2)c(-c2ccncc2)c1,KI,112.0,nM,6.950781977329818
CHEMBL508084,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of adrenergic alpha2A receptor,Cn1cc(-c2ccccc2[C@@H]2Cc3nccn3C2)cn1,KI,380.0,nM,6.42021640338319
CHEMBL448908,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of adrenergic alpha2A receptor,c1ccc(-n2cccn2)c([C@@H]2Cc3nccn3C2)c1,KI,1100.0,nM,5.958607314841775
CHEMBL513871,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of adrenergic alpha2A receptor,CS(=O)(=O)Nc1cccc(-c2ccccc2[C@@H]2Cc3nccn3C2)c1,KI,114.0,nM,6.943095148663527
CHEMBL469127,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of adrenergic alpha2A receptor,CNS(=O)(=O)CCc1ccccc1[C@@H]1Cc2nccn2C1,KI,280.0,nM,6.552841968657781
CHEMBL466012,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of adrenergic alpha2A receptor,CNC(=O)c1cccc(-c2ccccc2[C@@H]2Cc3nccn3C2)c1,KI,202.0,nM,6.694648630553376
CHEMBL466634,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of adrenergic alpha2A receptor,Fc1ccc(-c2ncco2)c(C2Cc3nccn3C2)c1,KI,469.0,nM,6.328827157284916
CHEMBL511211,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of adrenergic alpha2A receptor,Fc1ccc(C2Cc3nccn3C2)c(-c2ccn[nH]2)c1,KI,1470.0,nM,5.8326826652518236
CHEMBL571314,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting,CC(OC1=NCCN1)c1ccccc1,KI,26.92,nM,7.5699249444480605
CHEMBL570973,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting,C=CCc1ccccc1C(C)OC1=NCCN1,KI,57.54,nM,7.2400301424456925
CHEMBL570863,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting,Cc1ccccc1C(C)OC1=NCCN1,KI,24.55,nM,7.609948503541013
CHEMBL576078,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting,CCCc1ccccc1C(C)OC1=NCCN1,KI,50.12,nM,7.299988937677888
CHEMBL576623,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting,CC(OC1=NCCN1)c1ccccc1C1CC1,KI,22.91,nM,7.6399749108106025
CHEMBL13852,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting,c1ccc(C2CC2)c(OCC2=NCCN2)c1,KI,58.88,nM,7.230032198670558
CHEMBL576819,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting,Cc1ccccc1COC1=NCCN1,KI,34.67,nM,7.460046158343603
CHEMBL569933,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting,CCCc1ccccc1COC1=NCCN1,KI,48.98,nM,7.309981219211305
CHEMBL467094,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]Clonidine from human adrenergic alpha2A receptor,COc1cc2c3c(c1OC)-c1cc4c(cc1CC3N(C)CC2)OCO4,KI,1288.0,nM,5.890084136976206
CHEMBL589390,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]MK-912 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cells,Cc1ccc2c(c1)c1c(n2CCc2ccc(C)nc2)CCN(C)C1,KI,109.65,nM,6.959991363986458
CHEMBL605081,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]MK-912 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cells,Cc1ccc(CCn2c3c(c4cc(C)ccc42)CN(C)CC3)cc1,KI,0.8128,nM,9.090016305060155
CHEMBL592752,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]MK-912 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cells,Cc1ccc2c(c1)c1c(n2CCc2ccccc2)CCN(C)C1,KI,1.995,nM,8.700057099977233
CHEMBL605405,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]MK-912 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cells,Cc1ccc2c(c1)c1c(n2/C=C\c2ccccc2)CCN(C)C1,KI,0.2399,nM,9.61996975203217
CHEMBL226335,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity to adrenergic alpha2A receptor,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(-c4ccc(O)c(O)c4)oc4cc(O)cc(O)c4c3=O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,KI,9340.0,nM,5.029653123769906
CHEMBL1085510,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]rauwolscine from adrenergic alpha2A receptor,CN1CC2C(=NO[C@H]2CN2CCN(C/C=C/c3ccccc3)CC2)c2ccccc21,KI,1.6,nM,8.795880017344075
CHEMBL1224527,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity to adrenergic alpha2A receptor,Oc1ccc2c(c1O)C[C@@H](c1ccccc1)[C@@H]1CCNC[C@@H]21,KI,3500.0,nM,5.455931955649724
CHEMBL1221498,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]MK912 from human alpha2A receptor after 60 mins,COc1ccccc1N1CCN(CCNC(=O)c2ccc3ccccc3c2)CC1,KI,1.69,nM,8.772113295386326
CHEMBL1221499,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]MK912 from human alpha2A receptor after 60 mins,COc1ccccc1N1CCN(CCNS(=O)(=O)c2ccc3ccccc3c2)CC1,KI,5.19,nM,8.284832642151542
CHEMBL1221544,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]MK912 from human alpha2A receptor after 60 mins,COc1ccccc1N1CCN(CCCNC(=O)c2ccc3ccccc3c2)CC1,KI,4.59,nM,8.338187314462738
CHEMBL497749,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]MK912 from human alpha2A receptor after 60 mins,COc1ccccc1N1CCN(CCCNS(=O)(=O)c2ccc3ccccc3c2)CC1,KI,4.64,nM,8.33348201944512
CHEMBL25236,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]MK912 from human alpha2A receptor after 60 mins,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1,KI,2.75,nM,8.560667306169737
CHEMBL1221545,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]MK912 from human alpha2A receptor after 60 mins,COc1ccccc1N1CCN(CCCCNS(=O)(=O)c2ccc3ccccc3c2)CC1,KI,4.1,nM,8.387216143280265
CHEMBL1221591,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]MK912 from human alpha2A receptor after 60 mins,COc1ccccc1N1CCN(CCCCCNC(=O)c2ccc3ccccc3c2)CC1,KI,11.1,nM,7.954677021213342
CHEMBL1221592,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]MK912 from human alpha2A receptor after 60 mins,COc1ccccc1N1CCN(CCCCCNS(=O)(=O)c2ccc3ccccc3c2)CC1,KI,8.53,nM,8.069050968832476
CHEMBL1221593,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]MK912 from human alpha2A receptor after 60 mins,COc1ccccc1N1CCN(CCCCCCNC(=O)c2ccc3ccccc3c2)CC1,KI,6.15,nM,8.211124884224583
CHEMBL1221594,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]MK912 from human alpha2A receptor after 60 mins,COc1ccccc1N1CCN(CCCCCCNS(=O)(=O)c2ccc3ccccc3c2)CC1,KI,2.87,nM,8.542118103266008
CHEMBL1242950,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity to human adrenergic alpha2A receptor by radioligand displacement assay,CCCCC1CCN(CCCC(=O)c2ccccc2C)CC1,KI,530.0,nM,6.275724130399211
CHEMBL1255771,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting,C[C@]12C[C@@]1(c1c[nH]cn1)Cc1ccccc12,KI,0.4467,nM,9.349984047528162
CHEMBL1255770,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting,CC1(C)[C@@H]2c3ccccc3C[C@@]21c1c[nH]cn1,KI,1.072,nM,8.969805214643248
CHEMBL1255724,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting,CCC[C@H]1[C@@H]2c3ccccc3C[C@]12c1c[nH]cn1,KI,0.4074,nM,9.389978975335854
CHEMBL1255723,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting,CC[C@H]1[C@@H]2c3ccccc3C[C@]12c1c[nH]cn1,KI,0.138,nM,9.860120913598763
CHEMBL1256378,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting,C[C@H]1[C@@H]2c3ccccc3C[C@]12c1c[nH]cn1,KI,0.1738,nM,9.759950227887352
CHEMBL1255617,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting,c1ccc2c(c1)[C@H]1C[C@@]1(c1c[nH]cn1)C21CC1,KI,3.89,nM,8.410050398674292
CHEMBL1255617,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting,c1ccc2c(c1)[C@H]1C[C@@]1(c1c[nH]cn1)C21CC1,KI,0.3311,nM,9.480040819247932
CHEMBL1255617,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting,c1ccc2c(c1)[C@H]1C[C@@]1(c1c[nH]cn1)C21CC1,KI,0.6026,nM,9.219970872662662
CHEMBL1255616,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting,CCC[C@H]1c2ccccc2[C@H]2C[C@]21c1c[nH]cn1,KI,0.8511,nM,9.070019409484486
CHEMBL1256610,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting,CC[C@H]1c2ccccc2[C@H]2C[C@]21c1c[nH]cn1,KI,0.5129,nM,9.289967300934247
CHEMBL1256609,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting,C[C@H]1c2ccccc2[C@H]2C[C@]21c1c[nH]cn1,KI,0.2188,nM,9.659952682338607
CHEMBL1256608,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting,CC(C)O[C@H]1c2ccccc2[C@H]2C[C@]21c1c[nH]cn1,KI,45.71,nM,7.339988778710669
CHEMBL1256566,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting,CCCO[C@H]1c2ccccc2[C@H]2C[C@]21c1c[nH]cn1,KI,3.981,nM,8.400007822415901
CHEMBL1256565,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting,CCO[C@H]1c2ccccc2[C@H]2C[C@]21c1c[nH]cn1,KI,3.311,nM,8.480040819247932
CHEMBL1256503,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting,CO[C@H]1c2ccccc2[C@H]2C[C@]21c1c[nH]cn1,KI,54.95,nM,7.26003230324049
CHEMBL1256503,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting,CO[C@H]1c2ccccc2[C@H]2C[C@]21c1c[nH]cn1,KI,0.5623,nM,9.250031916490597
CHEMBL1256503,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting,CO[C@H]1c2ccccc2[C@H]2C[C@]21c1c[nH]cn1,KI,1.738,nM,8.759950227887352
CHEMBL1256502,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting,CO[C@@H]1c2ccccc2[C@H]2C[C@]21c1c[nH]cn1,KI,11.75,nM,7.9299621333922445
CHEMBL1256414,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting,c1ccc2c(c1)C[C@]1(c3c[nH]cn3)C[C@H]21,KI,0.02818,nM,10.550059011226661
CHEMBL1256414,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting,c1ccc2c(c1)C[C@]1(c3c[nH]cn3)C[C@H]21,KI,0.07943,nM,10.100015437450608
CHEMBL1256414,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting,c1ccc2c(c1)C[C@]1(c3c[nH]cn3)C[C@H]21,KI,0.06918,nM,10.160019442321657
CHEMBL1255582,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting,CCC1(c2c[nH]cn2)Cc2ccc(F)cc2C1,KI,7.244,nM,8.14002155835798
CHEMBL353972,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting,CCC1(c2c[nH]cn2)Cc2ccccc2C1,KI,1.862,nM,8.730020323354676
CHEMBL1258223,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity to human adrenergic alpha2A receptor,CCCCN1CCC(COC(=O)c2cc(Cl)c(NC)c3c2OCCO3)CC1,KI,2239.0,nM,5.649945906420969
CHEMBL273485,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells,CC(Oc1ccccc1)C1=NCCN1,KI,26.92,nM,7.5699249444480605
CHEMBL128168,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells,CC(Oc1ccccc1-c1ccccc1)C1=NCCN1,KI,47.86,nM,7.320027305722581
CHEMBL242265,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells,C[C@@H](Oc1ccccc1-c1ccccc1)C1=NCCN1,KI,186.21,nM,6.72999699989494
CHEMBL396013,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells,C[C@H](Oc1ccccc1-c1ccccc1)C1=NCCN1,KI,91.2,nM,7.0400051616715835
CHEMBL222928,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells,CC(Oc1ccccc1-c1cccc([N+](=O)[O-])c1)C1=NCCN1,KI,60.26,nM,7.219970872662662
CHEMBL242693,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells,C[C@@H](Oc1ccccc1-c1cccc([N+](=O)[O-])c1)C1=NCCN1,KI,81.28,nM,7.090016305060156
CHEMBL397753,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells,C[C@H](Oc1ccccc1-c1cccc([N+](=O)[O-])c1)C1=NCCN1,KI,72.44,nM,7.140021558357979
CHEMBL495095,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells,C=CCc1ccccc1OC(C)C1=NCCN1,KI,57.54,nM,7.2400301424456925
CHEMBL1276139,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells,C=CCc1ccccc1O[C@H](C)C1=NCCN1,KI,100.0,nM,7.0
CHEMBL1276140,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells,C=CCc1ccccc1O[C@@H](C)C1=NCCN1,KI,52.48,nM,7.280006173632396
CHEMBL1276218,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells,CC(Oc1ccccc1C1CC1)C1=NCCN1,KI,22.91,nM,7.6399749108106025
CHEMBL1276219,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells,C[C@@H](Oc1ccccc1C1CC1)C1=NCCN1,KI,44.67,nM,7.349984047528162
CHEMBL1276220,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells,C[C@H](Oc1ccccc1C1CC1)C1=NCCN1,KI,20.89,nM,7.680061560019691
CHEMBL385310,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells,CC(Oc1ccccc1-c1ccsc1)C1=NCCN1,KI,45.71,nM,7.339988778710669
CHEMBL1276247,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells,C[C@@H](Oc1ccccc1-c1ccsc1)C1=NCCN1,KI,165.96,nM,6.779996573843064
CHEMBL1276248,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells,C[C@H](Oc1ccccc1-c1ccsc1)C1=NCCN1,KI,44.67,nM,7.349984047528162
CHEMBL374584,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells,CC(Oc1ccccc1-c1cccc(O)c1)C1=NCCN1,KI,27.54,nM,7.560036064079095
CHEMBL1278084,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells,C[C@@H](Oc1ccccc1-c1cccc(O)c1)C1=NCCN1,KI,39.81,nM,7.400007822415902
CHEMBL1278085,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells,C[C@H](Oc1ccccc1-c1cccc(O)c1)C1=NCCN1,KI,97.72,nM,7.010016541698601
CHEMBL1643900,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of alpha2A adrenergic receptor,Fc1cccc(CCN[C@H]2C3C4CC5C6C4CC3C6C52)c1,KI,7609.0,nM,5.118672415899448
CHEMBL221753,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1.[Cl-],KI,1163.0,nM,5.9344202852715515
CHEMBL493,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12,KI,5.533,nM,8.257039329785847
CHEMBL990,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CN(Cc1ccc(C(C)(C)C)cc1)Cc1cccc2ccccc12,KI,1366.6,nM,5.864358583613331
CHEMBL508112,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),c1ccc2sc(SSc3nc4ccccc4s3)nc2c1,KI,337.0,nM,6.4723700991286615
CHEMBL290106,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),Oc1c(Cl)cc(Cl)cc1Sc1cc(Cl)cc(Cl)c1O,KI,1434.0,nM,5.843450848668219
CHEMBL1201203,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CN1[C@@H]2CC[C@H]1C[C@@H](OC(c1ccccc1)c1ccccc1)C2,KI,204.0,nM,6.690369832574101
CHEMBL296419,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1,KI,1817.0,nM,5.740645072691965
CHEMBL844,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),Brc1c(NC2=NCCN2)ccc2nccnc12,KI,112.0,nM,6.950781977329818
CHEMBL1113,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2,KI,493.0,nM,6.30715308072277
CHEMBL1381098,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),S=C=Nc1cccc2ccccc12,KI,2352.0,nM,5.6285626825958985
CHEMBL153062,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CCCCCCCCCc1ccc(O)cc1,KI,2543.0,nM,5.5946536398242905
CHEMBL195437,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CCCCCCCCc1ccc(O)cc1,KI,5358.0,nM,5.270997290727809
CHEMBL633,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1,KI,117.0,nM,6.931814138253838
CHEMBL1403281,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12,KI,2.98,nM,8.525783735923746
CHEMBL1365675,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),Cc1ccc(/N=C/N(C)/C=N/c2ccc(C)cc2C)c(C)c1,KI,347.6,nM,6.458920232223371
CHEMBL629,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CN(C)CCC=C1c2ccccc2CCc2ccccc21,KI,132.0,nM,6.8794260687941495
CHEMBL311469,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CC(=O)Nc1ccc2c(c1)Cc1ccccc1-2,KI,7898.0,nM,5.1024828705994745
CHEMBL1491,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl,KI,226.0,nM,6.645891560852599
CHEMBL1289,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),Clc1cc(Cl)c(OCC#CI)cc1Cl,KI,458.0,nM,6.339134521996131
CHEMBL305660,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1,KI,311.9,nM,6.505984625242856
CHEMBL64894,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1.[Cl-],KI,201.0,nM,6.6968039425795105
CHEMBL808,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1,KI,1622.0,nM,5.789949150124863
CHEMBL679,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CNC[C@H](O)c1ccc(O)c(O)c1,KI,276.0,nM,6.559090917934782
CHEMBL420,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),N=C(N)N/N=C/c1c(Cl)cccc1Cl,KI,15.0,nM,7.823908740944319
CHEMBL496,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),Oc1c(Cl)cc(Cl)c(Cl)c1Cc1c(O)c(Cl)cc(Cl)c1Cl,KI,2061.2,nM,5.685879866210962
CHEMBL50588,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21,KI,14.0,nM,7.853871964321762
CHEMBL862,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),N=C(N)NC(=O)Cc1c(Cl)cccc1Cl,KI,50.0,nM,7.301029995663981
CHEMBL1385840,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12,KI,2.361,nM,8.626904012921273
CHEMBL30008,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),Fc1ccc(C(c2ccc(F)cc2)N2CCN(C/C=C/c3ccccc3)CC2)cc1,KI,218.0,nM,6.661543506395395
CHEMBL119443,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),C[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1,KI,630.0,nM,6.200659450546418
CHEMBL726,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,KI,80.0,nM,7.096910013008056
CHEMBL442,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)C[C@H]21,KI,0.796,nM,9.099086932262331
CHEMBL1108,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1,KI,1112.0,nM,5.953895212753961
CHEMBL54,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,KI,1865.0,nM,5.729321163855293
CHEMBL134,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),Clc1cccc(Cl)c1NC1=NCCN1,KI,105.0,nM,6.978810700930062
CHEMBL7002,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CC1(COc2ccc(CC3SC(=O)NC3=O)cc2)CCCCC1,KI,6207.0,nM,5.207118254614603
CHEMBL1729,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CCCOc2ccc(F)cc2)CC1OC,KI,666.0,nM,6.176525770829699
CHEMBL1628227,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CN(C)CCC=C1c2ccccc2COc2ccccc21,KI,501.0,nM,6.300162274132754
CHEMBL648,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CN1CCN(C(c2ccccc2)c2ccccc2)CC1,KI,582.0,nM,6.235077015350111
CHEMBL1255837,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O.CS(=O)(=O)O,KI,0.747,nM,9.126679398184601
CHEMBL1732,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21,KI,0.387,nM,9.41228903498109
CHEMBL964,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CCN(CC)C(=S)SSC(=S)N(CC)CC,KI,1839.0,nM,5.735418270761922
CHEMBL104,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1,KI,4457.0,nM,5.350957365913823
CHEMBL411,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1,KI,5297.0,nM,5.275970027064402
CHEMBL954,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CCN(CC)CCOc1ccc(/C(=C(/Cl)c2ccccc2)c2ccccc2)cc1,KI,351.0,nM,6.454692883534176
CHEMBL42,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,KI,34.0,nM,7.468521082957745
CHEMBL1200406,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CN(C)CCOC(c1ccccc1)c1ccccc1.Cn1c(=O)c2[nH]c(Cl)nc2n(C)c1=O,KI,1617.0,nM,5.791289980093599
CHEMBL71,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21,KI,132.0,nM,6.8794260687941495
CHEMBL43064,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),C(=C/c1ccccc1)\CN1CCN(C(c2ccccc2)c2ccccc2)CC1,KI,167.0,nM,6.777283528852417
CHEMBL219916,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),O=c1[nH]c2ccccc2n1CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1,KI,1027.0,nM,5.988429556402721
CHEMBL415,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21,KI,530.0,nM,6.275724130399211
CHEMBL516,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CN1CCC(=C2c3ccccc3C=Cc3ccccc32)CC1,KI,106.0,nM,6.97469413473523
CHEMBL1479,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C,KI,6873.0,nM,5.16285365609094
CHEMBL1201353,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CN(C)CC[C@@H](c1ccc(Cl)cc1)c1ccccn1,KI,7625.0,nM,5.117760151981177
CHEMBL723,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12,KI,40.0,nM,7.3979400086720375
CHEMBL334255,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CCCCCCCCCCCCCCCC[n+]1ccccc1.[Br-],KI,91.0,nM,7.040958607678906
CHEMBL1626,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1,KI,69.0,nM,7.161150909262744
CHEMBL762,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1,KI,8.639,nM,8.063536525995254
CHEMBL55,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,KI,516.0,nM,6.287350298372789
CHEMBL564,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CN(C)CCCN1c2ccccc2Sc2ccccc21,KI,126.0,nM,6.899629454882437
CHEMBL643,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CC(CN1c2ccccc2Sc2ccccc21)N(C)C,KI,256.0,nM,6.59176003468815
CHEMBL531,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CCCN1C[C@H](CSC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21,KI,99.0,nM,7.00436480540245
CHEMBL2,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC,KI,989.0,nM,6.004803708402821
CHEMBL511,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),COc1ccc(CN(CCN(C)C)c2ccccn2)cc1,KI,1116.0,nM,5.95233580539844
CHEMBL715,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1,KI,203.0,nM,6.692503962086787
CHEMBL597,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),Cc1ccc(N(CC2=NCCN2)c2cccc(O)c2)cc1,KI,2.25,nM,8.647817481888637
CHEMBL1909072,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),NC(=O)C1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,KI,25.0,nM,7.6020599913279625
CHEMBL1262,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1,KI,1531.0,nM,5.81502480930174
CHEMBL445,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CNCCC=C1c2ccccc2CCc2ccccc21,KI,275.0,nM,6.560667306169737
CHEMBL716,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1,KI,934.3,nM,6.0295136511523495
CHEMBL728,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,KI,63.0,nM,7.200659450546418
CHEMBL7568,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12,KI,855.0,nM,6.068033885271827
CHEMBL900,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),Cc1ccccc1C(OCCN(C)C)c1ccccc1,KI,809.0,nM,6.092051478387727
CHEMBL21731,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CNCCCC12CCC(c3ccccc31)c1ccccc12,KI,684.0,nM,6.164943898279883
CHEMBL86,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC,KI,1020.0,nM,5.991399828238082
CHEMBL6437,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CN1CCN2c3ccccc3Cc3ccccc3C2C1,KI,16.0,nM,7.795880017344075
CHEMBL91,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1,KI,1487.0,nM,5.827689031478046
CHEMBL1200633,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2.CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(CC[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@]54O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O,KI,2189.9,nM,5.659575716410914
CHEMBL1221512,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CC[C@H](C)[C@@H](CO[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCS(C)(=O)=O)C(=O)OC(C)C)NC[C@@H](N)CS,KI,162.0,nM,6.790484985457369
CHEMBL19215,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CN1C[C@H](CNC(=O)OCc2ccccc2)C[C@@H]2c3cccc4c3c(cn4C)C[C@H]21,KI,22.0,nM,7.657577319177793
CHEMBL157138,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CCN(CC)C(=O)N[C@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1,KI,0.116,nM,9.935542010773082
CHEMBL787,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)O)CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1,KI,1470.0,nM,5.8326826652518236
CHEMBL1909065,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CO[C@@H]1[C@@H](OC)[C@H](C)[C@@](O)(CC(=O)O)O[C@H]1[C@H](C)[C@H]1O[C@@]2(CC[C@@](C)([C@H]3CC[C@@](C)([C@@H]4O[C@@H]([C@H]5O[C@](C)(O)[C@H](C)C[C@@H]5C)C[C@@H]4O[C@@H]4C[C@H](OC)[C@@H](OC)[C@H](C)O4)O3)O2)C[C@H](O)[C@H]1C,KI,67.0,nM,7.173925197299173
CHEMBL1411979,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CN(C)CCN(Cc1cccs1)c1ccccn1,KI,437.0,nM,6.359518563029578
CHEMBL60889,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CCOc1cc(N)c(Cl)cc1C(=O)NCC1CN(Cc2ccc(F)cc2)CCO1,KI,1379.8,nM,5.860183859389425
CHEMBL1201356,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1,KI,596.0,nM,6.2247537402597635
CHEMBL157101,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,KI,7419.0,nM,5.12965462891904
CHEMBL395110,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1,KI,546.0,nM,6.262807357295262
CHEMBL1670,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),Clc1ccc(C(c2ccccc2Cl)C(Cl)Cl)cc1,KI,2755.0,nM,5.559878396812197
CHEMBL1065,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4c3c(cn4C)C[C@H]2N(C)C1,KI,611.0,nM,6.213958789757446
CHEMBL534,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CN1CCC(=C2c3ccccc3CC(=O)c3sccc32)CC1,KI,820.0,nM,6.086186147616283
CHEMBL119385,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl,KI,12813.0,nM,4.892349173853513
CHEMBL621,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12,KI,341.0,nM,6.467245621007502
CHEMBL6966,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC,KI,217.0,nM,6.66354026615147
CHEMBL15245,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),COC(=O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O,KI,2.307,nM,8.636952405478906
CHEMBL611,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC,KI,5187.0,nM,5.285083752006415
CHEMBL479,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2,KI,50.0,nM,7.301029995663981
CHEMBL972,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),C#CCN(C)[C@H](C)Cc1ccccc1,KI,674.0,nM,6.17134010346468
CHEMBL1221,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),Clc1ccc(CSC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1,KI,1516.0,nM,5.819300798703965
CHEMBL83,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CC/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,KI,726.0,nM,6.139063379299906
CHEMBL84158,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CCN(CC)CCNC(=O)c1cc(S(C)(=O)=O)ccc1OC,KI,779.0,nM,6.108462542327436
CHEMBL822,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CN(C/C=C/C#CC(C)(C)C)Cc1cccc2ccccc12,KI,2138.6,nM,5.6698704375124755
CHEMBL85,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2,KI,3.628,nM,8.440332721611941
CHEMBL12948,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CC1CCC(NC(=O)N(CCCl)N=O)CC1,KI,1803.0,nM,5.744004273277598
CHEMBL809,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21,KI,108.3,nM,6.96537154337468
CHEMBL404849,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CCCCCCCCNC(C)C(O)c1ccc(SC(C)C)cc1,KI,758.7,nM,6.119929915935932
CHEMBL833,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),Clc1ccccc1CN1CCc2sccc2C1,KI,143.0,nM,6.844663962534938
CHEMBL1306,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,KI,369.0,nM,6.432973633840939
CHEMBL26,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC,KI,757.0,nM,6.120904120499928
CHEMBL81,CHEMBL1867,Alpha-2a adrenergic receptor,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2cc(O)ccc12,KI,624.0,nM,6.204815410317575
CHEMBL1956191,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells,CC(Oc1ccccc1Cl)C1=NCCN1,KI,28.84,nM,7.540004743952609
CHEMBL1956192,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells,CC(Oc1ccccc1Br)C1=NCCN1,KI,22.91,nM,7.6399749108106025
CHEMBL1956193,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells,CC(Oc1ccccc1C(F)(F)F)C1=NCCN1,KI,181.97,nM,6.740000204918113
CHEMBL156336,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells,CCc1ccccc1OC(C)C1=NCCN1,KI,23.99,nM,7.619969752032169
CHEMBL266613,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells,CC(Oc1ccccc1C(C)C)C1=NCCN1,KI,72.44,nM,7.140021558357979
CHEMBL1956194,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells,C=C(C)c1ccccc1OC(C)C1=NCCN1,KI,72.44,nM,7.140021558357979
CHEMBL1956195,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells,CC(Oc1ccccc1CC1CC1)C1=NCCN1,KI,36.31,nM,7.439973751087107
CHEMBL1956196,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells,CCOc1ccccc1OC(C)C1=NCCN1,KI,97.72,nM,7.010016541698601
CHEMBL14208,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells,CC(C)Oc1ccccc1OC(C)C1=NCCN1,KI,83.18,nM,7.079981083971085
CHEMBL1956197,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells,CC(Oc1ccccc1OC1CC1)C1=NCCN1,KI,83.18,nM,7.079981083971085
CHEMBL1956199,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells,COc1ccccc1OC(C)C1=NCCN1,KI,57.54,nM,7.2400301424456925
CHEMBL1956200,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells,CC(Oc1ccccc1S(C)(=O)=O)C1=NCCN1,KI,3162.28,nM,5.499999678657065
CHEMBL1956201,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells,CC(Oc1ccccc1C=O)C1=NCCN1,KI,1047.13,nM,5.979999397807417
CHEMBL1956202,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells,CC(=O)c1ccccc1OC(C)C1=NCCN1,KI,1023.29,nM,5.990001269951939
CHEMBL17860,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells,CC(Oc1c(Cl)cccc1Cl)C1=NCCN1,KI,4.365,nM,8.36001575195841
CHEMBL155866,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells,Cc1cccc(C)c1OC(C)C1=NCCN1,KI,11.75,nM,7.9299621333922445
CHEMBL157955,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells,CCc1cccc(CC)c1OC(C)C1=NCCN1,KI,31.62,nM,7.50003813440381
CHEMBL157206,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells,C=CCc1cccc(CC=C)c1OC(C)C1=NCCN1,KI,16.6,nM,7.779891911959945
CHEMBL1956203,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells,CC(Oc1c(-c2ccccc2)cccc1-c1ccccc1)C1=NCCN1,KI,489.78,nM,6.309998953116937
CHEMBL10316,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation counting,c1ccc2c(c1)OCC(C1=NCCN1)O2,KI,7.079,nM,8.15002808767115
CHEMBL1956900,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation counting,c1ccc(C2COC(C3=NCCN3)CO2)cc1,KI,501.19,nM,6.299997602857746
CHEMBL1956901,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation counting,c1ccc([C@H]2CO[C@H](C3=NCCN3)CO2)cc1,KI,7943.28,nM,5.100000128334196
CHEMBL1956902,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation counting,c1ccc([C@@H]2CO[C@@H](C3=NCCN3)CO2)cc1,KI,398.11,nM,6.399996913372259
CHEMBL1956903,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation counting,c1ccc([C@H]2COC[C@@H](C3=NCCN3)O2)cc1,KI,5370.32,nM,5.269999835325843
CHEMBL1956904,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation counting,c1ccc([C@@H]2COC[C@@H](C3=NCCN3)O2)cc1,KI,6309.57,nM,5.200000237109354
CHEMBL1956906,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation counting,c1ccc(C2(c3ccccc3)COCC(C3=NCCN3)O2)cc1,KI,3801.89,nM,5.420000452721522
CHEMBL2022269,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation counting,Clc1ccc2c(c1)N=C(N1CCNCC1)c1cccnc1O2,KI,729.0,nM,6.137272471682025
CHEMBL2022272,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation counting,Clc1ccc2c(c1)N=C(N1CCN(CCc3ccccc3)CC1)c1cccnc1O2,KI,374.0,nM,6.427128397799519
CHEMBL2022273,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation counting,Clc1ccc2c(c1)N=C(N1CCN(C3CCCCC3)CC1)c1cccnc1O2,KI,412.0,nM,6.3851027839668655
CHEMBL2022275,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation counting,OCCOCCN1CCN(C2=Nc3cc(Cl)ccc3Oc3ncccc32)CC1,KI,452.0,nM,6.3448615651886175
CHEMBL2022280,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation counting,CN1CCN(C2=Nc3cc(Cl)ccc3Oc3ncccc32)CC1.O=C(O)/C=C/C(=O)O,KI,180.0,nM,6.7447274948966935
CHEMBL42,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation counting,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,KI,185.0,nM,6.732828271596986
CHEMBL134,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counter,Clc1cccc(Cl)c1NC1=NCCN1,KI,8.71,nM,8.059981844992336
CHEMBL2058631,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counter,CC1CNC(Nc2c(Cl)cccc2Cl)=N1,KI,1949.84,nM,5.710001024518515
CHEMBL289480,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counter,C1COC(NC(C2CC2)C2CC2)=N1,KI,36.31,nM,7.439973751087107
CHEMBL2058632,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counter,CC1COC(NC(C2CC2)C2CC2)=N1,KI,4897.79,nM,5.309999839831226
CHEMBL2058633,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counter,Clc1ccccc1NC1=NCCC1,KI,3019.95,nM,5.520000247408364
CHEMBL2058635,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counter,CC1CCC(Nc2ccc(I)cc2Cl)=N1,KI,2570.4,nM,5.589999287456538
CHEMBL495095,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells after 30 mins by scintillation counting,C=CCc1ccccc1OC(C)C1=NCCN1,KI,57.54,nM,7.2400301424456925
CHEMBL1276139,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells after 30 mins by scintillation counting,C=CCc1ccccc1O[C@H](C)C1=NCCN1,KI,100.0,nM,7.0
CHEMBL1276140,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells after 30 mins by scintillation counting,C=CCc1ccccc1O[C@@H](C)C1=NCCN1,KI,52.48,nM,7.280006173632396
CHEMBL1956195,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells after 30 mins by scintillation counting,CC(Oc1ccccc1CC1CC1)C1=NCCN1,KI,36.31,nM,7.439973751087107
CHEMBL2089155,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells after 30 mins by scintillation counting,C[C@@H](Oc1ccccc1CC1CC1)C1=NCCN1,KI,44.67,nM,7.349984047528162
CHEMBL2089156,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells after 30 mins by scintillation counting,C[C@H](Oc1ccccc1CC1CC1)C1=NCCN1,KI,41.69,nM,7.3799681048737025
CHEMBL2205361,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]clonidine from alpha2A adrenergic receptor after 40 mins by scintillation counting analysis,Cc1c(C(=O)N(CCCN2CCCCC2)c2ccccc2)oc2ccccc12,KI,1232.0,nM,5.909389292171593
CHEMBL2205362,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]clonidine from alpha2A adrenergic receptor after 40 mins by scintillation counting analysis,COc1cc2oc(C(=O)N(CCCN3CCCCC3)c3ccccc3)c(C)c2cc1OC,KI,945.0,nM,6.0245681914907365
CHEMBL2205360,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]clonidine from alpha2A adrenergic receptor after 40 mins by scintillation counting analysis,COc1ccc2c(C)c(C(=O)N(CCCN3CCCCC3)c3ccccc3)oc2c1,KI,653.0,nM,6.185086818724926
CHEMBL2207493,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]UK 14.304 from human adrenergic alpha2A receptor,CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1,KI,17170.0,nM,4.765229704839084
CHEMBL2205836,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity to alpha2A adrenergic receptor,COc1ccccc1CCN1C2C3C4CC5C6C4C2C6C1(O)C53,KI,1301.0,nM,5.885722703438414
CHEMBL326702,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity to Homo sapiens (human) alpha2A receptor,CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1,KI,169.82,nM,6.770011163455189
CHEMBL2261346,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity to Homo sapiens (human) alpha2A receptor,Br.CS(=O)(=O)Nc1c(O)ccc2c1CCCC2C1=NCCN1,KI,33.11,nM,7.4800408192479315
CHEMBL30713,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]Clonidine from human recombinant adrenergic alpha2A receptor expressed in MDCK cells after 1 to 1.5 hrs by scintillation counting analysis,CC(N)Cc1c[nH]c2ccccc12,KI,635.0,nM,6.197226274708024
CHEMBL30713,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]Clonidine from human recombinant adrenergic alpha2A receptor expressed in MDCK cells after 1 to 1.5 hrs by scintillation counting analysis,CC(N)Cc1c[nH]c2ccccc12,KI,630.96,nM,6.199998172182031
CHEMBL15245,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]MK912 from human recombinant alpha2A adrenergic receptor expressed in Sf9 cells after 60 mins,COC(=O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O,KI,3.1,nM,8.508638306165727
CHEMBL481153,CHEMBL1867,Alpha-2a adrenergic receptor,Antagonist activity at adrenergic alpha2A receptor (unknown origin) by PDSP assay,O=C(OCCN1CCCC1)N1c2ccccc2Sc2ccccc21,KI,95.0,nM,7.022276394711152
CHEMBL2413154,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity to adrenergic alpha2A receptor (unknown origin),COc1ccccc1N1CCN(CCCCn2ncc(=O)n(C)c2=O)CC1,KI,96.0,nM,7.017728766960431
CHEMBL2413153,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity to adrenergic alpha2A receptor (unknown origin),Cn1c(=O)cnn(CCCCN2CCN(c3ccccc3OCCF)CC2)c1=O,KI,2751.0,nM,5.560509409610317
CHEMBL404505,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity at human alpha2A AR,c1ccc2oc(C3=NCCN3)cc2c1,KI,26915.35,nM,4.569999968362492
CHEMBL2431280,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity at human alpha2A AR,c1ccc(OC2CC2)c(OCC2=NCCN2)c1,KI,316.23,nM,6.499996931948306
CHEMBL2431279,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity at human alpha2A AR,Brc1ccccc1OCC1=NCCN1,KI,95.5,nM,7.019996628416253
CHEMBL13917,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity at human alpha2A AR,CCCc1ccccc1OCC1=NCCN1,KI,48.98,nM,7.309981219211305
CHEMBL13852,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity at human alpha2A AR,c1ccc(C2CC2)c(OCC2=NCCN2)c1,KI,58.88,nM,7.230032198670558
CHEMBL2431281,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity at human alpha2A AR,c1ccc(OCC2=NCCN2)c(CC2CC2)c1,KI,77.62,nM,7.110026361596004
CHEMBL14107,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity at human alpha2A AR,C=CCc1ccccc1OCC1=NCCN1,KI,125.89,nM,6.900008766455316
CHEMBL1956197,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity at human alpha2A AR,CC(Oc1ccccc1OC1CC1)C1=NCCN1,KI,83.18,nM,7.079981083971085
CHEMBL1956192,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity at human alpha2A AR,CC(Oc1ccccc1Br)C1=NCCN1,KI,22.91,nM,7.6399749108106025
CHEMBL2431282,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity at human alpha2A AR,CCCc1ccccc1OC(C)C1=NCCN1,KI,50.12,nM,7.299988937677888
CHEMBL1276220,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity at human alpha2A AR,C[C@H](Oc1ccccc1C1CC1)C1=NCCN1,KI,20.89,nM,7.680061560019691
CHEMBL1276219,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity at human alpha2A AR,C[C@@H](Oc1ccccc1C1CC1)C1=NCCN1,KI,44.67,nM,7.349984047528162
CHEMBL1276218,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity at human alpha2A AR,CC(Oc1ccccc1C1CC1)C1=NCCN1,KI,22.91,nM,7.6399749108106025
CHEMBL2089156,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity at human alpha2A AR,C[C@H](Oc1ccccc1CC1CC1)C1=NCCN1,KI,41.69,nM,7.3799681048737025
CHEMBL2089155,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity at human alpha2A AR,C[C@@H](Oc1ccccc1CC1CC1)C1=NCCN1,KI,44.67,nM,7.349984047528162
CHEMBL1956195,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity at human alpha2A AR,CC(Oc1ccccc1CC1CC1)C1=NCCN1,KI,36.31,nM,7.439973751087107
CHEMBL1276140,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity at human alpha2A AR,C=CCc1ccccc1O[C@@H](C)C1=NCCN1,KI,52.48,nM,7.280006173632396
CHEMBL1276139,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity at human alpha2A AR,C=CCc1ccccc1O[C@H](C)C1=NCCN1,KI,100.0,nM,7.0
CHEMBL495095,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity at human alpha2A AR,C=CCc1ccccc1OC(C)C1=NCCN1,KI,57.54,nM,7.2400301424456925
CHEMBL1643900,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of adrenergic alpha2A receptor (unknown origin) by PDSP assay,Fc1cccc(CCN[C@H]2C3C4CC5C6C4CC3C6C52)c1,KI,7609.0,nM,5.118672415899448
CHEMBL2432046,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of adrenergic alpha2A receptor (unknown origin) by PDSP assay,COc1ccc(CN[C@H]2C3C4CC5C6C4CC3C6C52)cc1OC,KI,5211.0,nM,5.283078926833239
CHEMBL2436555,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]Rauwolscine from human recombinant alpha2A-adrenoceptor expressed in MDCK cells after 90 mins by scintillation counting analysis,Cl.NC1=Nc2ccc(Cl)cc2CN1,KI,316.23,nM,6.499996931948306
CHEMBL2436555,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]Rauwolscine from human recombinant alpha2A-adrenoceptor expressed in MDCK cells after 90 mins by scintillation counting analysis,Cl.NC1=Nc2ccc(Cl)cc2CN1,KI,283.0,nM,6.548213564475709
CHEMBL2441619,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity to alpha2A adrenoceptor receptor (unknown origin),Cc1ccc2nc(C(F)(F)F)cc(N3CCNCC3)c2c1,KI,1202.0,nM,5.92009553233328
CHEMBL762,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin),Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1,KI,2.291,nM,8.639974910810603
CHEMBL762,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin),Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1,KI,0.29,nM,9.537602002101044
CHEMBL3104093,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin),CN1CCc2c(c3cccc4c3n2CCc2ccccc2-4)C1,KI,407.0,nM,6.39040559077478
CHEMBL3104092,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin),CN1CCc2c(c3cccc4c3n2Cc2ccccc2C4)C1,KI,1800.0,nM,5.7447274948966935
CHEMBL3104091,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin),CN1CCc2c(c3cccc4c3n2-c2ccccc2CC4)C1,KI,228.0,nM,6.642065152999546
CHEMBL3104093,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin),CN1CCc2c(c3cccc4c3n2CCc2ccccc2-4)C1,KI,407.38,nM,6.390000296157769
CHEMBL3104092,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin),CN1CCc2c(c3cccc4c3n2Cc2ccccc2C4)C1,KI,1819.7,nM,5.740000204918113
CHEMBL3104091,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin),CN1CCc2c(c3cccc4c3n2-c2ccccc2CC4)C1,KI,229.09,nM,6.639993867770901
CHEMBL715,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assay,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1,KI,1000.0,nM,6.0
CHEMBL42,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assay,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,KI,1000.0,nM,6.0
CHEMBL1112,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assay,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,KI,100.0,nM,7.0
CHEMBL85,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assay,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2,KI,1000.0,nM,6.0
CHEMBL3217984,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assay,CN1CCC2C(C1)c1cccc3c1N2c1ccccc1CS3,KI,63.1,nM,7.199970640755866
CHEMBL1256176,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,COC1(C2=NCCN2)COc2ccccc2O1.Cl,KI,1.905,nM,8.720105019988361
CHEMBL1705,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,Cl.Clc1cccc(Cl)c1NC1=NCCN1,KI,20.89,nM,7.680061560019691
CHEMBL3289533,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,CCOc1ccc(/N=C(/N)NCc2ccco2)cc1.Cl,KI,1479.11,nM,5.829999526735649
CHEMBL3289532,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,CN(C)c1ccc(/N=C(/N)NCc2ccco2)cc1.Cl,KI,213.8,nM,6.669992299127241
CHEMBL3289531,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,Cl.N=C(NCc1ccco1)Nc1ccc2c(c1)CCCC2,KI,512.86,nM,6.2900011719748115
CHEMBL3289530,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,CCNc1ccc(/N=C(/N)NCc2ccco2)cc1.Cl,KI,1071.52,nM,5.969999718407896
CHEMBL3289529,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,Cl.N=C(NCc1ccco1)Nc1ccc2c(c1)OCO2,KI,1513.56,nM,5.820000358220838
CHEMBL3289528,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,CCOc1ccc(NC(=N)NCCO)cc1.Cl,KI,19054.61,nM,4.719999935717911
CHEMBL3289527,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,CN(C)c1ccc(NC(=N)NCCO)cc1.Cl,KI,1862.09,nM,5.7299993321845495
CHEMBL3289526,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,Cl.N=C(NCCO)Nc1ccc2c(c1)CCCC2,KI,1737.8,nM,5.760000207113128
CHEMBL3289525,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,CCNc1ccc(NC(=N)NCCO)cc1.Cl,KI,18620.87,nM,4.730000031873875
CHEMBL3289524,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,Cl.N=C(NCCO)Nc1ccc2c(c1)OCO2,KI,11748.98,nM,4.9299998354858525
CHEMBL3289523,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,CCOc1ccc(NC(=N)Nc2ccccc2)cc1.Cl,KI,2238.72,nM,5.650000220873455
CHEMBL3289522,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,CN(C)c1ccc(NC(=N)Nc2ccccc2)cc1.Cl,KI,389.05,nM,6.40999458034867
CHEMBL3289521,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,Cl.N=C(Nc1ccccc1)Nc1ccc2c(c1)CCCC2,KI,263.03,nM,6.579994715040948
CHEMBL3289520,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,CCNc1ccc(NC(=N)Nc2ccccc2)cc1.Cl,KI,4897.79,nM,5.309999839831226
CHEMBL3289534,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,Cl.N=C(Nc1ccccc1)Nc1ccc2c(c1)OCO2,KI,4365.16,nM,5.359999833093898
CHEMBL3289535,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,CCCNC(=N)Nc1ccc(OCC)cc1.Cl,KI,4265.8,nM,5.369999510099088
CHEMBL3289536,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,CCCNC(=N)Nc1ccc(N(C)C)cc1.Cl,KI,1122.02,nM,5.949999401714239
CHEMBL3289537,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,CCCNC(=N)Nc1ccc2c(c1)CCCC2.Cl,KI,676.08,nM,6.17000191130262
CHEMBL3289538,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,CCCNC(=N)Nc1ccc(NCC)cc1.Cl,KI,8317.64,nM,5.079999880484295
CHEMBL3289539,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,CCCNC(=N)Nc1ccc2c(c1)OCO2.Cl,KI,15135.61,nM,4.820000071285178
CHEMBL3289540,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,CCOc1ccc(NC(=N)N)cc1.Cl,KI,141.25,nM,6.850011543508524
CHEMBL3289541,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,CCOc1ccc(/N=C2/NCC(C)N2)cc1.Cl,KI,14125.38,nM,4.849999859991125
CHEMBL3289542,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,CC1CN/C(=N/c2ccc(N(C)C)cc2)N1.Cl,KI,3311.31,nM,5.480000159330324
CHEMBL3289543,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,CC1CN/C(=N/c2ccc3c(c2)CCCC3)N1.Cl,KI,1000.0,nM,6.0
CHEMBL3289544,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,CCNc1ccc(/N=C2/NCC(C)N2)cc1.Cl,KI,12302.69,nM,4.909999919094989
CHEMBL3289545,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,CC1CN/C(=N/c2ccc3c(c2)OCO3)N1.Cl,KI,2344.23,nM,5.629999780524884
CHEMBL3289546,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,CCOc1ccc(/N=C2/NCC(c3ccco3)N2)cc1.Cl,KI,2630.27,nM,5.579999668433626
CHEMBL3289547,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,CN(C)c1ccc(/N=C2/NCC(c3ccco3)N2)cc1.Cl,KI,1318.26,nM,5.879998925531604
CHEMBL3289548,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,Cl.c1coc(C2CN/C(=N/c3ccc4c(c3)CCCC4)N2)c1,KI,691.83,nM,6.160000609491408
CHEMBL3289549,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,CCNc1ccc(/N=C2/NCC(c3ccco3)N2)cc1.Cl,KI,2187.76,nM,5.660000322371772
CHEMBL3289550,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,Cl.c1coc(C2CN/C(=N/c3ccc4c(c3)OCO4)N2)c1,KI,1698.24,nM,5.770000934050708
CHEMBL3289551,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,CCOc1ccc(N=C2NCCN2)cc1.Cl,KI,79.43,nM,7.100015437450609
CHEMBL3289656,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]clonidine from human adrenergic-alpha2A receptor by PDSP assay,c1cnc(N2CCN(CCCc3nc4ccccc4s3)CC2)nc1,KI,844.0,nM,6.073657553374344
CHEMBL3289656,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]clonidine from human adrenergic-alpha2A receptor by PDSP assay,c1cnc(N2CCN(CCCc3nc4ccccc4s3)CC2)nc1,KI,851.14,nM,6.069998998990925
CHEMBL3104093,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity to adrenergic alpha 2A receptor (unknown origin),CN1CCc2c(c3cccc4c3n2CCc2ccccc2-4)C1,KI,407.0,nM,6.39040559077478
CHEMBL1186220,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RS-79948-197 from human alpha2A adrenoceptor expressed in CHO-K1 cells after 45 mins by liquid scintillation counting,c1ccc2c(c1)cnn2N=C1NCCN1,KI,52.0,nM,7.2839966563652006
CHEMBL3343699,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RS-79948-197 from human alpha2A adrenoceptor expressed in CHO-K1 cells after 45 mins by liquid scintillation counting,Fc1ccc2cnn(N=C3NCCN3)c2c1,KI,33.0,nM,7.481486060122112
CHEMBL3343700,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RS-79948-197 from human alpha2A adrenoceptor expressed in CHO-K1 cells after 45 mins by liquid scintillation counting,Fc1cccc2cnn(N=C3NCCN3)c12,KI,65.0,nM,7.187086643357144
CHEMBL3608450,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity to alpha2A adrenoceptor (unknown origin),COc1cc2c3c(c1OC)-c1cc4c(cc1CC3N(C)CC2c1ccccc1)OCO4,KI,719.0,nM,6.1432711096171175
CHEMBL3735756,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]Rauwolscine from human recombinant alpha 2A receptor stably expressed in MDCK cells after 90 mins by scintillation counting method,COc1ccc(CCN(CCCc2ccccc2)CCc2ccc3c(c2)OCO3)cc1OC,KI,102.0,nM,6.991399828238082
CHEMBL3754496,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity to alpha-2A adrenergic receptor (unknown origin) by competition binding assay,C=CCN(CC=C)CCc1c[nH]c2ccc(F)cc12,KI,117.49,nM,6.929999096197655
CHEMBL3752900,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity to alpha-2A adrenergic receptor (unknown origin) by competition binding assay,C=CCN(CC=C)CCc1c[nH]c2ccc(Cl)cc12,KI,81.28,nM,7.090016305060156
CHEMBL3754166,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity to alpha-2A adrenergic receptor (unknown origin) by competition binding assay,C=CCN(CC=C)CCc1c[nH]c2ccc(Br)cc12,KI,83.18,nM,7.079981083971085
CHEMBL3753318,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity to alpha-2A adrenergic receptor (unknown origin) by competition binding assay,C=CCN(CC=C)CCc1c[nH]c2ccc(C)cc12,KI,194.98,nM,6.710009933945681
CHEMBL2391541,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity to alpha-2A adrenergic receptor (unknown origin) by competition binding assay,C=CCN(CC=C)CCc1c[nH]c2ccc(OC)cc12,KI,213.8,nM,6.669992299127241
CHEMBL3752576,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity to alpha-2A adrenergic receptor (unknown origin) by competition binding assay,C=CCN(CC=C)CCc1c[nH]c2ccccc12,KI,123.03,nM,6.909988975992853
CHEMBL3769968,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity to human alpha-2A adrenergic receptor by radioligand binding assay,C=CCOc1cc(F)c(F)cc1C1CC1CN.Cl,KI,165.96,nM,6.779996573843064
CHEMBL3769968,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity to human alpha-2A adrenergic receptor by radioligand binding assay,C=CCOc1cc(F)c(F)cc1C1CC1CN.Cl,KI,661.0,nM,6.17979854051436
CHEMBL3897499,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]Rauwolscine from human Alpha2A receptor expressed in MDCK cells measured after 90 mins by microbeta scintillation counting method,CCCN1CC[C@H]2c3cc4ccc(C(F)(F)F)cc4nc3[C@H](CC)[C@H]3CCC[C@@H]1[C@@H]32,KI,1586.0,nM,5.799696817018415
CHEMBL4082473,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H] MK-912 from human adrenergic alpha 2A receptor expressed in HT29 cells after 60 mins,COc1ccc2c(c1)c(CN1CCN(C)CC1)cn2S(=O)(=O)c1ccccc1Br.CS(=O)(=O)O.O,KI,2570.0,nM,5.590066876668706
CHEMBL4090355,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]Rauwolscine from human adrenergic alpha2A receptor,CNC(=O)[C@H]1O[C@@H](n2cnc3c(NC)nc(C#Cc4ccc(Cl)s4)nc32)[C@H](O)[C@@H]1O,KI,5000.0,nM,5.301029995663981
CHEMBL4086593,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]Rauwolscine from human adrenergic alpha2A receptor,CCCNc1nc(C#Cc2ccc(Cl)s2)nc2c1ncn2[C@@H]1O[C@H](C(=O)NC)[C@@H](O)[C@H]1O,KI,5000.0,nM,5.301029995663981
CHEMBL267014,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of alpha2A adrenergic receptor (unknown origin),Clc1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1,KI,170.0,nM,6.769551078621726
CHEMBL346389,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of alpha2A adrenergic receptor (unknown origin),O=C1COc2cc(CN3CCN(c4ccc(Cl)cc4)CC3)ccc2N1,KI,411.0,nM,6.386158178123931
CHEMBL146556,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of alpha2A adrenergic receptor (unknown origin),c1ccc2c(c1)CC(CN1CCN(c3ccc4c(c3)OCCO4)CC1)C2,KI,249.0,nM,6.603800652904264
CHEMBL4161503,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]-Rauwolscine from human adrenergic alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting method,c1ccc(CN2Cc3ccc(N4CCOCC4)cc3C2)cc1,KI,2089.0,nM,5.680061560019691
CHEMBL4169752,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]-Rauwolscine from human adrenergic alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting method,c1ccc(CN2CCc3cc(N4CCOCC4)ccc3C2)cc1,KI,321.0,nM,6.493494967595128
CHEMBL4167315,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]-Rauwolscine from human adrenergic alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting method,COc1cccc(-c2ccc3c(c2)CN(Cc2ccccc2)C3)c1,KI,1685.0,nM,5.773400094792643
CHEMBL4163428,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]-Rauwolscine from human adrenergic alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting method,CN1CCN(c2ccc3c(c2)CN(C(=O)OCc2ccccc2)C3)CC1,KI,487.0,nM,6.3124710387853655
CHEMBL4173095,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]-Rauwolscine from human adrenergic alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting method,C=C(C)CN1CCN(c2ccc3c(c2)CN(C(=O)OCc2ccccc2)CC3)CC1,KI,876.0,nM,6.05749589383192
CHEMBL4165863,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]-Rauwolscine from human adrenergic alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting method,O=C(OCc1ccccc1)N1CCc2ccc(N3CCN(C4CCCC4)CC3)cc2C1,KI,506.0,nM,6.2958494831602
CHEMBL4217398,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]Rauwolscine from human adrenergic alpha2A receptor expressed in MDCK cell membranes after 90 mins by scintillation counting method,CC(C)(C)OC(=O)NCCCCCCn1cc(CCCCN2CCC(c3ccc(-c4cc(C(=O)O)cc5cc(-c6ccc(C(F)(F)F)cc6)ccc45)cc3)CC2)nn1,KI,5280.0,nM,5.277366077466188
CHEMBL4216870,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]Rauwolscine from human adrenergic alpha2A receptor expressed in MDCK cell membranes after 90 mins by scintillation counting method,NCCCCCCn1cc(CCCCN2CCC(c3ccc(-c4cc(C(=O)O)cc5cc(-c6ccc(C(F)(F)F)cc6)ccc45)cc3)CC2)nn1,KI,28.0,nM,7.552841968657781
CHEMBL4285281,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity to andrenergic alpha2A receptor (unknown origin) assessed as inhibition of radioligand binding by radioligand competition binding assay,COc1cc2c3c(c1OC)-c1ccccc1[C@@H](O)[C@@H]3NCC2,KI,1147.0,nM,5.940436582098732
CHEMBL76,CHEMBL1867,Alpha-2a adrenergic receptor,Activity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscine,CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12,KI,4365.16,nM,5.359999833093898
CHEMBL1626,CHEMBL1867,Alpha-2a adrenergic receptor,Activity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscine,CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1,KI,169.82,nM,6.770011163455189
CHEMBL1535,CHEMBL1867,Alpha-2a adrenergic receptor,Activity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscine,CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12,KI,6456.54,nM,5.190000154058473
CHEMBL53325,CHEMBL1867,Alpha-2a adrenergic receptor,Activity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscine,COc1cccc2c1CCCC2CCCN1CCN(C2CCCCC2)CC1,KI,1513.56,nM,5.820000358220838
CHEMBL4088272,CHEMBL1867,Alpha-2a adrenergic receptor,Activity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscine,CCCN1CCC=C(c2cc(-c3ccc(C)cc3)no2)C1,KI,8317.64,nM,5.079999880484295
CHEMBL4472703,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]-Rauwolscine from human recombinant adrenergic Alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting method,CC[C@H]1c2cc(OC)ccc2CC[C@@]1(C)N,KI,6309.57,nM,5.200000237109354
CHEMBL4572167,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]-Rauwolscine from human recombinant adrenergic Alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting method,CC[C@H]1c2ccccc2N(c2ccccc2)C[C@@]1(C)N,KI,398.11,nM,6.399996913372259
CHEMBL4442460,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H] RX821002 from alpha2A adrenergic receptor (unknown origin),COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccccc2)c2ccccc2)CC1,KI,400.0,nM,6.3979400086720375
CHEMBL4544086,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H] RX821002 from alpha2A adrenergic receptor (unknown origin),COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccc(F)cc2)c2ccccc2)CC1,KI,860.0,nM,6.065501548756432
CHEMBL4533687,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3ccc(Oc4ccccc4)cc3)C(=O)C21,KI,3715.35,nM,5.430000267796055
CHEMBL4590209,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3ccc(-c4ccccc4)cc3)C(=O)C21,KI,7585.78,nM,5.119999756699334
CHEMBL4438801,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3cccc([N+](=O)[O-])c3)C(=O)C21,KI,0.06607,nM,10.179995693191682
CHEMBL4459403,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3c(Cl)cc(Cl)cc3Cl)C(=O)C21,KI,6918.31,nM,5.159999981744464
CHEMBL4456882,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3cc(Cl)cc(Cl)c3)C(=O)C21,KI,602.56,nM,6.219999701663429
CHEMBL4528557,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3ccccc3Cl)C(=O)C21,KI,707.95,nM,6.149997413907538
CHEMBL4475933,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3ccc(F)cc3)C(=O)C21,KI,4570.88,nM,5.3400001801593495
CHEMBL4476557,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3ccc(C(F)(F)F)cc3)C(=O)C21,KI,18620.87,nM,4.730000031873875
CHEMBL4553853,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(C3Cc4ccccc4C3)C(=O)C21,KI,363078.05,nM,3.4400000057057394
CHEMBL4587003,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(CCc3ccc(F)cc3)C(=O)C21,KI,2238.72,nM,5.650000220873455
CHEMBL4434967,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(CCc3ccccc3)C(=O)C21,KI,169824.37,nM,3.7699999878429686
CHEMBL4438158,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(Cc3ccccc3)C(=O)C21,KI,7.762,nM,8.110026361596004
CHEMBL4445396,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(CC34CC5CC(CC(C5)C3)C4)C(=O)C21,KI,48977.88,nM,4.3100000171743025
CHEMBL4554450,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(C(C)(C)C)C(=O)C21,KI,169.82,nM,6.770011163455189
CHEMBL4587519,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(CC)C(=O)C21,KI,1412.54,nM,5.849999245077862
CHEMBL4568994,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CCOP(=O)(OCC)C1(Cc2ccc(F)cc2)N=CC2C(=O)N(c3ccccc3)C(=O)C21,KI,63.1,nM,7.199970640755866
CHEMBL4469237,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CCOP(=O)(OCC)C1(Cc2ccccc2)N=CC2C(=O)N(c3ccccc3)C(=O)C21,KI,114815.36,nM,3.940000008131297
CHEMBL4584406,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CCOP(=O)(OCC)C1(c2ccc(OC)cc2)N=CC2C(=O)N(c3ccccc3)C(=O)C21,KI,141253.75,nM,3.8500000137195762
CHEMBL4465834,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CCOP(=O)(OCC)C1(c2ccc(F)cc2)N=CC2C(=O)N(c3ccc(F)c(Cl)c3)C(=O)C21,KI,416869.38,nM,3.380000003615395
CHEMBL4454147,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CCOP(=O)(OCC)C1(c2ccc(F)cc2)N=CC2C(=O)N(c3ccccc3)C(=O)C21,KI,169.82,nM,6.770011163455189
CHEMBL4534152,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3ccc(OC)cc3)C(=O)C21,KI,25703.96,nM,4.589999963296594
CHEMBL4450506,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3ccc(F)c(Cl)c3)C(=O)C21,KI,537.03,nM,6.270001452716578
CHEMBL4450506,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3ccc(F)c(Cl)c3)C(=O)C21,KI,53.0,nM,7.275724130399211
CHEMBL4482861,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3ccccc3)C(=O)C21,KI,0.04169,nM,10.379968104873702
CHEMBL4535472,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(C3CCCCC3)C(=O)C21,KI,0.9772,nM,9.010016541698601
CHEMBL4459090,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(C)C(=O)C21,KI,1174.9,nM,5.929999096197655
CHEMBL4536304,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CCOP(=O)(OCC)C1N=CC2C(=O)N(c3ccc(OC)cc3)C(=O)C21,KI,0.0537,nM,10.270025714300445
CHEMBL4439953,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CCOP(=O)(OCC)C1N=CC2C(=O)N(c3ccc(F)c(Cl)c3)C(=O)C21,KI,3.236,nM,8.489991487059765
CHEMBL4546903,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CCOP(=O)(OCC)C1N=CC2C(=O)N(c3ccccc3)C(=O)C21,KI,9549.93,nM,5.019999811738259
CHEMBL4483022,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CCOP(=O)(OCC)C1N=CC2C(=O)N(C3CCCCC3)C(=O)C21,KI,0.3236,nM,9.489991487059765
CHEMBL4467833,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CCOP(=O)(OCC)C1N=CC2C(=O)N(C)C(=O)C21,KI,4.467,nM,8.349984047528162
CHEMBL151697,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,c1ccc2oc(-c3ncc[nH]3)cc2c1,KI,6760.83,nM,5.169999984192582
CHEMBL404505,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,c1ccc2oc(C3=NCCN3)cc2c1,KI,229.09,nM,6.639993867770901
CHEMBL275970,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,C(=C/c1ccccc1)\C1=NCCN1,KI,46773.51,nM,4.330000038335378
CHEMBL2179398,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,c1ccc(-c2ncc3cc(-n4ccnc4)ccc3n2)cc1,KI,2238721.14,nM,2.6499999997222687
CHEMBL41103,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,Cn1c(C2=NCCN2)cc2ccccc21,KI,42657.95,nM,4.3700000191416315
CHEMBL4471712,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of alpha2a receptor (unknown origin),O[C@@H]1[C@H](O)[C@@H]2C[C@@H]2[C@H]1n1cnc2c(NC(C3CCC3)C3CCC3)nc(Cl)nc21,KI,6960.0,nM,5.157390760389438
CHEMBL4554295,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of alpha2a receptor (unknown origin),O[C@H]1[C@H](n2cnc3c(NC(C4CCC4)C4CCC4)ncnc32)[C@H]2C[C@@]2(CCl)[C@H]1O,KI,6800.0,nM,5.167491087293763
CHEMBL299031,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX 821002 from human recombinant adrenergic alpha-2A receptor expressed in CHO cell membranes incubated for 60 mins,CC[C@@H]1CN2CCc3c([nH]c4cccc(OC)c34)[C@@H]2C[C@@H]1/C(=C\OC)C(=O)OC,KI,4720.0,nM,5.3260580013659125
CHEMBL15245,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX 821002 from human recombinant adrenergic alpha-2A receptor expressed in CHO cell membranes incubated for 60 mins,COC(=O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O,KI,3.13,nM,8.504455662453552
CHEMBL4277264,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]-rauwolscine from recombinant human alpha2A adrenergic receptor stably expressed in MDCK cells measured after 90 mins by microbeta scintillation counting method,Cc1cc(Oc2nccc3occc23)ccc1-c1c(C)ncc2nccn12,KI,3400.0,nM,5.468521082957745
CHEMBL4572614,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]-rauwolscine from recombinant human alpha2A adrenergic receptor stably expressed in MDCK cells measured after 90 mins by microbeta scintillation counting method,Cc1ncc2nccn2c1-c1ccc(Oc2nccc3occc23)cc1C(F)(F)F,KI,6800.0,nM,5.167491087293763
CHEMBL4469848,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]-rauwolscine from recombinant human alpha2A adrenergic receptor stably expressed in MDCK cells measured after 90 mins by microbeta scintillation counting method,FC(F)(F)c1cc(Oc2nccc3occc23)ccc1-c1cccc2nccn12,KI,5100.0,nM,5.292429823902063
CHEMBL4466483,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]-rauwolscine from recombinant human alpha2A adrenergic receptor stably expressed in MDCK cells measured after 90 mins by microbeta scintillation counting method,FC(F)(F)c1cc(Oc2nccc3ccsc23)ccc1-c1cccc2nccn12,KI,2600.0,nM,5.585026652029182
CHEMBL4514672,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H] NECA from human adrenergic alpha 2A receptor expressed in MDCK cells by radioligand binding assay,CC1=NC2(CCN(C)CC2)C(=O)N(c2c(C)cccc2C)C1=O,KI,3364.0,nM,5.473144012874125
CHEMBL4544251,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity to human alpha2A receptor expressed in MDCK cells by PDSP assay,O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)cc(-n2cc(-c3ccc(Cl)s3)nn2)c1,KI,1560.0,nM,5.806875401645538
CHEMBL4633982,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity to adrenergic alpha2A receptor (unknown origin),O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)cc(-c2cn(-c3ccc(C(F)(F)F)cc3)nn2)c1,KI,960.0,nM,6.017728766960431
CHEMBL49623,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha-2A adrenergic receptor (unknown origin),C[C@@H]([C@H](O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1,KI,1600.0,nM,5.795880017344075
CHEMBL113830,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha-2A adrenergic receptor (unknown origin),C[C@H]([C@@H](O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1,KI,2300.0,nM,5.638272163982407
CHEMBL493054,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha-2A adrenergic receptor (unknown origin),C[C@H]([C@H](O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1,KI,5500.0,nM,5.259637310505756
CHEMBL319706,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from alpha-2A adrenergic receptor (unknown origin),C[C@@H]([C@@H](O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1,KI,6100.0,nM,5.214670164989233
CHEMBL4777306,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity to alpha 2A adrenoceptor (unknown origin),C=C1CCN2Cc3ccc(OC)cc3[C@H]3CCCC[C@]32C1,KI,531.0,nM,6.274905478918531
CHEMBL4784373,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity to alpha2 adrenergic receptor (unknown origin),CC(=O)Nc1ccc(OCCCN2CCC(c3noc4cc(F)ccc34)CC2)cc1,KI,16.3,nM,7.787812395596042
CHEMBL85,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity to alpha2 adrenergic receptor (unknown origin),Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2,KI,28.2,nM,7.549750891680639
CHEMBL4794963,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity to alpha2 adrenergic receptor (unknown origin),CC(=O)Nc1ccc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)cc1,KI,193.0,nM,6.714442690992226
CHEMBL4848380,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity to alpha2a (unknown origin),O=CN1CCC(c2ccc(-c3cc(C(=O)O)cc4cc(-c5ccc(C(F)(F)F)cc5)ccc34)cc2)CC1,KI,3970.0,nM,5.401209493236885
CHEMBL4875858,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of alpha2a adrenergic receptor (unknown origin),O=[N+]([O-])C1=Cc2cc(I)ccc2OC1C(F)(F)F,KI,4800.0,nM,5.318758762624412
CHEMBL4851349,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of alpha2a adrenergic receptor (unknown origin),C[Si](C)(C)C#Cc1ccc2c(c1)C=C([N+](=O)[O-])C(C(F)(F)F)O2,KI,4700.0,nM,5.327902142064282
CHEMBL4848838,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of alpha2a adrenergic receptor (unknown origin),CC(=O)NCC#Cc1ccc2c(c1)C=C([N+](=O)[O-])C(C(F)(F)F)O2,KI,2200.0,nM,5.657577319177793
CHEMBL4856060,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of alpha2a adrenergic receptor (unknown origin),CC(C)(C)OC(=O)NCC#Cc1ccc2c(c1)C=C([N+](=O)[O-])C(C(F)(F)F)O2,KI,940.0,nM,6.026872146400301
CHEMBL4857492,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of alpha2a adrenergic receptor (unknown origin),O=C(O)c1ccc(C#Cc2ccc3c(c2)C=C([N+](=O)[O-])C(C(F)(F)F)O3)cc1,KI,1800.0,nM,5.7447274948966935
CHEMBL4845850,CHEMBL1867,Alpha-2a adrenergic receptor,Inhibition of alpha2a adrenergic receptor (unknown origin),O=C1c2ccccc2C(=O)N1CC#Cc1ccc2c(c1)C=C([N+](=O)[O-])C(C(F)(F)F)O2,KI,650.0,nM,6.187086643357144
CHEMBL4867565,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity to human adrenergic alpha 2A receptor,O=S(=O)(c1cccc(F)c1)n1ccc2c(N3CCNCC3)nc3ccccc3c21,KI,110.0,nM,6.958607314841775
CHEMBL4535474,CHEMBL1867,Alpha-2a adrenergic receptor,GPCRScan assay: inhibition of Alpha2A,CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1,KI,381.33,nM,6.418699026559686
CHEMBL4535474,CHEMBL1867,Alpha-2a adrenergic receptor,GPCRScan assay: inhibition of Alpha2A,CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1,KI,380.19,nM,6.41999931041096
CHEMBL4520788,CHEMBL1867,Alpha-2a adrenergic receptor,GPCRScan assay: inhibition of Alpha2A,CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1,KI,127.42,nM,6.8947623992539775
CHEMBL4520788,CHEMBL1867,Alpha-2a adrenergic receptor,GPCRScan assay: inhibition of Alpha2A,CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1,KI,125.89,nM,6.900008766455316
CHEMBL4558518,CHEMBL1867,Alpha-2a adrenergic receptor,GPCRScan assay: inhibition of Alpha2A,CC(C)(C)OC(=O)N1CCCC1CNC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1,KI,237.0,nM,6.625251653989896
CHEMBL4558518,CHEMBL1867,Alpha-2a adrenergic receptor,GPCRScan assay: inhibition of Alpha2A,CC(C)(C)OC(=O)N1CCCC1CNC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1,KI,234.42,nM,6.630005338391571
CHEMBL1800685,CHEMBL1867,Alpha-2a adrenergic receptor,Adrenergic alpha2A Eurofins-Panlabs radioligand binding assay,O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1,KI,1530.0,nM,5.815308569182401
CHEMBL3582478,CHEMBL1867,Alpha-2a adrenergic receptor,GPCRScan assay: inhibition of Alpha2A,CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1,KI,2606.75,nM,5.583900617787052
CHEMBL3582478,CHEMBL1867,Alpha-2a adrenergic receptor,GPCRScan assay: inhibition of Alpha2A,CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1,KI,2630.27,nM,5.579999668433626
CHEMBL3480577,CHEMBL1867,Alpha-2a adrenergic receptor,GPCRScan assay: inhibition of Alpha2A,Cc1ccc2nc(CNCCCOc3ccccc3)cc(O)c2c1,KI,10000.0,nM,5.0
CHEMBL3480577,CHEMBL1867,Alpha-2a adrenergic receptor,GPCRScan assay: inhibition of Alpha2A,Cc1ccc2nc(CNCCCOc3ccccc3)cc(O)c2c1,KI,1000000000.0,nM,0.0
CHEMBL4549667,CHEMBL1867,Alpha-2a adrenergic receptor,GPCRScan assay: inhibition of Alpha2A,CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21,KI,2355.74,nM,5.627872643764517
CHEMBL4549667,CHEMBL1867,Alpha-2a adrenergic receptor,GPCRScan assay: inhibition of Alpha2A,CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21,KI,2344.23,nM,5.629999780524884
CHEMBL5191141,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX 821002 from recombinant human alpha2A receptor measured after 60 mins by scintillation counting analysis,[2H]c1c([2H])c([2H])c([C@@H]2C[C@@H](N3CCN(C([2H])([2H])[2H])C(C)(C)C3)c3cc(Cl)ccc32)c([2H])c1[2H],KI,560.0,nM,6.251811972993799
CHEMBL5201983,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX 821002 from recombinant human alpha2A receptor measured after 60 mins by scintillation counting analysis,[2H]c1c([2H])c([2H])c([C@@H]2C[C@@H](N3CCNC(C)(C)C3)c3cc(Cl)ccc32)c([2H])c1[2H],KI,2500.0,nM,5.6020599913279625
CHEMBL4520788,CHEMBL1867,Alpha-2a adrenergic receptor,Selectivity interaction (GPCR panel (PDSP screen)) EUB0000743a ADRA2A,CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1,KI,127.42,nM,6.8947623992539775
CHEMBL4558518,CHEMBL1867,Alpha-2a adrenergic receptor,Selectivity interaction (GPCR panel (PDSP screen)) EUB0000741a ADRA2A,CC(C)(C)OC(=O)N1CCCC1CNC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1,KI,237.0,nM,6.625251653989896
CHEMBL4549667,CHEMBL1867,Alpha-2a adrenergic receptor,Selectivity interaction (GPCR panel (PDSP screen)) EUB0000720a ADRA2A,CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21,KI,2355.74,nM,5.627872643764517
CHEMBL4576555,CHEMBL1867,Alpha-2a adrenergic receptor,Selectivity interaction (GPCR panel (PDSP screen)) EUB0000705a ADRA2A,CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5cc(C(C)(C)C)cc(C(C)(C)C)c5)ccc4n3)cc2)CC1,KI,2659.0,nM,5.5752816626684325
CHEMBL4576555,CHEMBL1867,Alpha-2a adrenergic receptor,GPCRScan assay: inhibition of Alpha2A,CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5cc(C(C)(C)C)cc(C(C)(C)C)c5)ccc4n3)cc2)CC1,KI,2658.89,nM,5.5752996293405594
CHEMBL4576555,CHEMBL1867,Alpha-2a adrenergic receptor,GPCRScan assay: inhibition of Alpha2A,CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5cc(C(C)(C)C)cc(C(C)(C)C)c5)ccc4n3)cc2)CC1,KI,2630.27,nM,5.579999668433626
CHEMBL4642079,CHEMBL1867,Alpha-2a adrenergic receptor,GPCRScan assay: inhibition of Alpha2A,Cc1c(N2CCNCC2)nc2ccc(Br)cc2c1C(=O)NC[C@H](CCC(=O)O)c1ccccc1Cl,KI,8468.01,nM,5.072218637787456
CHEMBL4642079,CHEMBL1867,Alpha-2a adrenergic receptor,GPCRScan assay: inhibition of Alpha2A,Cc1c(N2CCNCC2)nc2ccc(Br)cc2c1C(=O)NC[C@H](CCC(=O)O)c1ccccc1Cl,KI,8511.38,nM,5.070000019492822
CHEMBL5094181,CHEMBL1867,Alpha-2a adrenergic receptor,GPCRScan assay: inhibition of Alpha2A,O=C(NCCCn1ccnc1)c1cc2nc(-c3ccccc3)cc(-c3ccccc3)n2n1,KI,3826.48,nM,5.417200552271113
CHEMBL5094181,CHEMBL1867,Alpha-2a adrenergic receptor,GPCRScan assay: inhibition of Alpha2A,O=C(NCCCn1ccnc1)c1cc2nc(-c3ccccc3)cc(-c3ccccc3)n2n1,KI,3801.89,nM,5.420000452721522
CHEMBL5395401,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity to alpha2A receptor (unknown origin) assessed as inhibition constant,CCN(CC)CCCC(C)Nc1cnc(C(=O)Nc2ccc(Cl)c3cccnc23)cn1,KI,2738.0,nM,5.562566556202029
CHEMBL5431371,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity to alpha2A receptor (unknown origin) assessed as inhibition constant,CCN(CC)CCCC(C)Nc1cnc(C(=O)Nc2cc(F)cc3cccnc23)cn1,KI,673.0,nM,6.171984935776023
CHEMBL5400876,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity to alpha2A adrenergic receptor (unknown origin) assessed as inhibition constant,c1ccc(N2CCN(CCCc3nc4ccccc4s3)CC2)nc1,KI,356.0,nM,6.448550002027124
CHEMBL5404195,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]-Rauwolscine from human adrenergic alpha2A receptor assessed as inhibition constant by radioligand displacement assay,O=C(O)c1cc(-c2ccc(C3(O)C[C@H]4CNC[C@@H]4C3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1,KI,5700.0,nM,5.2441251443275085
CHEMBL5403404,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity to human alpha 2A adrenergic receptor assessed as inhibition constant,CCCN1CCN(c2ccc3c(c2)C(N(C)C(=O)OCc2ccccc2)CCC3)CC1,KI,1031.0,nM,5.986741334716483
CHEMBL5400232,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from adrenergic alpha 2A receptor (unknown origin) expressed in HEK293T cells assessed as inhibition constant by competition binding assay,COc1ccccc1N1CCN(CCCNC(=O)Nc2ccccc2-c2ccccc2)CC1,KI,28.0,nM,7.552841968657781
CHEMBL5422870,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from adrenergic alpha 2A receptor (unknown origin) expressed in HEK293T cells assessed as inhibition constant by competition binding assay,COCCOCCOc1ccc(NC(=O)NCCCN2CCN(c3ccccc3OC)CC2)c(-c2ccccc2)c1,KI,410.0,nM,6.3872161432802645
CHEMBL5394229,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from adrenergic alpha 2A receptor (unknown origin) expressed in HEK293T cells assessed as inhibition constant by competition binding assay,COc1ccccc1N1CCN(CCCNC(=O)Nc2ccccc2-c2ccc(-c3ccccc3)cc2)CC1,KI,150.0,nM,6.823908740944319
CHEMBL5425252,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from adrenergic alpha 2A receptor (unknown origin) expressed in HEK293T cells assessed as inhibition constant by competition binding assay,COc1ccccc1N1CCN(CCCNC(=O)NCc2ccccc2-c2ccccc2)CC1,KI,120.0,nM,6.920818753952375
CHEMBL5403204,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from adrenergic alpha 2A receptor (unknown origin) expressed in HEK293T cells assessed as inhibition constant by competition binding assay,COc1ccc(-c2ccccc2)c(CNC(=O)NCCCN2CCN(c3ccccc3OC)CC2)c1,KI,200.0,nM,6.698970004336019
CHEMBL5398630,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]-rauwolscine from human recombinant adrenergic alpha-2A receptor expressed in CHO-K1 cells assessed as inhibition constant incubated for 60 mins by spectrophotometric analysis,O=C(O)/C=C/C(=O)O.[2H]C([2H])(Cc1c[nH]c2ccccc12)N(C)C,KI,1520.0,nM,5.818156412055227
CHEMBL3183055,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]-rauwolscine from human recombinant adrenergic alpha-2A receptor expressed in CHO-K1 cells assessed as inhibition constant incubated for 60 mins by spectrophotometric analysis,CN(C)CCc1c[nH]c2ccccc12.O=C(O)/C=C/C(=O)O,KI,1110.0,nM,5.954677021213342
CHEMBL5398701,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity to alpha2A adrenergic receptor (unknown origin),CC(C)(C)Cc1c(C#Cc2ccc(F)c(F)c2)sc(N)c1C(=O)c1ccc(Cl)cc1,KI,8000.0,nM,5.096910013008056
CHEMBL1256876,CHEMBL1867,Alpha-2a adrenergic receptor,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",Cl.NC[C@@H]1O[C@H](C23CC4CC(CC(C4)C2)C3)Cc2c1ccc(O)c2O,KI,898.46,nM,6.046501253186028
CHEMBL1490875,CHEMBL1867,Alpha-2a adrenergic receptor,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",Br.Br.N=C(N)SCCc1c[nH]cn1,KI,4035.52,nM,5.394100495990234
CHEMBL1489369,CHEMBL1867,Alpha-2a adrenergic receptor,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",Br.CN1CCc2cc(Br)c(O)cc2C(c2ccccc2)C1,KI,2852.66,nM,5.544749987516804
CHEMBL83894,CHEMBL1867,Alpha-2a adrenergic receptor,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",O=S1(=O)c2cccc3cccc(c23)N1CCCN1CCN(c2ccc(F)cc2)CC1,KI,2018.37,nM,5.694999217569398
CHEMBL405355,CHEMBL1867,Alpha-2a adrenergic receptor,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",COC(=O)C1=C(C)NC(C)=C(C(=O)OCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)[C@H]1c1cccc([N+](=O)[O-])c1,KI,2271.43,nM,5.643700642552708
CHEMBL24778,CHEMBL1867,Alpha-2a adrenergic receptor,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",C[C@H](Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1ccccc1OCC(F)(F)F,KI,682.73,nM,6.165751013292747
CHEMBL1215,CHEMBL1867,Alpha-2a adrenergic receptor,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CNC[C@H](O)c1cccc(O)c1,KI,3216.62,nM,5.492600242066908
CHEMBL300555,CHEMBL1867,Alpha-2a adrenergic receptor,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",O=C1NCN(c2ccccc2)C12CCN(CC1COc3ccccc3O1)CC2,KI,616.88,nM,6.209799309883173
CHEMBL445102,CHEMBL1867,Alpha-2a adrenergic receptor,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",OC1(c2ccc(Cl)cc2)CCN(Cc2c[nH]c3ccccc23)CC1,KI,3847.25,nM,5.41484959167791
CHEMBL1256998,CHEMBL1867,Alpha-2a adrenergic receptor,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CCCCN1CCC(COC(=O)c2cc(Cl)c(N)c3c2OCCO3)CC1.Cl,KI,1525.11,nM,5.816698831287587
CHEMBL2106195,CHEMBL1867,Alpha-2a adrenergic receptor,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",Cc1cccc([C@H](C)c2c[nH]cn2)c1C.Cl,KI,50.55,nM,7.29627884007298
CHEMBL281350,CHEMBL1867,Alpha-2a adrenergic receptor,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",Cc1nc(-c2ccc(-c3ccc(C(=O)N4CCc5cc6c(cc54)C4(CCN(C)CC4)CO6)cc3)c(C)c2)no1,KI,2431.08,nM,5.614200749512531
CHEMBL103769,CHEMBL1867,Alpha-2a adrenergic receptor,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",S=C(NCCCc1c[nH]cn1)NCCCN(Cc1ccc(Cl)c(Cl)c1)c1ccc(Br)cn1,KI,177.83,nM,6.749994971513104
CHEMBL59898,CHEMBL1867,Alpha-2a adrenergic receptor,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CCOC(=O)c1c(C)[nH]c2ccc3c(c12)CN1CCc2cc(OC)ccc2C1O3,KI,767.0,nM,6.115204636051019
CHEMBL542139,CHEMBL1867,Alpha-2a adrenergic receptor,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",COc1ccc(NS(=O)(=O)c2sc3ccc(Cl)cc3c2C)cc1N1CCNCC1.Cl,KI,589.99,nM,6.229155349343659
CHEMBL267777,CHEMBL1867,Alpha-2a adrenergic receptor,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",Cc1nc2sccn2c(=O)c1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1,KI,367.45,nM,6.434801748284334
CHEMBL1256844,CHEMBL1867,Alpha-2a adrenergic receptor,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CC1CCN(CC[C@H]2CCCN2S(=O)(=O)c2cccc(O)c2)CC1.Cl,KI,1178.29,nM,5.928747808106066
CHEMBL543113,CHEMBL1867,Alpha-2a adrenergic receptor,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CN1C2CCC1CC(OC(c1ccc(F)cc1)c1ccc(F)cc1)C2.Cl,KI,242.27,nM,6.615700360691616
CHEMBL79834,CHEMBL1867,Alpha-2a adrenergic receptor,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",O=C1NCN(c2ccccc2)C12CCN(CCCOc1ccc(F)cc1)CC2,KI,2284.29,nM,5.641248761457376
CHEMBL1615374,CHEMBL1867,Alpha-2a adrenergic receptor,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",Cl.N#Cc1ccc2[nH]cc(CCCCN3CCN(c4ccc5oc(C(N)=O)cc5c4)CC3)c2c1,KI,2494.41,nM,5.603032161080781
CHEMBL214957,CHEMBL1867,Alpha-2a adrenergic receptor,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",COc1cc(-n2cnc3cc(-c4ccc(Cl)cc4)sc3c2=O)ccc1OCCN1CCCC1,KI,2943.41,nM,5.5311492389756225
CHEMBL589390,CHEMBL1867,Alpha-2a adrenergic receptor,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",Cc1ccc2c(c1)c1c(n2CCc2ccc(C)nc2)CCN(C)C1,KI,728.95,nM,6.137302259705077
CHEMBL1200809,CHEMBL1867,Alpha-2a adrenergic receptor,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CN1CCCC(n2nc(Cc3ccc(Cl)cc3)c3ccccc3c2=O)CC1.Cl,KI,1451.11,nM,5.838299665038285
CHEMBL1766103,CHEMBL1867,Alpha-2a adrenergic receptor,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",Cc1cc(C)cc(-c2cnc3cc(Cl)c(-c4cccc(O)c4)cc3c2OCCCN)c1,KI,852.22,nM,6.069448277941578
CHEMBL1633,CHEMBL1867,Alpha-2a adrenergic receptor,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CN1CCC(=C2c3ccccc3CC(=O)c3sccc32)CC1.O=C(O)/C=C/C(=O)O,KI,1084.43,nM,5.964798476471266
CHEMBL1200492,CHEMBL1867,Alpha-2a adrenergic receptor,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1.Cl,KI,1370.88,nM,5.863000559520276
CHEMBL2024517,CHEMBL1867,Alpha-2a adrenergic receptor,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1.Cl,KI,1742.21,nM,5.758899497810329
CHEMBL1474387,CHEMBL1867,Alpha-2a adrenergic receptor,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",Cc1c(P(=S)(c2ccccc2)c2ccccc2)n2ccccc2[n+]1C/C=C/c1ccccc1.[Br-],KI,568.33,nM,6.245399418580328
CHEMBL2164327,CHEMBL1867,Alpha-2a adrenergic receptor,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",Cc1nn(C)c(C)c1-c1cccc2c1CC[C@H](N(C)C)C2,KI,647.22,nM,6.18894807088368
CHEMBL2105760,CHEMBL1867,Alpha-2a adrenergic receptor,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",O=c1ccc2ccc(OCCCCN3CCN(c4cccc5sccc45)CC3)cc2[nH]1,KI,212.25,nM,6.673152301084009
CHEMBL1200389,CHEMBL1867,Alpha-2a adrenergic receptor,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",Brc1c(NC2=NCCN2)ccc2nccnc12.O=C(O)[C@H](O)[C@@H](O)C(=O)O,KI,197.28,nM,6.704916940748344
CHEMBL1200517,CHEMBL1867,Alpha-2a adrenergic receptor,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21.CS(=O)(=O)O,KI,14.62,nM,7.835052627378158
CHEMBL1257131,CHEMBL1867,Alpha-2a adrenergic receptor,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",COC(=O)[C@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@H]2CC[C@@H]1O.Cl,KI,18.88,nM,7.72399801003795
CHEMBL5087452,CHEMBL1867,Alpha-2a adrenergic receptor,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",NC[C@H](O)c1ccc(O)c(O)c1.O.O=C(O)[C@H](O)[C@@H](O)C(=O)O,KI,5713.47,nM,5.243100048648939
CHEMBL1705,CHEMBL1867,Alpha-2a adrenergic receptor,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",Cl.Clc1cccc(Cl)c1NC1=NCCN1,KI,163.03,nM,6.787732471451062
CHEMBL1256863,CHEMBL1867,Alpha-2a adrenergic receptor,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",NCCc1c[nH]c2ccc(C(N)=O)cc12.O=C(O)/C=C\C(=O)O,KI,2157.0,nM,5.666149854897455
CHEMBL5076314,CHEMBL1867,Alpha-2a adrenergic receptor,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CN1CCN(c2ccc(Nc3c4ccccc4nc4ccccc34)cc2)CC1.Cl.Cl.O,KI,2272.48,nM,5.643499930296473
CHEMBL540612,CHEMBL1867,Alpha-2a adrenergic receptor,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1.Cl,KI,253.34,nM,6.596296233787092
CHEMBL567303,CHEMBL1867,Alpha-2a adrenergic receptor,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",Cc1cc(NC(=O)NCCN2CCC(O)(Cc3ccccc3)CC2)c2ccccc2n1,KI,1018.35,nM,5.992102932269928
CHEMBL5075931,CHEMBL1867,Alpha-2a adrenergic receptor,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",NCCc1cn(S(=O)(=O)c2c(Cl)nc3sccn23)c2ccccc12.O=C(O)C(=O)O,KI,153.21,nM,6.814712887424797
CHEMBL5089005,CHEMBL1867,Alpha-2a adrenergic receptor,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",COc1ccc(NC(=O)c2ccc(-c3ccc(-c4noc(C)n4)cc3C)cc2)cc1OCCN(C)C.Cl,KI,440.05,nM,6.356497974672
CHEMBL15245,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]MK912 from human recombinant adrenergic alpha2A receptor expressed in Sf9 cells,COC(=O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O,EC50,8.5,nM,8.070581074285707
CHEMBL4860528,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis,CCCCCNC(=O)/N=C(\N)NCCCc1sc(N)nc1C,EC50,891.25,nM,6.050000457140078
CHEMBL5207281,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis,CCCCCNC(=O)/N=C(\N)NCCCc1nnc(N)s1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F,EC50,4897.79,nM,5.309999839831226
CHEMBL5206565,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis,N/C(=N\C(=O)NCc1ccccc1)NCCCc1nnc(N)s1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F,EC50,1258.93,nM,5.899998417198648
CHEMBL5201074,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis,C[C@@H](NC(=O)/N=C(\N)NCCCc1ncn[nH]1)c1ccccc1.Cl.Cl,EC50,851.14,nM,6.069998998990925
CHEMBL3335523,CHEMBL1867,Alpha-2a adrenergic receptor,"Displacement of [3H]4-[2-[7-amino-2-(2-furyl)-1,2,4-triazolo[1,5-a][1,3,5]triazin-5-yl-amino]ethylphenol from human adenosine A2a receptor K150A mutant expressed in COS-7 cells assessed as radioligand Kd compound preincubated for 30 mins",CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(NCCc4ccc(CCC(=O)Nc5ccc(OC(C)=O)c([N+](=O)[O-])c5)cc4)nc32)[C@H](O)[C@@H]1O,KD,1.03,nM,8.987162775294827
CHEMBL4860528,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis,CCCCCNC(=O)/N=C(\N)NCCCc1sc(N)nc1C,KD,0.6,nM,9.221848749616356
CHEMBL5207281,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis,CCCCCNC(=O)/N=C(\N)NCCCc1nnc(N)s1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F,KD,0.6,nM,9.221848749616356
CHEMBL5206565,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis,N/C(=N\C(=O)NCc1ccccc1)NCCCc1nnc(N)s1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F,KD,0.6,nM,9.221848749616356
CHEMBL5201074,CHEMBL1867,Alpha-2a adrenergic receptor,Displacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis,C[C@@H](NC(=O)/N=C(\N)NCCCc1ncn[nH]1)c1ccccc1.Cl.Cl,KD,0.6,nM,9.221848749616356
CHEMBL4297337,CHEMBL1867,Alpha-2a adrenergic receptor,Binding affinity to alpha2A receptor (unknown origin),[11CH3]OCc1cccnc1N1CCN(C[C@H]2COc3ccccc3O2)CC1,KD,109.0,nM,6.962573502059376
